| NCT04320953 |
Non-contact Endoscopy at Covid-19 Outbreak |
https://ClinicalTrials.gov/show/NCT04320953 |
| NCT04727424 |
Repurposed Approved Therapies for Outpatient Treatment of Patients With Early-Onset COVID-19 and Mild Symptoms |
https://ClinicalTrials.gov/show/NCT04727424 |
| NCT04727775 |
Antiviral Drugs on the Treatment of SARS-CoV-2 |
https://ClinicalTrials.gov/show/NCT04727775 |
| NCT04726371 |
Best Practices to Prevent COVID-19 Illness in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living Settings |
https://ClinicalTrials.gov/show/NCT04726371 |
| NCT04726111 |
COVID-19 and Pregnancy: Placental and Immunological Impacts |
https://ClinicalTrials.gov/show/NCT04726111 |
| NCT04726098 |
Low or High Dose of Dexamethasone in Patients With Respiratory Failure by COVID-19 |
https://ClinicalTrials.gov/show/NCT04726098 |
| NCT04724629 |
Survival TRial Using CytoKines in COVID-19 (STRUCK Trial) |
https://ClinicalTrials.gov/show/NCT04724629 |
| NCT04724616 |
CARTOON: CoronAviRus (COVID-19) educaTional prOgram fOr childreN |
https://ClinicalTrials.gov/show/NCT04724616 |
| NCT04724538 |
Inhalation Low Dose Radionuclide Therapy in Treatment COVID-19 |
https://ClinicalTrials.gov/show/NCT04724538 |
| NCT04724720 |
Famotidine vs Placebo for the Treatment of Non-Hospitalized Adults With COVID-19 |
https://ClinicalTrials.gov/show/NCT04724720 |
| NCT04724681 |
Continuous Wireless Monitoring of Vital Signs and Automated Alerts of Patient Deterioration in Patients Admitted With COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04724681 |
| NCT04720404 |
Mindful Prevention of Psychopathology in Healthcare Workers During the COVID-19 Crisis (COVID-19 MindPreP) |
https://ClinicalTrials.gov/show/NCT04720404 |
| NCT04721236 |
Early Use of Hyperimmune Plasma in COVID-19 |
https://ClinicalTrials.gov/show/NCT04721236 |
| NCT04723576 |
Mental and Physical Well-Being of Frontline Health Care Workers During Coronavirus Disease 2019 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04723576 |
| NCT04723550 |
COVID-19 Lockdown Related Telemedicine for Type 2 Diabetes |
https://ClinicalTrials.gov/show/NCT04723550 |
| NCT04721457 |
The Efficacy of Pre-procedural Mouth Rinses on COVID-19 Saliva Viral Load |
https://ClinicalTrials.gov/show/NCT04721457 |
| NCT04720794 |
A Study To Evaluate The Performance of the Lucira Health All-In-One COVID-19 Test Kit vs Hologic Panther Fusion |
https://ClinicalTrials.gov/show/NCT04720794 |
| NCT04719234 |
Lung Ultrasonography in COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04719234 |
| NCT04720235 |
A Follow On Community Testing Study To Evaluate The Performance of the Lucira COVID-19 All-In-One Test Kit |
https://ClinicalTrials.gov/show/NCT04720235 |
| NCT04719208 |
[COVID-19] Reduction of Sars-CoV-2 Oral Viral Load With Prophylactic Mouth Rinse |
https://ClinicalTrials.gov/show/NCT04719208 |
| NCT04718506 |
Rehabilitation for Post-COVID-19 Syndrome Through a Supervised Exercise Intervention |
https://ClinicalTrials.gov/show/NCT04718506 |
| NCT04718480 |
Fluvoxamine Administration in Moderate SARS-CoV-2 (COVID-19) Infected Patients |
https://ClinicalTrials.gov/show/NCT04718480 |
| NCT04716998 |
Safety and the Efficacy of MesenCure for the Treatment of Pulmonary Manifestations of COVID-19 |
https://ClinicalTrials.gov/show/NCT04716998 |
| NCT04716985 |
Evaluation of the Daily Intake of 0.5 L of Water Saturated With Molecular Hydrogen for 21 Days in COVID-19 Patients Treated in Ambulatory Care |
https://ClinicalTrials.gov/show/NCT04716985 |
| NCT04716179 |
Prospective Two-arm Study of Fertility in Men With COVID-19 |
https://ClinicalTrials.gov/show/NCT04716179 |
| NCT04716647 |
Feasibility of Ayurveda in Patients With Mild-to-Moderate COVID-19: A Community-Based Participatory Research |
https://ClinicalTrials.gov/show/NCT04716647 |
| NCT04716556 |
TranSfUsion of coNvalescent plAsma for the Early Treatment of pneuMonIa in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04716556 |
| NCT04715997 |
Safety and Immunogenicity Study of GX-19N, a COVID-19 Preventive DNA Vaccine in Healthy Adults |
https://ClinicalTrials.gov/show/NCT04715997 |
| NCT04715360 |
Management of Cytokine Storms in Severe COVID-19 Patients With Autologous Activated Platelet-rich Plasma Therapy |
https://ClinicalTrials.gov/show/NCT04715360 |
| NCT04715295 |
Safety and Efficacy of Doxycycline and Rivaroxaban in COVID-19 |
https://ClinicalTrials.gov/show/NCT04715295 |
| NCT04715607 |
COVID-19: SARS-CoV-2 Detection in Saliva, Oropharyngeal and Nasopharyngeal Specimens |
https://ClinicalTrials.gov/show/NCT04715607 |
| NCT04715243 |
Comparison of High Flow Nasal Cannula (HFNC), Face-mask Non-Invasive Ventilation (NIV) & Helmet NIV in COVID-19 ARDS Patients |
https://ClinicalTrials.gov/show/NCT04715243 |
| NCT04713878 |
Mesenchymal Stem Cells Therapy in Patients With COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04713878 |
| NCT04713111 |
Stress and Recovery in Frontline COVID-19 Workers |
https://ClinicalTrials.gov/show/NCT04713111 |
| NCT04712357 |
Clinical Experimentation With Tenofovir Disoproxyl Fumarate and Emtricitabine for COVID-19 |
https://ClinicalTrials.gov/show/NCT04712357 |
| NCT04712344 |
Assessment of Efficacy and Safety of Therapy With COVID-19 Convalescent Plasma in Subjects With Severe COVID-19 (IPCO) |
https://ClinicalTrials.gov/show/NCT04712344 |
| NCT04711863 |
Fluvoxamine for Adults With Mild to Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04711863 |
| NCT04710394 |
Visual-OLfactory Training in Participants With COVID-19 Resultant Loss of Smell |
https://ClinicalTrials.gov/show/NCT04710394 |
| NCT04712045 |
Rational Use of Personal Protective Equipment During COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04712045 |
| NCT04709172 |
Pilot Study of Cefditoren Pivoxil in COVID-19 Patients With Mild to Moderate Pneumonia |
https://ClinicalTrials.gov/show/NCT04709172 |
| NCT04707833 |
Evaluation of Serological Techniques for Screening for COVID-19 Infection at the University Hospital of Rouen |
https://ClinicalTrials.gov/show/NCT04707833 |
| NCT04708236 |
A Study of ORTD-1 in Patients Hospitalized With COVID-19 Related Pneumonia |
https://ClinicalTrials.gov/show/NCT04708236 |
| NCT04707820 |
Antiviral T Lymphocyte Immunity During Acute COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04707820 |
| NCT04707742 |
Antiseptic Mouth Rinses to Reduce Salivary Viral Load in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04707742 |
| NCT04706416 |
N-Acetyl Glucosamine as Therapeutic Intervention for Coronavirus Disease-19 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04706416 |
| NCT04705831 |
Study to Evaluate the Benefit of RUCONEST in Improving Neurological Symptoms in Post COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04705831 |
| NCT04705753 |
Assessment of the Clinical Effectiveness of a Herbal Extract (Cretan IAMA) in Patients With Viral Respiratory Infections, Including COVID-19, in Primary Healthcare Settings, and Co-assessment of Its Prophylactic Effect in People Cohabiting With These Patients |
https://ClinicalTrials.gov/show/NCT04705753 |
| NCT04703907 |
Auricular Stimulation for Relief of Stress and Anxiety |
https://ClinicalTrials.gov/show/NCT04703907 |
| NCT04703205 |
Study in COvid-19 Patients With iveRmectin (CORVETTE-01) |
https://ClinicalTrials.gov/show/NCT04703205 |
| NCT04701710 |
Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan |
https://ClinicalTrials.gov/show/NCT04701710 |
| NCT04701528 |
Anti-Viral Effects of Voclosporin in COVID-19 Positive Kidney Transplant Recipients |
https://ClinicalTrials.gov/show/NCT04701528 |
| NCT04701502 |
Efficacy and Safety of Viusid and Asbrip in Hospitalized Patients With Mild and Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04701502 |
| NCT04700137 |
Mental Health Among Patients, Providers, and Staff During the COVID-19 Era |
https://ClinicalTrials.gov/show/NCT04700137 |
| NCT04699851 |
Optimization of the Management of COVID-19 Through Tailored Recommendations to the Citizens |
https://ClinicalTrials.gov/show/NCT04699851 |
| NCT04699227 |
Can RIC Prevent Deterioration to Critical Care in Covid19 |
https://ClinicalTrials.gov/show/NCT04699227 |
| NCT04695743 |
Group CST Using Zoom: A Proof of Concept Study |
https://ClinicalTrials.gov/show/NCT04695743 |
| NCT04686760 |
Efficacy of Inhaled Nitroglycerin in Moderate to Critically Ill COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04686760 |
| NCT04685603 |
Dendritic Cell Vaccine to Prevent COVID-19 |
https://ClinicalTrials.gov/show/NCT04685603 |
| NCT04685213 |
Electrical Stimulation for Critically Ill Covid-19 Patients |
https://ClinicalTrials.gov/show/NCT04685213 |
| NCT04682574 |
Role of Mega Dose of Vitamin C in Critical COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04682574 |
| NCT04680858 |
Impact of Digital Communication Assist Tools in Endoscopic Team Communication During COVID-19 |
https://ClinicalTrials.gov/show/NCT04680858 |
| NCT04679415 |
Efficacy and Safety of hzVSF-v13 in Moderate to Severe Patients With COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04679415 |
| NCT04678778 |
Virtual Reality Study - COVID-19 Protocol |
https://ClinicalTrials.gov/show/NCT04678778 |
| NCT04678739 |
Efficacy and Safety of Remdesivir and Tociluzumab for the Management of Severe COVID-19: A Randomized Controlled Trial |
https://ClinicalTrials.gov/show/NCT04678739 |
| NCT04673214 |
Evaluation of Prognostic Modification in COVID-19 Patients in Early Intervention Treatment |
https://ClinicalTrials.gov/show/NCT04673214 |
| NCT04668339 |
A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy Adults |
https://ClinicalTrials.gov/show/NCT04668339 |
| NCT04666558 |
Heal-Me Personalized Online Nutrition and Exercise Routines |
https://ClinicalTrials.gov/show/NCT04666558 |
| NCT04666493 |
Adapting Anxiety Intervention for Youth With Autism for Rapid Response to COVID-19 |
https://ClinicalTrials.gov/show/NCT04666493 |
| NCT04666441 |
COVID-19 Study Assessing the Virologic Efficacy of REGN10933+REGN10987 Across Different Dose Regimens in Adult Outpatients With SARS-CoV-2 Infection |
https://ClinicalTrials.gov/show/NCT04666441 |
| NCT04666116 |
Changes in Viral Load in COVID-19 After Probiotics |
https://ClinicalTrials.gov/show/NCT04666116 |
| NCT04662684 |
Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy: The MICHELLE Trial |
https://ClinicalTrials.gov/show/NCT04662684 |
| NCT04661410 |
Reward Re-Training: A New Treatment to Address Reward Imbalance During the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04661410 |
| NCT04659941 |
Use of BCG Vaccine as a Preventive Measure for COVID-19 in Health Care Workers |
https://ClinicalTrials.gov/show/NCT04659941 |
| NCT04659486 |
Adolescents With COVID-19/MIS-C at HCFMUSP |
https://ClinicalTrials.gov/show/NCT04659486 |
| NCT04657484 |
Comparison of Two Corticosteroid Regimens for Post COVID-19 Diffuse Lung Disease |
https://ClinicalTrials.gov/show/NCT04657484 |
| NCT04657471 |
Hospitalization or Outpatient ManagEment of Patients With SRAS-CoV-2 Infection - Revised HOME-CoV Score Study |
https://ClinicalTrials.gov/show/NCT04657471 |
| NCT04694638 |
Use of Combined Prone Positioning and High-Flow Nasal Cannula, and Non-invasive Positive Pressure Ventilation to Prevent Intubation in COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04694638 |
| NCT04694612 |
Efficacy of Favipiravir in Treatment of Mild & Moderate COVID-19 Infection in Nepal |
https://ClinicalTrials.gov/show/NCT04694612 |
| NCT04693026 |
Efficacy of Ramdicivir and Baricitinib for the Treatment of Severe COVID 19 Patients |
https://ClinicalTrials.gov/show/NCT04693026 |
| NCT04691947 |
Safety and Immunogenicity of Two Different Strengths of the Inactivated COVID-19 Vaccine ERUCOV-VAC |
https://ClinicalTrials.gov/show/NCT04691947 |
| NCT04691908 |
Immunogenicity, Efficacy and Safety of QazCovid-in® COVID-19 Vaccine |
https://ClinicalTrials.gov/show/NCT04691908 |
| NCT04690920 |
Theranostic Implication of Complementary Medicines Against Interleukin Receptors and Gp-130 Proteins |
https://ClinicalTrials.gov/show/NCT04690920 |
| NCT04690413 |
NOWDx Test for the Detection of Antibodies to COVID-19 |
https://ClinicalTrials.gov/show/NCT04690413 |
| NCT04690387 |
Dendritic Cell Vaccine, AV-COVID-19, to Prevent COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04690387 |
| NCT04689399 |
Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Test Compared to RT-PCR Test |
https://ClinicalTrials.gov/show/NCT04689399 |
| NCT04687488 |
Aerosol and Droplet Dispersion During Gastrointestinal Motility Investigations |
https://ClinicalTrials.gov/show/NCT04687488 |
| NCT04685512 |
Effect of Tenofovir/Emtricitabine in Patients Recently Infected With SARS-COV2 (Covid-19) Discharged Home |
https://ClinicalTrials.gov/show/NCT04685512 |
| NCT04685447 |
Effects of Different Dialysis Strategies on Inflammation in COVID-19 Maintenance Hemodialysis Patients |
https://ClinicalTrials.gov/show/NCT04685447 |
| NCT04682873 |
A Clinical Study to Assess the Efficacy and Safety of Amizon® Max in the Treatment of Moderate Covid-19 |
https://ClinicalTrials.gov/show/NCT04682873 |
| NCT04681001 |
Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care Workers |
https://ClinicalTrials.gov/show/NCT04681001 |
| NCT04337996 |
Dynamic Evaluation of COVID-19 Diagnostic Tests |
https://ClinicalTrials.gov/show/NCT04337996 |
| NCT04677270 |
Evaluation of Two Versions of a Digital Problem Solving Tool for the General Public Specific for the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04677270 |
| NCT04676867 |
Effect of Dalcetrapib in Patients With Confirmed Mild to Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04676867 |
| NCT04676971 |
Efficacy and Safety of hzVSF-v13 in Patients With COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04676971 |
| NCT04674189 |
A Study to Evaluate the Safety and Immunogenicity of Vaccine CVnCoV in Healthy Adults in Germany for COVID-19 |
https://ClinicalTrials.gov/show/NCT04674189 |
| NCT04673149 |
GLS-5310 Vaccine for the Prevention of SARS-CoV-2 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04673149 |
| NCT04668469 |
Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04668469 |
| NCT04668209 |
Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04668209 |
| NCT04667247 |
Mushroom-based Product for COVID-19 |
https://ClinicalTrials.gov/show/NCT04667247 |
| NCT04667780 |
Study to Investigate the Treatment Effect of Colchicine in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04667780 |
| NCT04666012 |
Safety and Immunogenicity Study of AdCLD-CoV19: A COVID-19 Preventive Vaccine in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT04666012 |
| NCT04665193 |
An Approach to Screening for COVID-19 at Vancouver Airport |
https://ClinicalTrials.gov/show/NCT04665193 |
| NCT04664010 |
Efficacy and Safety of High-dose Vitamin C Combined With Chinese Medicine Against Coronavirus Pneumonia (COVID-19) |
https://ClinicalTrials.gov/show/NCT04664010 |
| NCT04663594 |
Online Culture for Mental Health in People Aged 16-24 |
https://ClinicalTrials.gov/show/NCT04663594 |
| NCT04662021 |
Aerobic Training Versus Cognitive Behavioral Therapy in Management of Anxiety |
https://ClinicalTrials.gov/show/NCT04662021 |
| NCT04661930 |
Fenofibrate for Patients With COVID-19 Requiring Hospitalization |
https://ClinicalTrials.gov/show/NCT04661930 |
| NCT04661527 |
Sarilumab Treatment In cytoKinE Storm Caused by Infection With COVID-19 |
https://ClinicalTrials.gov/show/NCT04661527 |
| NCT04659772 |
A Study to Evaluate Clazakizumab in Patients With Life-threatening COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04659772 |
| NCT04659746 |
MejoraCare-Paraguay: mHealth Solution for Chronic Patients During the COVID-19 Outbreak in Paraguay |
https://ClinicalTrials.gov/show/NCT04659746 |
| NCT04658979 |
Pulmonary TELE-REHABilitation Program : Feasibility and Safety Study |
https://ClinicalTrials.gov/show/NCT04658979 |
| NCT04658433 |
The Effect of Omega -3 Supplements on the Serum Levels of ACE/ACE2 Ratio as a Potential Key in Cardiovascular Disease and COVID-19; A Randomized Clinical Trial in the Covid-19 Uninfected Jordanian People |
https://ClinicalTrials.gov/show/NCT04658433 |
| NCT04657809 |
Clinical Assessment of Insulin Fast Dissolving Film in Treatment of Post Infection Anosmia |
https://ClinicalTrials.gov/show/NCT04657809 |
| NCT04657497 |
A Study of FOY-305 in Patients With SARS-Cov-2 Infection (COVID-19) |
https://ClinicalTrials.gov/show/NCT04657497 |
| NCT04656691 |
At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04656691 |
| NCT04656626 |
Brief Mindfulness Based Intervention to Improve Psychological Wellbeing |
https://ClinicalTrials.gov/show/NCT04656626 |
| NCT04559035 |
Nasal Irrigation to Reduce COVID-19 Morbidity |
https://ClinicalTrials.gov/show/NCT04559035 |
| NCT04653831 |
Treatment With Pirfenidone for COVID-19 Related Severe ARDS |
https://ClinicalTrials.gov/show/NCT04653831 |
| NCT04652518 |
LYT-100 in Post-acute COVID-19 Respiratory Disease |
https://ClinicalTrials.gov/show/NCT04652518 |
| NCT04654481 |
Study of AffloVest in At-Risk Respiratory Patients During COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04654481 |
| NCT04652674 |
Impact of Postoperative Telemedicine Visit vs In-person Visit on Patient Satisfaction During the COVID-19 Pandemic: A Prospective Randomized Trial |
https://ClinicalTrials.gov/show/NCT04652674 |
| NCT04652648 |
Rapid Development and Implementation of a Remote ECG-monitored Prospective Randomized Clinical Trial During a Pandemic: Hydroxychloroquine Prophylaxis in COVID-19 Household Contacts |
https://ClinicalTrials.gov/show/NCT04652648 |
| NCT04652102 |
A Study to Determine the Safety and Efficacy of SARS-CoV-2 mRNA Vaccine CVnCoV in Adults for COVID-19 |
https://ClinicalTrials.gov/show/NCT04652102 |
| NCT04649736 |
Home-based Respiratory Physiotherapy and Telephone-Based Psychological Support in Severe COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04649736 |
| NCT04649515 |
Efficacy and Safety of TY027, a Treatment for COVID-19, in Humans |
https://ClinicalTrials.gov/show/NCT04649515 |
| NCT04648800 |
Clinical Trial Evaluating the Effect of BCG Vaccination on the Incidence and Severity of SARS-CoV-2 Infections Among Healthcare Professionals During the COVID-19 Pandemic in Poland |
https://ClinicalTrials.gov/show/NCT04648800 |
| NCT04646655 |
Enoxaparin at Prophylactic or Therapeutic Doses in COVID-19 |
https://ClinicalTrials.gov/show/NCT04646655 |
| NCT04647604 |
Resolving Inflammatory Storm in COVID-19 Patients by Omega-3 Polyunsaturated Fatty Acids - |
https://ClinicalTrials.gov/show/NCT04647604 |
| NCT04647695 |
IFN-beta 1b and Remdesivir for COVID19 |
https://ClinicalTrials.gov/show/NCT04647695 |
| NCT04646109 |
Ivermectin for Severe COVID-19 Management |
https://ClinicalTrials.gov/show/NCT04646109 |
| NCT04646044 |
A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19 |
https://ClinicalTrials.gov/show/NCT04646044 |
| NCT04645407 |
Effects of Fuzheng Huayu Tablets on COVID-19 |
https://ClinicalTrials.gov/show/NCT04645407 |
| NCT04644705 |
Safety and Pharmacokinetics of a Novel Niclosamide Solution in Combination With Camostat |
https://ClinicalTrials.gov/show/NCT04644705 |
| NCT04644172 |
Improving Thinking in Everyday Life After Covid-19 |
https://ClinicalTrials.gov/show/NCT04644172 |
| NCT04643691 |
Losartan and Spironolactone Treatment for ICU Patients With COVID-19 Suffering From ARDS |
https://ClinicalTrials.gov/show/NCT04643691 |
| NCT04643964 |
Brief Video Interventions for Depression |
https://ClinicalTrials.gov/show/NCT04643964 |
| NCT04643561 |
Using Travelan to Boost Immune Response in Vitro to COVID-19 |
https://ClinicalTrials.gov/show/NCT04643561 |
| NCT04642638 |
Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Healthy Seronegative Adults at High Risk of SARS-CoV-2 Exposure |
https://ClinicalTrials.gov/show/NCT04642638 |
| NCT04642326 |
Study Investigating the Effects of UVC Beam and Laser Beam Therapy According to Standard Therapy in Patients With Covid-19 Diagnosis |
https://ClinicalTrials.gov/show/NCT04642326 |
| NCT04641858 |
BCG to Reduce Absenteeism Among Health Care Workers During the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04641858 |
| NCT04641481 |
An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers |
https://ClinicalTrials.gov/show/NCT04641481 |
| NCT04642040 |
Effectiveness of Pulmonary Rehabilitation Program in Patients With SARS-CoV-2 Pneumonia |
https://ClinicalTrials.gov/show/NCT04642040 |
| NCT04640038 |
Contrast Enhanced Ultrasound in COVID-19 |
https://ClinicalTrials.gov/show/NCT04640038 |
| NCT04640402 |
A Phase â…¡ Clinical Trial of Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells) |
https://ClinicalTrials.gov/show/NCT04640402 |
| NCT04639466 |
A Synthetic MVA-based SARS-CoV-2 Vaccine, COH04S1, for the Prevention of COVID-19 |
https://ClinicalTrials.gov/show/NCT04639466 |
| NCT04639349 |
Effect of Home Exercise Activity on Cortisol and Depression in COPD During the Pandemic COVID |
https://ClinicalTrials.gov/show/NCT04639349 |
| NCT04638842 |
Online Multi-component Psychological Intervention for Prevention of Grief Disorder Due to COVID-19 |
https://ClinicalTrials.gov/show/NCT04638842 |
| NCT04637906 |
Short and Long-term Effects of Adding Oral L-arginine to Standard Therapy in Patients With COVID-19 (SARS-CoV-2) |
https://ClinicalTrials.gov/show/NCT04637906 |
| NCT04638673 |
NeuroCovid Rehab and Recovery Related to COVID-19 Diagnosis |
https://ClinicalTrials.gov/show/NCT04638673 |
| NCT04637867 |
COVID-19 - Multicentre Study on Nosocomial Transmission of SARS-CoV-2 Virus: an Ancillary Study (NOSO-COR IMMUNO) |
https://ClinicalTrials.gov/show/NCT04637867 |
| NCT04637828 |
A Study to Compare the Efficacy of GNS561 Versus Standard of Care in Patients With SARS-CoV-2 (COVID-19) Infection |
https://ClinicalTrials.gov/show/NCT04637828 |
| NCT04637477 |
Virtual Enhanced Lifestyle for Metabolic Syndrome (ELM) Proof-of-Concept Study |
https://ClinicalTrials.gov/show/NCT04637477 |
| NCT04635943 |
Randomized Phase IIA Clinical Trial to Evaluate the Efficacy of Ivermectin to Obtain Negative PCR Results in Patients With Early Phase COVID-19 |
https://ClinicalTrials.gov/show/NCT04635943 |
| NCT04636086 |
Effect of Vitamin D on Hospitalized Adults With COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04636086 |
| NCT04636034 |
The Effect of Ganglion Sphenopalatine Block Versus Placebo on Persistent Headache Following COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04636034 |
| NCT04635618 |
Psychotherapy Strategies for the Treatment of Professionals and Students From Essential Services With High Levels of Emotional Distress in the Context of COVID-19 |
https://ClinicalTrials.gov/show/NCT04635618 |
| NCT04636333 |
Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell) |
https://ClinicalTrials.gov/show/NCT04636333 |
| NCT04636320 |
Prevalence of Myocardial Scars on CMR After COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04636320 |
| NCT04635241 |
Inhaled Heparin for Hospitalised COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04635241 |
| NCT04634422 |
Plasma Exchange (PLEX) and Convalescent Plasma (CCP) in COVID-19 Patients With Multiorgan Failure |
https://ClinicalTrials.gov/show/NCT04634422 |
| NCT04634903 |
Testing Scalable, Single-Session Interventions for Adolescent Depression in the Context of COVID-19 |
https://ClinicalTrials.gov/show/NCT04634903 |
| NCT04634799 |
Study To antagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04634799 |
| NCT04634318 |
Organization of Pulmonary Rehabilitation of Post-COVID-19 Patient With Sequelae (REHABCOVID) |
https://ClinicalTrials.gov/show/NCT04634318 |
| NCT04632719 |
The MentalPlus® for Assessment and Rehabilitation of Cognitive Function After Remission of the Symptoms of COVID-19 |
https://ClinicalTrials.gov/show/NCT04632719 |
| NCT04632706 |
Exploratory Ph I Trial of the Active IMP in Healthy Volunteers in Relation to COVID-19 |
https://ClinicalTrials.gov/show/NCT04632706 |
| NCT04633772 |
Use of Angiotensin-(1-7) in COVID-19 |
https://ClinicalTrials.gov/show/NCT04633772 |
| NCT04632602 |
Awake Prone Position to Reduce Ventilation Inhomogeneity in COVID-19 Acute Respiratory Failure |
https://ClinicalTrials.gov/show/NCT04632602 |
| NCT04632537 |
BCG Vaccination to Prevent COVID-19 |
https://ClinicalTrials.gov/show/NCT04632537 |
| NCT04632368 |
Targeting the Health Care Provider (HCP) Burnout Crisis During the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04632368 |
| NCT04632082 |
Telepsychoeducation for the Prevention of Emotional Distress in Professionals and Students From Essential Services in the Context of COVID-19 |
https://ClinicalTrials.gov/show/NCT04632082 |
| NCT04631380 |
Prayer in Commbate to Corona Virus - Covid -19 |
https://ClinicalTrials.gov/show/NCT04631380 |
| NCT04630054 |
Face Masks to Reduce COVID-19 in Bangladesh |
https://ClinicalTrials.gov/show/NCT04630054 |
| NCT04629989 |
Comparison of the Surgical Facemask With the Double-trunk Mask on Oxygenation in COVID-19 |
https://ClinicalTrials.gov/show/NCT04629989 |
| NCT04629157 |
The LAVA (Lateral Flow Antigen Validation and Applicability) Study for COVID-19 |
https://ClinicalTrials.gov/show/NCT04629157 |
| NCT04629105 |
Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Longeveron Mesenchymal Stem Cells (LMSCs) (RECOVER) |
https://ClinicalTrials.gov/show/NCT04629105 |
| NCT04627467 |
Prevention With Chloroquine in Health Personnel Exposed to Infection With Coronavirus Disease 2019 (COVID-19) (TS-COVID) |
https://ClinicalTrials.gov/show/NCT04627467 |
| NCT04625114 |
The Potential of Oral Camostat in Early COVID-19 Disease in an Ambulatory Setting to Reduce Viral Load and Disease Burden |
https://ClinicalTrials.gov/show/NCT04625114 |
| NCT04625985 |
Metformin Glycinate, Treatment of Patients With COVID-19 and Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2. |
https://ClinicalTrials.gov/show/NCT04625985 |
| NCT04625972 |
Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults |
https://ClinicalTrials.gov/show/NCT04625972 |
| NCT04622891 |
Clarithromycin Versus Azithromycin in Treatment of Mild COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04622891 |
| NCT04623255 |
Randomised Study of Plasma Exchange in Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04623255 |
| NCT04622865 |
Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04622865 |
| NCT04622826 |
plasmApuane CoV-2 : Efficacy and Safety of Immune Covid-19 Plasma in Covid-19 Pneumonia in Non ITU Patients |
https://ClinicalTrials.gov/show/NCT04622826 |
| NCT04621903 |
A Pilot Study on Efficacy and Safety of Ayurveda Combination in Patients With Mild-to-Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04621903 |
| NCT04621149 |
An Outpatient Study Investigating Non-prescription Treatments for COVID-19 |
https://ClinicalTrials.gov/show/NCT04621149 |
| NCT04621123 |
Plasma for Early Treatment in Non-hospitalised Mild or Moderate COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04621123 |
| NCT04621071 |
Efficacy of Probiotics in Reducing Duration and Symptoms of COVID-19 |
https://ClinicalTrials.gov/show/NCT04621071 |
| NCT04621058 |
Efficacy of Vitamin D Treatment in Mortality Reduction Due to COVID-19. |
https://ClinicalTrials.gov/show/NCT04621058 |
| NCT04620798 |
Longitudinal COVID-19 Antibody Testing in Indiana University Undergraduate Students |
https://ClinicalTrials.gov/show/NCT04620798 |
| NCT04619706 |
Ultramicronized Palmitoylethanolamide (PEA) Treatment in Hospitalized Participants With COVID-19 |
https://ClinicalTrials.gov/show/NCT04619706 |
| NCT04619680 |
The Study Will Evaluate the Use of Nintedanib in Slowing Lung Fibrosis in Patients With Pulmonary Infiltrates Related to COVID-19 |
https://ClinicalTrials.gov/show/NCT04619680 |
| NCT04619290 |
Outpatient Treatment With CoVid-19 With Prexablu |
https://ClinicalTrials.gov/show/NCT04619290 |
| NCT04619628 |
Safety and Immunogenicity of COVI-VAC, a Live Attenuated Vaccine Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04619628 |
| NCT04618042 |
FX06 to Rescue Acute Respiratory Distress Syndrome During Covid-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04618042 |
| NCT04617483 |
Study of the Commercial Scale SARS-CoV-2 Vaccine Against the Pilot Scale Among Adults, and Bridging Study of the Immunogenicity in Elderly Against That in Adults |
https://ClinicalTrials.gov/show/NCT04617483 |
| NCT04616846 |
Thromboembolic Risk Screening in Patients With Cancer and COVID-19 |
https://ClinicalTrials.gov/show/NCT04616846 |
| NCT04615741 |
Finding Wellness in the Pandemic |
https://ClinicalTrials.gov/show/NCT04615741 |
| NCT04615975 |
Ketogenic Diet as Protective Factor During COVID-19 |
https://ClinicalTrials.gov/show/NCT04615975 |
| NCT04615936 |
Nasal Photodisinfection COVID Proof of Concept Study |
https://ClinicalTrials.gov/show/NCT04615936 |
| NCT04615416 |
Emotion Regulation Training Via Telehealth During the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04615416 |
| NCT04613739 |
Asthma in Families Facing Out-of-pocket Requirements Due to COVID-19 |
https://ClinicalTrials.gov/show/NCT04613739 |
| NCT04614883 |
Analysis of Volatile Organic Compounds in Exhaled Air and in Sweat in the Context of Suspicion of COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04614883 |
| NCT04614025 |
Open-label Multicenter Study to Evaluate the Efficacy of PLX-PAD for the Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04614025 |
| NCT04614012 |
Hyperimmune Plasma for Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04614012 |
| NCT04615052 |
Home-based Exercise in COVID-19 Survivors |
https://ClinicalTrials.gov/show/NCT04615052 |
| NCT04613050 |
Effect of Respiratory Versus Aerobic Training on Respiratory and Immunity Efficiency in Recovered COVID- 19 Patients |
https://ClinicalTrials.gov/show/NCT04613050 |
| NCT04613310 |
PCR and Rapid Diagnostic Test on Saliva and Nasopharyngeal Swabs for the Detection of SARS-CoV-2 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04613310 |
| NCT04613297 |
HLA-G Immuno-Inhibitor Checkpoint Study in Patients With COVID-19 Infection: Molecular and Cellular Assessment |
https://ClinicalTrials.gov/show/NCT04613297 |
| NCT04612972 |
Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Adult Population In Peru |
https://ClinicalTrials.gov/show/NCT04612972 |
| NCT04475575 |
Can the Electronic Nose Smell COVID-19 Antibodies? |
https://ClinicalTrials.gov/show/NCT04475575 |
| NCT04611256 |
Mesenchymal Stem Cells in Patients Diagnosed With COVID-19 |
https://ClinicalTrials.gov/show/NCT04611256 |
| NCT04610541 |
REMdesivir-HU Clinical Study and Severe Covid-19 Patients |
https://ClinicalTrials.gov/show/NCT04610541 |
| NCT04610502 |
Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04610502 |
| NCT04609969 |
Diagnostic Performance Evaluation of a Novel SARS-CoV-2 (COVID-19) Antigen Detection Test |
https://ClinicalTrials.gov/show/NCT04609969 |
| NCT04610801 |
Evaluation of the Efficacy of Xylitol Nasal Spray Against SARS-CoV-2 |
https://ClinicalTrials.gov/show/NCT04610801 |
| NCT04610567 |
Treatment of Patients With Mild Coronavirus-19 (COVID-19) Disease With Methotrexate Associated to LDL Like Nanoparticles (Nano-COVID19) |
https://ClinicalTrials.gov/show/NCT04610567 |
| NCT04609865 |
Impact of Intravenous Lidocaine on Clinical Outcomes of Patients With ARDS During COVID-19 Pandemia |
https://ClinicalTrials.gov/show/NCT04609865 |
| NCT04609423 |
Cod Liver Oil for Covid-19 Prevention Study |
https://ClinicalTrials.gov/show/NCT04609423 |
| NCT04609722 |
Effect of Solution-Focused Support Program on Anxiety Levels of Parents During the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04609722 |
| NCT04609371 |
PanDirect: Self-care Tools and Telephone Coaching for Depression and Anxiety During Pandemics |
https://ClinicalTrials.gov/show/NCT04609371 |
| NCT04608266 |
CAMOVID : Evaluation of Efficacy and Safety of Camostat Mesylate for the Treatment of SARS-CoV-2 Infection - COVID-19 in Ambulatory Adult Patients |
https://ClinicalTrials.gov/show/NCT04608266 |
| NCT04608201 |
Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Hospitalized Patients |
https://ClinicalTrials.gov/show/NCT04608201 |
| NCT04608305 |
Evaluate the Safety, Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine |
https://ClinicalTrials.gov/show/NCT04608305 |
| NCT04608097 |
Understanding Reactions to Emotional Material in the Media During COVID-19 |
https://ClinicalTrials.gov/show/NCT04608097 |
| NCT04606563 |
Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan on Outcomes of Coronavirus Infection? |
https://ClinicalTrials.gov/show/NCT04606563 |
| NCT04607928 |
Pirfenidone Compared to Placebo in Post-COVID19 Pulmonary Fibrosis COVID-19 |
https://ClinicalTrials.gov/show/NCT04607928 |
| NCT04606784 |
Study of Nebulized Ampion for the Treatment of Adult COVID-19 Patients With Respiratory Distress |
https://ClinicalTrials.gov/show/NCT04606784 |
| NCT04605887 |
Angiotensin 1-7 as a Therapy in the Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04605887 |
| NCT04475562 |
Can the Electronic Nose Smell COVID-19? |
https://ClinicalTrials.gov/show/NCT04475562 |
| NCT04605588 |
A Triple Combination Antiviral Coronavirus Therapy (TriACT) for COVID-19 |
https://ClinicalTrials.gov/show/NCT04605588 |
| NCT04604977 |
Feasibility and Effectiveness of Home-behavioral Program for Adolescents With Migraine |
https://ClinicalTrials.gov/show/NCT04604977 |
| NCT04604327 |
Comparison of Two Different Doses of Bemiparin in COVID-19 |
https://ClinicalTrials.gov/show/NCT04604327 |
| NCT04603794 |
Efficacy of Mouthwash in Reducing Salivary Carriage of COVID-19 |
https://ClinicalTrials.gov/show/NCT04603794 |
| NCT04603781 |
CBD Oil for Reducing Emotional Impact of COVID-19 |
https://ClinicalTrials.gov/show/NCT04603781 |
| NCT04603729 |
Comparison of Efficacy of Dexamethasone and Methylprednisolone in Moderate to Severe Covid 19 Disease |
https://ClinicalTrials.gov/show/NCT04603729 |
| NCT04603963 |
Inspiratory Muscle Training in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04603963 |
| NCT04602871 |
Early Detection of COVID-19 Using Breath Analysis - Feasibility Study |
https://ClinicalTrials.gov/show/NCT04602871 |
| NCT04602832 |
Enduring Happiness and Continued Self-Enhancement (ENHANCE) for COVID-19 |
https://ClinicalTrials.gov/show/NCT04602832 |
| NCT04602507 |
Ivermectin in Adults With Severe COVID-19. |
https://ClinicalTrials.gov/show/NCT04602507 |
| NCT04602442 |
Safety and Efficiency of Method of Exosome Inhalation in COVID-19 Associated Pneumonia |
https://ClinicalTrials.gov/show/NCT04602442 |
| NCT04602000 |
To Evaluate the Safety and Efficacy of CT-P59 in Patients With Mild to Moderate Syptoms of Severe Acute Respiratory Syndrome COVID-19 |
https://ClinicalTrials.gov/show/NCT04602000 |
| NCT04602286 |
How Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Pain Sample) |
https://ClinicalTrials.gov/show/NCT04602286 |
| NCT04602312 |
How Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Healthy Sample) |
https://ClinicalTrials.gov/show/NCT04602312 |
| NCT04601077 |
The Evaluation of Nitric Oxide Generating Lozenges on Outcome in Newly Diagnosed COVID-19 Patient of African Americans |
https://ClinicalTrials.gov/show/NCT04601077 |
| NCT04600999 |
Clinical Trial of Favipiravir Treatment of Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04600999 |
| NCT04600895 |
The Prevent Severe COVID-19 (PRESECO) Study |
https://ClinicalTrials.gov/show/NCT04600895 |
| NCT04600440 |
Convalescent Plasma in the Treatment of Covid-19 |
https://ClinicalTrials.gov/show/NCT04600440 |
| NCT04599959 |
COVID-19 Tests: Nasopharyngeal Swab vs Saliva Collected With Salivette® Cortisol for Viral RNA Sampling for RT-qPCR |
https://ClinicalTrials.gov/show/NCT04599959 |
| NCT04598594 |
Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Intensive Care Unit Patients |
https://ClinicalTrials.gov/show/NCT04598594 |
| NCT04598581 |
Low Dose Radiation Therapy for Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2), COVID-19 |
https://ClinicalTrials.gov/show/NCT04598581 |
| NCT04596839 |
Antiviral Activity and Safety of Remdesivir in Bangladeshi Patients With Severe Coronavirus Disease (COVID-19) |
https://ClinicalTrials.gov/show/NCT04596839 |
| NCT04597047 |
Research & Evaluation of LumiraDx SARS-CoV-2 (COVID-19) Point of Care Ab Test |
https://ClinicalTrials.gov/show/NCT04597047 |
| NCT04597034 |
Efficacy and Safety of a Highly Selective Semipermeable Membrane (AN-69 Oxiris) vs (Standard AN-69) in COVID-19 |
https://ClinicalTrials.gov/show/NCT04597034 |
| NCT04596085 |
Study to Evaluate Efficacy and Safety of “VIRACIDE” IN THE MANAGEMENT OF CORONA VIRUS DISEASE 2019 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04596085 |
| NCT04594668 |
Senicapoc in COVID-19 Patients With Severe Respiratory Insufficiency |
https://ClinicalTrials.gov/show/NCT04594668 |
| NCT04594343 |
Clinical Study to Evaluate the Effects of Disulfiram in Patients With Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04594343 |
| NCT04594330 |
Virgin Coconut Oil (VCO) as a Potential Adjuvant Therapy in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04594330 |
| NCT04592354 |
Anhydrous Enol-Oxaloacetate (AEO) on Improving Fatigue in Post-COVID-19 Survivors |
https://ClinicalTrials.gov/show/NCT04592354 |
| NCT04593641 |
This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19) |
https://ClinicalTrials.gov/show/NCT04593641 |
| NCT04593069 |
The COGCOV Study in ICU Patients |
https://ClinicalTrials.gov/show/NCT04593069 |
| NCT04592549 |
This is a Phase 1 Clinical Trial to Evaluate the Safety, Pharmacokinetics, and Immunogenicity of ADM03820, a Monoclonal Antibody Cocktail Being Tested for the Treatment and Prevention of COVID-19 |
https://ClinicalTrials.gov/show/NCT04592549 |
| NCT04591158 |
COVID-19 and Lung Ultrasound Utility |
https://ClinicalTrials.gov/show/NCT04591158 |
| NCT04591600 |
Effectiveness of Ivermectin and Doxycycline on COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04591600 |
| NCT04590053 |
Allocetra-OTS in COVID-19, Phase II |
https://ClinicalTrials.gov/show/NCT04590053 |
| NCT04589949 |
Early Convalescent Plasma Therapy for High-risk Patients With COVID-19 in Primary Care (the CoV-Early Study) |
https://ClinicalTrials.gov/show/NCT04589949 |
| NCT04589936 |
Prone Position to Improve Oxygenation in COVID-19 Patients Outside Critical Care |
https://ClinicalTrials.gov/show/NCT04589936 |
| NCT04589117 |
Expressive Writing for COVID-19 Resilience for Parents |
https://ClinicalTrials.gov/show/NCT04589117 |
| NCT04589104 |
Expressive Writing for COVID-19 Resilience |
https://ClinicalTrials.gov/show/NCT04589104 |
| NCT04588480 |
Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Japanese Adults |
https://ClinicalTrials.gov/show/NCT04588480 |
| NCT04587921 |
Feasibility and Impact of Remote Oximetry in Patients Hospitalized With Covid-19 |
https://ClinicalTrials.gov/show/NCT04587921 |
| NCT04587414 |
eHealth Intervention on Physical Activity for Type 2 Diabetics - Frustrated by COVID-19 |
https://ClinicalTrials.gov/show/NCT04587414 |
| NCT04587219 |
The Study of “Gam-COVID-Vac” Vaccine Against COVID-19 With the Participation of Volunteers of 60 y.o and Older |
https://ClinicalTrials.gov/show/NCT04587219 |
| NCT04584684 |
Mouth Rinses for Inactivation of COVID-19 |
https://ClinicalTrials.gov/show/NCT04584684 |
| NCT04584593 |
Pilot Study to Detect SARS-CoV-2 Virus in Sperm |
https://ClinicalTrials.gov/show/NCT04584593 |
| NCT04584580 |
D-dimer Adjusted Versus Therapeutic Dose Low-molecular-weight Heparin in Patients With COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04584580 |
| NCT04584541 |
SarS-Cov-2 Viral Infection (COVID-19) in Patients With Chronic Inflammatory Rheumatism |
https://ClinicalTrials.gov/show/NCT04584541 |
| NCT04583995 |
A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom |
https://ClinicalTrials.gov/show/NCT04583995 |
| NCT04583449 |
Mental Imagery to Increase Face Covering Use in UK-based Public Places During the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04583449 |
| NCT04429724 |
Health Professional Exposure Assessment to Covid-19 |
https://ClinicalTrials.gov/show/NCT04429724 |
| NCT04583189 |
Evaluation of the Performance of the Covid-19 Ag BSS Rapid Antigenic Test in Symptomatic Children in a Pediatric Emergency Department |
https://ClinicalTrials.gov/show/NCT04583189 |
| NCT04582318 |
A Phase 1/2 Study to Assess the Safety, Tolerability and Pharmacokinetics of NGM621 in Healthy Subjects, and to Assess the Safety, PK and Efficacy in Subjects With Moderate to Severe ARDS Caused by COVID-19 |
https://ClinicalTrials.gov/show/NCT04582318 |
| NCT04582214 |
Oscillation and Lung Expansion Therapy in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04582214 |
| NCT04581954 |
Inflammatory Signal Inhibitors for COVID-19 (MATIS) |
https://ClinicalTrials.gov/show/NCT04581954 |
| NCT04581915 |
PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04581915 |
| NCT04581811 |
Prolonged Prone Positioning for COVID-19-induced Acute Respiratory Distress Syndrome (ARDS) |
https://ClinicalTrials.gov/show/NCT04581811 |
| NCT04581746 |
Impact of the Epidemic of COVID-19 Infection Among People Living With HIV (SARS-CoV-2) |
https://ClinicalTrials.gov/show/NCT04581746 |
| NCT04581291 |
The Effect of Aerobic Exercise on Immune Biomarkers and Symptoms Severity and Progression in Patients With COVID-19: A Pilot Randomized Control Trial |
https://ClinicalTrials.gov/show/NCT04581291 |
| NCT04581161 |
Proportional Open Ventilation (POV) Device and Its Efficacy in Managing Acute Respiratory Failure in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04581161 |
| NCT04581031 |
COntinuous Signs Monitoring In Covid-19 Patients |
https://ClinicalTrials.gov/show/NCT04581031 |
| NCT04581018 |
An Evaluation of a Synbiotic Formula for Patients With COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04581018 |
| NCT04579640 |
Trial of Vitamin D to Reduce Risk and Severity of COVID-19 and Other Acute Respiratory Infections |
https://ClinicalTrials.gov/show/NCT04579640 |
| NCT04579549 |
Repeat Testing for SARS-CoV-2 |
https://ClinicalTrials.gov/show/NCT04579549 |
| NCT04577534 |
COVID-19: Salvage TOcilizumab as a Rescue Measure |
https://ClinicalTrials.gov/show/NCT04577534 |
| NCT04578210 |
Safety Infusion of NatuRal KillEr celLs or MEmory T Cells as Adoptive Therapy in COVID-19 pnEumonia or Lymphopenia |
https://ClinicalTrials.gov/show/NCT04578210 |
| NCT04577235 |
Correlation Between Thoracic Ultrasound and Thorax Computed Tomography Scores. |
https://ClinicalTrials.gov/show/NCT04577235 |
| NCT04575064 |
An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY |
https://ClinicalTrials.gov/show/NCT04575064 |
| NCT04576312 |
Study to Assess the Safety of Ascending Doses of UNI911 INHALATION in Healthy Volunteers in Preparation for Evaluation in Adults With COVID-19 |
https://ClinicalTrials.gov/show/NCT04576312 |
| NCT04576728 |
Efficacy and Safety of Trimodulin in Subjects With Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04576728 |
| NCT04575610 |
IRAK4 Inhibition in Treatment of COVID-19 With ARDS (I-RAMIC) |
https://ClinicalTrials.gov/show/NCT04575610 |
| NCT04425720 |
Use of Remote Monitoring for COVID-19 Patient |
https://ClinicalTrials.gov/show/NCT04425720 |
| NCT04574219 |
Virtual Parental Presence on Induction |
https://ClinicalTrials.gov/show/NCT04574219 |
| NCT04573270 |
Mesenchymal Stem Cells for the Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04573270 |
| NCT04573361 |
Access to Chiropractic Care During the COVID-19 Healthcare Emergency in Spain |
https://ClinicalTrials.gov/show/NCT04573361 |
| NCT04573322 |
Safety and Efficacy of Trans Sodium Crocetinate (TSC) in SARS-CoV-2 (COVID-19) Infected Subjects |
https://ClinicalTrials.gov/show/NCT04573322 |
| NCT04573153 |
Metabolic Cofactor Supplementation and Hydroxychloroquine Combination in Covid-19 Patients |
https://ClinicalTrials.gov/show/NCT04573153 |
| NCT04572412 |
Low Dose Lung Radiotherapy to Treat COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04572412 |
| NCT04572399 |
UVA Light Device to Treat COVID-19 |
https://ClinicalTrials.gov/show/NCT04572399 |
| NCT04570488 |
Predicting Favorable Outcomes in Hospitalized Covid-19 Patients |
https://ClinicalTrials.gov/show/NCT04570488 |
| NCT04570397 |
Ravulizumab and COVID-19 |
https://ClinicalTrials.gov/show/NCT04570397 |
| NCT04570384 |
Intravenous L-Citrulline to Delay and Potentially Prevent the Need for Invasive Mechanical Ventilation for Acute Hypoxemic Respiratory Failure in Patients With COVID-19 (SARS-CoV-2) Illness |
https://ClinicalTrials.gov/show/NCT04570384 |
| NCT04570462 |
Mild Hypothermia for COVID-19 ARDS |
https://ClinicalTrials.gov/show/NCT04570462 |
| NCT04570254 |
Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04570254 |
| NCT04569877 |
GM-CSF Inhalation to Prevent ARDS in COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04569877 |
| NCT04569825 |
Effect of Nasal Steroid in the Treatment of Anosmia Due to COVID-19 Disease |
https://ClinicalTrials.gov/show/NCT04569825 |
| NCT04570202 |
Health cAre woRkers exposeD to COVID-19 |
https://ClinicalTrials.gov/show/NCT04570202 |
| NCT04569266 |
Effectiveness of an Exercise Re-training Program on Dyspnea in Patients After Acute Respiratory Distress Syndrome Secondary to Severe COVID-19 Pneumonia in Post-ICU |
https://ClinicalTrials.gov/show/NCT04569266 |
| NCT04569383 |
Safety, Tolerability and Immunogenicity of the Candidate Vaccine MVA-SARS-2-S Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04569383 |
| NCT04569188 |
Convalescent Plasma in COVID-19 Elderly Patients |
https://ClinicalTrials.gov/show/NCT04569188 |
| NCT04568876 |
Micronized and Ultramicronized Palmitoylethanolamide in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04568876 |
| NCT04568863 |
Efficacy of Intravenous Melatonin on Mortality in Adult Patients Admitted to the Intensive Care Unit With COVID-19 |
https://ClinicalTrials.gov/show/NCT04568863 |
| NCT04568356 |
A Clinical Evaluation of COVID-19 Rapid Point of Care Antigen Tests |
https://ClinicalTrials.gov/show/NCT04568356 |
| NCT04568564 |
Telerehabilitation in Lung Surgery Patients |
https://ClinicalTrials.gov/show/NCT04568564 |
| NCT04568525 |
Passive Microwave Radiometry (MWR) and AI for COVID-19 Complications Early Diagnostics of Lungs |
https://ClinicalTrials.gov/show/NCT04568525 |
| NCT04568031 |
Study of AZD1222 for the Prevention of COVID-19 in Japan |
https://ClinicalTrials.gov/show/NCT04568031 |
| NCT04567953 |
COVID-19 Tests With Saliva Specimens |
https://ClinicalTrials.gov/show/NCT04567953 |
| NCT04567810 |
Safety, Tolerability, and Pharmacokinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Chicken Egg Antibody (IgY) (COVID-19) |
https://ClinicalTrials.gov/show/NCT04567810 |
| NCT04567173 |
Convalescent Plasma as Adjunctive Therapy for Hospitalized Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04567173 |
| NCT04565665 |
Cord Blood-Derived Mesenchymal Stem Cells for the Treatment of COVID-19 Related Acute Respiratory Distress Syndrome |
https://ClinicalTrials.gov/show/NCT04565665 |
| NCT04565509 |
Supporting the Health and Well-being of Children With Intellectual and Developmental Disability During COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04565509 |
| NCT04565197 |
Convalescent Plasma Therapy for COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04565197 |
| NCT04563702 |
Safety and Immunogenicity Trial of an Oral SARS-CoV-2 Vaccine (VXA-CoV2-1) for Prevention of COVID-19 in Healthy Adults |
https://ClinicalTrials.gov/show/NCT04563702 |
| NCT04563689 |
Pilot Study to Evaluate Effect of CHX0.12/CPC 0.05 of SARS-CoV-2 Viral Load in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04563689 |
| NCT04563676 |
Physiopathology and Sequelae of COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04563676 |
| NCT04563650 |
COVID-19 Serology and Immunosenescence |
https://ClinicalTrials.gov/show/NCT04563650 |
| NCT04566770 |
A Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) |
https://ClinicalTrials.gov/show/NCT04566770 |
| NCT04425707 |
Ivermectin In Treatment of COVID 19 Patients |
https://ClinicalTrials.gov/show/NCT04425707 |
| NCT04565379 |
Clinical Trial to Investigate the Efficacy and Safety of NuSepin® in COVID-19 Pneumonia Patients |
https://ClinicalTrials.gov/show/NCT04565379 |
| NCT04564716 |
Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus |
https://ClinicalTrials.gov/show/NCT04564716 |
| NCT04563208 |
Study of Oral Administration of Ribavirin and Nitazoxamide Versus Placebo in COVID-19 |
https://ClinicalTrials.gov/show/NCT04563208 |
| NCT04563065 |
Active Pregnancy Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04563065 |
| NCT04561219 |
Nitazoxanide Therapy for Patients With COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04561219 |
| NCT04561154 |
Identifying Functional and Psycho-social Complaints After Hospitalization for SARS-CoV-2 Infection( COVID 19)- REPERCOV |
https://ClinicalTrials.gov/show/NCT04561154 |
| NCT04561063 |
COVID-19 Prophylaxis South Africa (COVER HCW) |
https://ClinicalTrials.gov/show/NCT04561063 |
| NCT04560881 |
Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19) |
https://ClinicalTrials.gov/show/NCT04560881 |
| NCT04559113 |
Methylprednisolone in COVID-19 Patients (Methyl19LGH) |
https://ClinicalTrials.gov/show/NCT04559113 |
| NCT04560257 |
High Flow Nasal Cannula HFNC In Covid-19 Patients |
https://ClinicalTrials.gov/show/NCT04560257 |
| NCT04560231 |
Remdesivir in COVID-19 Lahore General Hospital |
https://ClinicalTrials.gov/show/NCT04560231 |
| NCT04560205 |
Tocilizumab in COVID-19 Lahore General Hospital |
https://ClinicalTrials.gov/show/NCT04560205 |
| NCT04559074 |
Personalised Electronic Record Supported Optimisation When Alone for Patients With Hypertension- Pilot Study for Remote Medical Management of Hypertension During the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04559074 |
| NCT04558476 |
Efficacy of CONvalescent Plasma in Patients With COVID-19 Treated With Mechanical Ventilation |
https://ClinicalTrials.gov/show/NCT04558476 |
| NCT04558463 |
The Effectivity and Safety of Favipiravir Compared to Oseltamivir as Adjuvant Therapy for COVID-19 |
https://ClinicalTrials.gov/show/NCT04558463 |
| NCT04558372 |
Genosvid Diagnostic Test for Early Detection of COVID-19 |
https://ClinicalTrials.gov/show/NCT04558372 |
| NCT04558411 |
Pilot Study of a Brief, Scaleable Intervention for Coronavirus (COVID-19) Mental Health Sequelae in College Students |
https://ClinicalTrials.gov/show/NCT04558411 |
| NCT04558125 |
Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism |
https://ClinicalTrials.gov/show/NCT04558125 |
| NCT04558021 |
A Study To Evaluate The Efficacy And Safety Of a Novel Niclosamide Suspension Formulation For COVID-19 |
https://ClinicalTrials.gov/show/NCT04558021 |
| NCT04557605 |
Effects of a Face Mask on Oxygenation During Exercise |
https://ClinicalTrials.gov/show/NCT04557605 |
| NCT04554264 |
Complicated Grief in ICU in the Aftermath of COVID-19 |
https://ClinicalTrials.gov/show/NCT04554264 |
| NCT04555213 |
A Dose Escalation and Dose Expansion Study of NOX66 in the Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04555213 |
| NCT04555148 |
COVIDIG (COVID-19 Hyper-ImmunoGlobulin) |
https://ClinicalTrials.gov/show/NCT04555148 |
| NCT04555096 |
A Trial of GC4419 in Patients With Critical Illness Due to COVID-19 |
https://ClinicalTrials.gov/show/NCT04555096 |
| NCT04555005 |
Mindfulness-based Crisis Intervention for COVID-19 Frontline Healthcare Workers During COVID-19 |
https://ClinicalTrials.gov/show/NCT04555005 |
| NCT04554992 |
Convalescent Plasma for the Treatment of COVID-19 (Coronavirus Disease 2019) |
https://ClinicalTrials.gov/show/NCT04554992 |
| NCT04553705 |
Omega-3, Nigella Sativa, Indian Costus, Quinine, Anise Seed, Deglycyrrhizinated Licorice, Artemisinin, Febrifugine on Immunity of Patients With (COVID-19) |
https://ClinicalTrials.gov/show/NCT04553705 |
| NCT04552951 |
Effect of Vitamin D on Morbidity and Mortality of the COVID-19 |
https://ClinicalTrials.gov/show/NCT04552951 |
| NCT04551781 |
Short Term Low Dose Corticosteroids for Management of Post covid19 Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT04551781 |
| NCT04552483 |
Effects of Early Use of Nitazoxanide in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04552483 |
| NCT04552379 |
The Containing Coronavirus Disease 19 (COVID-19) Trial |
https://ClinicalTrials.gov/show/NCT04552379 |
| NCT04552366 |
A Clinical Trial of a Recombinant Adenovirus 5 Vectored COVID-19 Vaccine (Ad5-nCoV) With Two Doses in Healthy Adults |
https://ClinicalTrials.gov/show/NCT04552366 |
| NCT04551911 |
Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04551911 |
| NCT04549337 |
Feasibility and Safety of High-intensity Exercise Training in Patients Surviving COVID-19 |
https://ClinicalTrials.gov/show/NCT04549337 |
| NCT04551339 |
Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19 |
https://ClinicalTrials.gov/show/NCT04551339 |
| NCT04550351 |
Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2 Phase I Clinical Trial (≥60 Years Old) |
https://ClinicalTrials.gov/show/NCT04550351 |
| NCT04550325 |
Safety, PK and PD of Kamada Anti-SARS-CoV-2 in COVID-19 |
https://ClinicalTrials.gov/show/NCT04550325 |
| NCT04549922 |
Antisense Therapy to Block the Kallikrein-kinin Pathway in COVID-19 |
https://ClinicalTrials.gov/show/NCT04549922 |
| NCT04551547 |
Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of COVID-19 |
https://ClinicalTrials.gov/show/NCT04551547 |
| NCT04549376 |
Virucidal Effect of Povidone Iodine on COVID-19 In-Vivo |
https://ClinicalTrials.gov/show/NCT04549376 |
| NCT04548544 |
A Randomized Controlled Feasibility Study of Emotional Well-being of Adolescents Undergoing a Mindfulness Training During COVID-19 |
https://ClinicalTrials.gov/show/NCT04548544 |
| NCT04548531 |
Engaging Patients in Colon Cancer Screening Decisions During COVID-19 |
https://ClinicalTrials.gov/show/NCT04548531 |
| NCT04547634 |
Telerehabilitation in Oncology Patients |
https://ClinicalTrials.gov/show/NCT04547634 |
| NCT04547283 |
Awake-Prone Positioning Strategy for Hypoxic Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04547283 |
| NCT04547140 |
Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19) |
https://ClinicalTrials.gov/show/NCT04547140 |
| NCT04546841 |
Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults |
https://ClinicalTrials.gov/show/NCT04546841 |
| NCT04546737 |
Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients |
https://ClinicalTrials.gov/show/NCT04546737 |
| NCT04545749 |
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine |
https://ClinicalTrials.gov/show/NCT04545749 |
| NCT04545541 |
Nebulised Heparin in Patients With Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04545541 |
| NCT04543760 |
Effect of Prone Positioning Combined With High Flow Oxygen Therapy on Oxygenation During Acute Respiratory Failure Due to COVID-19 |
https://ClinicalTrials.gov/show/NCT04543760 |
| NCT04542993 |
Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy |
https://ClinicalTrials.gov/show/NCT04542993 |
| NCT04542967 |
Study on the Safety and Efficacy of Convalescent Plasma in Patients With Severe COVID-19 Disease |
https://ClinicalTrials.gov/show/NCT04542967 |
| NCT04542941 |
Assessment of Safety and Efficacy of CCP |
https://ClinicalTrials.gov/show/NCT04542941 |
| NCT04542694 |
Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04542694 |
| NCT04542876 |
Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04542876 |
| NCT04542850 |
Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC in Subjects With COVID-19 |
https://ClinicalTrials.gov/show/NCT04542850 |
| NCT04542447 |
To Evaluate Safety and Efficacy of Nuvastatic as an Immunomodulator Adjuvant Therapy in COVID-19 Patients. |
https://ClinicalTrials.gov/show/NCT04542447 |
| NCT04542421 |
Lung Ultrasound Implementation in the Management of Patients Hospitalized With COVID-19 |
https://ClinicalTrials.gov/show/NCT04542421 |
| NCT04542408 |
Hamburg Edoxaban for Anticoagulation in COVID-19 Study |
https://ClinicalTrials.gov/show/NCT04542408 |
| NCT04542343 |
COVID-19 Risk Reduction Among African American Parishioners |
https://ClinicalTrials.gov/show/NCT04542343 |
| NCT04542330 |
Using BCG to Protect Senior Citizens During the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04542330 |
| NCT04541979 |
Aerosoliserat DNase for Treatment of Respiratory Failure in Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04541979 |
| NCT04542213 |
Dipeptidyl Peptidase-4 Inhibitor (DPP4i) for the Control of Hyperglycemia in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04542213 |
| NCT04540939 |
Neural Mechanisms of Mindfulness-based Cognitive Therapy (MBCT) for Posttraumatic Stress Disorder (PTSD) - COVID Related Substudy |
https://ClinicalTrials.gov/show/NCT04540939 |
| NCT04541680 |
Nintedanib for the Treatment of SARS-Cov-2 Induced Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT04541680 |
| NCT04540185 |
A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19 |
https://ClinicalTrials.gov/show/NCT04540185 |
| NCT04539821 |
Virtual Pain Care Management (COVID-19) |
https://ClinicalTrials.gov/show/NCT04539821 |
| NCT04539795 |
COVID-19 Study of Safety and Tolerability of Alvelestat |
https://ClinicalTrials.gov/show/NCT04539795 |
| NCT04539275 |
COVID-19 (VA CURES-1) |
https://ClinicalTrials.gov/show/NCT04539275 |
| NCT04402944 |
Pulmozyme to Improve COVID-19 ARDS Outcomes |
https://ClinicalTrials.gov/show/NCT04402944 |
| NCT04537351 |
The MEseNchymal coviD-19 Trial: a Pilot Study to Investigate Early Efficacy of MSCs in Adults With COVID-19 |
https://ClinicalTrials.gov/show/NCT04537351 |
| NCT04537962 |
Evaluationof the Load of SARS-CoV-2 Virus in Oral Cavity, Oropharinge and Saliva of Patients With Covid-19 After Disinfection With Oral Antimicrobial Solutions: a Pilot Study |
https://ClinicalTrials.gov/show/NCT04537962 |
| NCT04537858 |
Virtual Reality Therapy Influence on Heart Rate Variability of Inpatients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04537858 |
| NCT04537806 |
A Study of Brexanolone for Acute Respiratory Distress Syndrome Due to COVID-19 |
https://ClinicalTrials.gov/show/NCT04537806 |
| NCT04537663 |
Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults |
https://ClinicalTrials.gov/show/NCT04537663 |
| NCT04536935 |
Mobile Mental Health Apps for Suicide Prevention |
https://ClinicalTrials.gov/show/NCT04536935 |
| NCT04537208 |
Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older |
https://ClinicalTrials.gov/show/NCT04537208 |
| NCT04536298 |
Vitamin D and COVID-19 Trial |
https://ClinicalTrials.gov/show/NCT04536298 |
| NCT04536441 |
Ultra-brief Online Mindfulness-based Intervention During COVID-19 Movement Control Order |
https://ClinicalTrials.gov/show/NCT04536441 |
| NCT04535856 |
Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04535856 |
| NCT04536051 |
A Study of a Candidate COVID-19 Vaccine (COV003) |
https://ClinicalTrials.gov/show/NCT04536051 |
| NCT04535869 |
Efficacy and Safety of Direct Anti HCV Drugs in the Treatment of SARS-COV-2 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04535869 |
| NCT04535791 |
Efficacy of Vitamin D Supplementation to Prevent the Risk of Acquiring COVID-19 in Healthcare Workers |
https://ClinicalTrials.gov/show/NCT04535791 |
| NCT04535700 |
Clinical Trial of Pioglitazone Treatment in Patients With Type 2 Diabetes Mellitus and Covid-19 |
https://ClinicalTrials.gov/show/NCT04535700 |
| NCT04535674 |
Asunercept in Patients With Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04535674 |
| NCT04535167 |
First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19. |
https://ClinicalTrials.gov/show/NCT04535167 |
| NCT04535453 |
A Study to Evaluate a Range of Dose Levels and Vaccination Intervals of Ad26.COV2.S in Healthy Adults and Adolescents |
https://ClinicalTrials.gov/show/NCT04535453 |
| NCT04534673 |
Pegylated Interferon Lambda for Treatment of COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04534673 |
| NCT04535063 |
Convalescent Plasma as Potential Therapy for Severe COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04535063 |
| NCT04533399 |
A Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African Adults |
https://ClinicalTrials.gov/show/NCT04533399 |
| NCT04532931 |
COVID-19 Treatment in South Africa |
https://ClinicalTrials.gov/show/NCT04532931 |
| NCT04534725 |
COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial; |
https://ClinicalTrials.gov/show/NCT04534725 |
| NCT04532372 |
Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy |
https://ClinicalTrials.gov/show/NCT04532372 |
| NCT04532294 |
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants |
https://ClinicalTrials.gov/show/NCT04532294 |
| NCT04531774 |
RECHARGE: A Brief Psychological Intervention to Build Resilience in Healthcare Workers During COVID-19 |
https://ClinicalTrials.gov/show/NCT04531774 |
| NCT04531618 |
Mother-infant Bonding During COVID-19 |
https://ClinicalTrials.gov/show/NCT04531618 |
| NCT04530448 |
Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization |
https://ClinicalTrials.gov/show/NCT04530448 |
| NCT04530604 |
Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS) |
https://ClinicalTrials.gov/show/NCT04530604 |
| NCT04530578 |
Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19 |
https://ClinicalTrials.gov/show/NCT04530578 |
| NCT04530435 |
PEP Flute-selfcare in COVID-19 |
https://ClinicalTrials.gov/show/NCT04530435 |
| NCT04530422 |
Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard Treatment |
https://ClinicalTrials.gov/show/NCT04530422 |
| NCT04530396 |
Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04530396 |
| NCT04530370 |
Efficacy and Safety of Recovered Covid 19 Plasma Transfusion to Covid 19 Severly Ill Patients |
https://ClinicalTrials.gov/show/NCT04530370 |
| NCT04530357 |
Reactogenicity, Safety and Immunogenicity of QazCovid-in® COVID-19 Vaccine |
https://ClinicalTrials.gov/show/NCT04530357 |
| NCT04394208 |
Silymarin in COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04394208 |
| NCT04530136 |
Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04530136 |
| NCT04526990 |
Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above |
https://ClinicalTrials.gov/show/NCT04526990 |
| NCT04528641 |
GRAd-COV2 Vaccine Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04528641 |
| NCT04527471 |
Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04527471 |
| NCT04527432 |
COVID-19 Health Professional Impact Study |
https://ClinicalTrials.gov/show/NCT04527432 |
| NCT04527354 |
Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04527354 |
| NCT04527614 |
Influence of Prior Infection With COVID-19 on Occurrence of Influenza-like Illness or Acute Respiratory Infection |
https://ClinicalTrials.gov/show/NCT04527614 |
| NCT04527562 |
Colchicine in Moderate Symptomatic COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04527562 |
| NCT04527133 |
An Open Non-comparative Study of the Efficacy and Safety of Aprotinin in Patients Hospitalized With COVID-19 |
https://ClinicalTrials.gov/show/NCT04527133 |
| NCT04527081 |
Study of COVID-19 DNA Vaccine (AG0302-COVID19) |
https://ClinicalTrials.gov/show/NCT04527081 |
| NCT04526912 |
Treatment and Prevention of Acute Lung Injury (ALI) in Patients With COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04526912 |
| NCT04525820 |
High Dose Vitamin-D Substitution in Patients With COVID-19: a Randomized Controlled, Multi Center Study |
https://ClinicalTrials.gov/show/NCT04525820 |
| NCT04526054 |
Morphological Abnormalities of the Olfactory Bulb on MRI and Olfactometry in Anosmic Versus Normosmic COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04526054 |
| NCT04525742 |
COVID-19 Pandemic and Parents of Disabled Children |
https://ClinicalTrials.gov/show/NCT04525742 |
| NCT04524598 |
A CBT-based Mobile Intervention as First Line Treatment for Adolescent Depression During COVID-19 |
https://ClinicalTrials.gov/show/NCT04524598 |
| NCT04524507 |
COVID-19 Antibody Plasma Research Study in Hospitalized Patients |
https://ClinicalTrials.gov/show/NCT04524507 |
| NCT04525378 |
MSC-based Therapy in COVID-19-associated Acute Respiratory Distress Syndrome |
https://ClinicalTrials.gov/show/NCT04525378 |
| NCT04524663 |
Oral Camostat Compared With Standard Supportive Care in Mild-Moderate COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04524663 |
| NCT04523246 |
Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents |
https://ClinicalTrials.gov/show/NCT04523246 |
| NCT04523831 |
Clinical Trial of Ivermectin Plus Doxycycline for the Treatment of Confirmed Covid-19 Infection |
https://ClinicalTrials.gov/show/NCT04523831 |
| NCT04523571 |
Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b1) in Chinese Healthy Subjects |
https://ClinicalTrials.gov/show/NCT04523571 |
| NCT04523181 |
Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients |
https://ClinicalTrials.gov/show/NCT04523181 |
| NCT04523090 |
Catalysing the Containment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04523090 |
| NCT04522492 |
Impact of COVID-19 on Mental Health of Patients With Skin Picking |
https://ClinicalTrials.gov/show/NCT04522492 |
| NCT04522466 |
Evaluation of the Pharmacokinetics and Pharmacodynamics of Hydroxychloroquine in COVID-19 Intensive Care Unit Patients |
https://ClinicalTrials.gov/show/NCT04522466 |
| NCT04522128 |
Does Quality of Life Decline During the COVID-19 Pandemic and Can we Change Behaviour to Improve Poor Quality of Life? |
https://ClinicalTrials.gov/show/NCT04522128 |
| NCT04522089 |
A Study to Evaluate the Safety and Immunogenicity of COVID-19 (AdimrSC-2f) Vaccine |
https://ClinicalTrials.gov/show/NCT04522089 |
| NCT04521322 |
Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Prophylaxis of COVID-19 Disease in Health Personnel Dedicated to Patients Care With COVID-19 Disease |
https://ClinicalTrials.gov/show/NCT04521322 |
| NCT04519437 |
Study Assessing the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Repeated Subcutaneous Doses of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (REGN10933+REGN10987) in Adult Volunteers as Related to COVID-19 |
https://ClinicalTrials.gov/show/NCT04519437 |
| NCT04519385 |
Toclizumam Versus Dexamethasone in Severe Covid-19 Cases |
https://ClinicalTrials.gov/show/NCT04519385 |
| NCT04519320 |
Medium and Long Term Follow-up of COVID-19 Infected Patients: Research and Characterization of Pulmonary Sequelae |
https://ClinicalTrials.gov/show/NCT04519320 |
| NCT04518969 |
Determination of the Hemoadsorption Impact as Adjunctive Treatment Upon the Support Therapy of COVID-19 |
https://ClinicalTrials.gov/show/NCT04518969 |
| NCT04519216 |
Breastfeeding Education in the Time of COVID-19 |
https://ClinicalTrials.gov/show/NCT04519216 |
| NCT04518410 |
ACTIV-2: A Study for Outpatients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04518410 |
| NCT04518514 |
Telemedical Risk Assessment and Preoperative Evaluation (TAPE) |
https://ClinicalTrials.gov/show/NCT04518514 |
| NCT04517396 |
FEnofibRate as a Metabolic INtervention for COVID-19 |
https://ClinicalTrials.gov/show/NCT04517396 |
| NCT04517123 |
Prone Position and Respiratory Outcomes in Non-Intubated COVID-19 PatiEnts The “PRONE” Study |
https://ClinicalTrials.gov/show/NCT04517123 |
| NCT04516746 |
Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults |
https://ClinicalTrials.gov/show/NCT04516746 |
| NCT04516954 |
Convalescent Plasma for COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04516954 |
| NCT04516915 |
IMU-838 and Oseltamivir in the Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04516915 |
| NCT04516837 |
Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19) |
https://ClinicalTrials.gov/show/NCT04516837 |
| NCT04516811 |
Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04516811 |
| NCT04514900 |
Exploring Optimal Treatment Components for Contactless Online Group-based Behavioral Weight Loss Program |
https://ClinicalTrials.gov/show/NCT04514900 |
| NCT04516564 |
A Study of AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy Subjects |
https://ClinicalTrials.gov/show/NCT04516564 |
| NCT04515147 |
A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19 |
https://ClinicalTrials.gov/show/NCT04515147 |
| NCT04514705 |
Characteristics in Post Covid-19 Patients |
https://ClinicalTrials.gov/show/NCT04514705 |
| NCT04514627 |
Neuromodulation With Percutaneous Electrical Nerve Field Stimulation for Adults With COVID-19 |
https://ClinicalTrials.gov/show/NCT04514627 |
| NCT04513158 |
Convalescent Plasma in the Early Treatment of High-Risk Patients With SARS-CoV-2 (COVID-19) Infection |
https://ClinicalTrials.gov/show/NCT04513158 |
| NCT04513990 |
Novel Point-of-Care Diagnostic Test for SARS-CoV-2 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04513990 |
| NCT04513470 |
Allocetra-OTS in COVID-19 |
https://ClinicalTrials.gov/show/NCT04513470 |
| NCT04512027 |
Prolectin-M in COVID-19 Patients Having Mild to Moderate Symptoms Not Requiring Oxygen Support. |
https://ClinicalTrials.gov/show/NCT04512027 |
| NCT04513184 |
Randomized Clinical Trial of Intranasal Dexamethasone as an Adjuvant in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04513184 |
| NCT04511650 |
A Study to Evaluate the Safety and Efficacy of Razuprotafib, a Novel Tie 2 Activator, in Hospitalized Subjects With Moderate to Severe Coronavirus Disease 2019 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04511650 |
| NCT04510493 |
Canakinumab in Patients With COVID-19 and Type 2 Diabetes |
https://ClinicalTrials.gov/show/NCT04510493 |
| NCT04510662 |
Telmisartan in Respiratory Failure Due to COVID-19 |
https://ClinicalTrials.gov/show/NCT04510662 |
| NCT04510207 |
A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above |
https://ClinicalTrials.gov/show/NCT04510207 |
| NCT04510194 |
MET-COVID – Outpatient Metformin Use for COVID-19 |
https://ClinicalTrials.gov/show/NCT04510194 |
| NCT04509999 |
Bicalutamide to Block TMPRSS2 in Males With COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04509999 |
| NCT04509973 |
Higher vs. Lower Doses of Dexamethasone for COVID-19 and Severe Hypoxia |
https://ClinicalTrials.gov/show/NCT04509973 |
| NCT04509947 |
A Study of Ad26.COV2.S in Adults (COVID-19) |
https://ClinicalTrials.gov/show/NCT04509947 |
| NCT04508868 |
Treatment of Depressive Symptoms in Older Individuals in Isolation During Covid-19 |
https://ClinicalTrials.gov/show/NCT04508868 |
| NCT04508439 |
Effect of the Use of Anticoagulant Therapy During Hospitalization and Discharge in Patients With COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04508439 |
| NCT04508075 |
Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine |
https://ClinicalTrials.gov/show/NCT04508075 |
| NCT04507256 |
AZD7442 - a Potential Combination Therapy for the Prevention and Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04507256 |
| NCT04506268 |
COVID-19 SAFE Enrollment |
https://ClinicalTrials.gov/show/NCT04506268 |
| NCT04505774 |
Anti-thrombotics for Adults Hospitalized With COVID-19 (ACTIV-4) |
https://ClinicalTrials.gov/show/NCT04505774 |
| NCT04505592 |
Tenecteplase in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04505592 |
| NCT04505761 |
The Usability, Feasibility, and Tolerability of Virtual Reality for Rehabilitation From COVID-19 |
https://ClinicalTrials.gov/show/NCT04505761 |
| NCT04504734 |
Bucillamine in Treatment of Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04504734 |
| NCT04504240 |
Role of Famotidine in the Symptomatic Improvement of COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04504240 |
| NCT04504877 |
Burnout and Distress preventiOn With caNnabidiol in Front-line Health Care workerS deAling wIth COVID-19 |
https://ClinicalTrials.gov/show/NCT04504877 |
| NCT04502472 |
Open-label Treatment of Severe Coronavirus Disease 2019 (COVID-19) With Convalescent Plasma |
https://ClinicalTrials.gov/show/NCT04502472 |
| NCT04502667 |
Efficacy of Vitamin D Treatment in Pediatric Patients Hospitalized by COVID-19 |
https://ClinicalTrials.gov/show/NCT04502667 |
| NCT04502342 |
Add on to Azythromycine, Phytomedicine and/or Antimalarial Drug vs Hydroxychloroquine in Uncomplicated COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04502342 |
| NCT04502433 |
Poractant Alfa - Curosurf and SARS-COV-19 ARDS (Covid-19) |
https://ClinicalTrials.gov/show/NCT04502433 |
| NCT04501965 |
Phytomedicines Versus Hydroxychloroquine as an Add on Therapy to Azythromycin in Asymptomatic Covid-19 Patients |
https://ClinicalTrials.gov/show/NCT04501965 |
| NCT04501796 |
A Trial of NT-I7 in COVID-19 (SPESELPIS) |
https://ClinicalTrials.gov/show/NCT04501796 |
| NCT04501783 |
Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04501783 |
| NCT04502056 |
Covid-19 Messaging to Underserved Communities - 2nd Experiment |
https://ClinicalTrials.gov/show/NCT04502056 |
| NCT04501445 |
Psychological Symptoms and Families of COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04501445 |
| NCT04500132 |
To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia |
https://ClinicalTrials.gov/show/NCT04500132 |
| NCT04500418 |
Charité Trial of Cenicriviroc (CVC) Treatment for COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04500418 |
| NCT04500067 |
Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex Treatment |
https://ClinicalTrials.gov/show/NCT04500067 |
| NCT04500366 |
GERAS Frailty Rehabilitation at Home During COVID-19 |
https://ClinicalTrials.gov/show/NCT04500366 |
| NCT04499677 |
FLARE: Favipiravir +/- Lopinavir: A RCT of Early Antivirals |
https://ClinicalTrials.gov/show/NCT04499677 |
| NCT04499391 |
COVID-19 Project ECHO in Nursing Homes |
https://ClinicalTrials.gov/show/NCT04499391 |
| NCT04498273 |
COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 |
https://ClinicalTrials.gov/show/NCT04498273 |
| NCT04498247 |
A Study to Assess Safety, Tolerability, and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Participants (V591-001) |
https://ClinicalTrials.gov/show/NCT04498247 |
| NCT04499313 |
Dexamethasone Vs Methylprednisolone for the Treatment of Patients With ARDS Caused by COVID-19 |
https://ClinicalTrials.gov/show/NCT04499313 |
| NCT04498936 |
Sofosbuvir/Ledipasvir and Nitazoxanide for Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04498936 |
| NCT04497948 |
Acalabrutinib Study With Best Supportive Care in Participants Hospitalized With COVID-19 |
https://ClinicalTrials.gov/show/NCT04497948 |
| NCT04497623 |
Clinical Evaluation of Ventilador Innovation Product in Colombia in the SARS COVID 19 Pandemic, Unisabana Herons. |
https://ClinicalTrials.gov/show/NCT04497623 |
| NCT04497649 |
Sofosbuvir Containing Regimens in Treatment of COVID 19 Patients |
https://ClinicalTrials.gov/show/NCT04497649 |
| NCT04497272 |
Assesment of the Metabolomic Signature in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04497272 |
| NCT04497415 |
The COVID-19 and Healthcare Workers: An Active Intervention |
https://ClinicalTrials.gov/show/NCT04497415 |
| NCT04497389 |
Safety and Feasibility of Amniotic Fluid as a Treatment for COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04497389 |
| NCT04497298 |
Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine |
https://ClinicalTrials.gov/show/NCT04497298 |
| NCT04497454 |
Mechanical Ventilation Strategy for Coronavirus Disease 2019 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04497454 |
| NCT04494724 |
Clazakizumab vs. Placebo - COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04494724 |
| NCT04495933 |
A Study on the Safety, Tolerability and Immune Response of SARS-CoV-2 Sclamp (COVID-19) Vaccine in Healthy Adults |
https://ClinicalTrials.gov/show/NCT04495933 |
| NCT04495543 |
Mitigating Suicide Risk With Single Session ‘Brief Skills for Safer Living’ |
https://ClinicalTrials.gov/show/NCT04495543 |
| NCT04495101 |
Study to Evaluate the Safety and Efficacy of Prolastin in Hospitalized Subjects With COVID-19 |
https://ClinicalTrials.gov/show/NCT04495101 |
| NCT04496245 |
Reducing Acute Severe Respiratory Events in Health Care Workers During the Covid-19 Pandemic With OM85 |
https://ClinicalTrials.gov/show/NCT04496245 |
| NCT04495842 |
The Effect of Aromatherapy on COVID-19-induced Anxiety |
https://ClinicalTrials.gov/show/NCT04495842 |
| NCT04495816 |
COVID-19 Anosmia Study |
https://ClinicalTrials.gov/show/NCT04495816 |
| NCT04494867 |
Core Warming in COVID-19 Patients Undergoing Mechanical Ventilation |
https://ClinicalTrials.gov/show/NCT04494867 |
| NCT04494204 |
Effect of a Combination of Treatment of Reginmune Capsule and Immunofree Tablets in the Treatment of Mild to Moderate COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04494204 |
| NCT04494399 |
IFN Beta-1b and Ribavirin for Covid-19 |
https://ClinicalTrials.gov/show/NCT04494399 |
| NCT04494386 |
Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS |
https://ClinicalTrials.gov/show/NCT04494386 |
| NCT04493359 |
Switch of Renin-Angiotensin System Inhibitors in Patients With Covid-19 |
https://ClinicalTrials.gov/show/NCT04493359 |
| NCT04492527 |
Student-delivered Telehealth Program for COVID-19 Education and Health Promotion |
https://ClinicalTrials.gov/show/NCT04492527 |
| NCT04492891 |
Cyclosporine For The Treatment Of COVID-19(+) |
https://ClinicalTrials.gov/show/NCT04492891 |
| NCT04492514 |
Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflation |
https://ClinicalTrials.gov/show/NCT04492514 |
| NCT04492501 |
Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan |
https://ClinicalTrials.gov/show/NCT04492501 |
| NCT04492358 |
Treatment for Moderate/Severe COVID-19 in a Fragile and Vulnerable Population, Admitted to a Geriatric Hospital Unit or in a Transicional Care Center |
https://ClinicalTrials.gov/show/NCT04492358 |
| NCT04491994 |
Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 Progression |
https://ClinicalTrials.gov/show/NCT04491994 |
| NCT04492228 |
Eucaloric Ketogenic Diet in COVID-19 Cytokine Storm Syndrome |
https://ClinicalTrials.gov/show/NCT04492228 |
| NCT04491240 |
Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Pneumonia. |
https://ClinicalTrials.gov/show/NCT04491240 |
| NCT04490850 |
COVID-19 Seroprevalence Study in French Guiana |
https://ClinicalTrials.gov/show/NCT04490850 |
| NCT04490473 |
Turkish of the SARS-CoV-2 Anxiety Scale |
https://ClinicalTrials.gov/show/NCT04490473 |
| NCT04489446 |
Sildenafil in COVID-19 |
https://ClinicalTrials.gov/show/NCT04489446 |
| NCT04490278 |
CoV-PICS: A Virtual Post-ICU Clinic |
https://ClinicalTrials.gov/show/NCT04490278 |
| NCT04488796 |
STAND UP to SARS-CoV-2 (COVID-19): Using Behavioural Economics to Reduce Sedentary Behaviour in At-home Office Workers |
https://ClinicalTrials.gov/show/NCT04488796 |
| NCT04488484 |
Medical and Serological Follow-up of the Staff of the Paris Saint-Joseph Hospital Group Infected With Severe Acute Respiratory Syndrome Coronavirus 2. |
https://ClinicalTrials.gov/show/NCT04488484 |
| NCT04488081 |
I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients |
https://ClinicalTrials.gov/show/NCT04488081 |
| NCT04487964 |
Complementary Intervention for COVID-19 |
https://ClinicalTrials.gov/show/NCT04487964 |
| NCT04487886 |
Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19) |
https://ClinicalTrials.gov/show/NCT04487886 |
| NCT04487990 |
CoV-Hep Study: Regional Anticoagulation Modalities in Continuous Venous Venous Hemodialysis in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04487990 |
| NCT04487639 |
Presence of SARS-CoV-2 in Semen: Impact on Fertility Preservation in Male Oncological Patients ? |
https://ClinicalTrials.gov/show/NCT04487639 |
| NCT04487444 |
Thymalfasin (Thymosin Alpha 1) to Treat COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04487444 |
| NCT04487574 |
A Study to Assess the Efficacy and Safety of XC221 in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04487574 |
| NCT04487691 |
Nebulized PL for Post-COVID-19 Syndrome |
https://ClinicalTrials.gov/show/NCT04487691 |
| NCT04485429 |
Efficacy Assessment of Methylprednisolone and Heparin in Patients With COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04485429 |
| NCT04487210 |
A Study to Evaluate the Safety and Immunogenicity of MVC-COV1901 Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04487210 |
| NCT04487171 |
Screening for Postpartum Depression and Associated Risk Factors Among Women Who Deliver in Four Hospital in France During the COVID-19 Epidemic |
https://ClinicalTrials.gov/show/NCT04487171 |
| NCT04486482 |
A Clinical Study to Assess the Physiologic Effects of KB109 in Patients With COVID-19 on Gut Microbiota Structure and Function |
https://ClinicalTrials.gov/show/NCT04486482 |
| NCT04485169 |
Therapeutic Plasma Exchange for Coronavirus Disease-2019 Triggered Cytokine Release Storm; |
https://ClinicalTrials.gov/show/NCT04485169 |
| NCT04484493 |
Corticosteroid Nasal Spray in COVID-19 Anosmia |
https://ClinicalTrials.gov/show/NCT04484493 |
| NCT04483960 |
Australasian COVID-19 Trial (ASCOT) ADAptive Platform Trial |
https://ClinicalTrials.gov/show/NCT04483960 |
| NCT04483752 |
Predicting the Progression to Chronic Fibrosis of Lung Lesions Related to Covid-19 Infection From Chest CT Images |
https://ClinicalTrials.gov/show/NCT04483752 |
| NCT04483830 |
Suloexide in the Treatment of Early Stages of COVID-19 |
https://ClinicalTrials.gov/show/NCT04483830 |
| NCT04484207 |
Addressing COVID-19 Mental Health Problems Among US Veterans |
https://ClinicalTrials.gov/show/NCT04484207 |
| NCT04483375 |
Safety, Tolerability and Pharmacokinetics of SCTA01, an Anti-SARS-CoV-2 Monoclonal Antibody, in Healthy Chinese Subjects |
https://ClinicalTrials.gov/show/NCT04483375 |
| NCT04482387 |
DigiVis: Self-testing Vision App for Telephone Consultations |
https://ClinicalTrials.gov/show/NCT04482387 |
| NCT04483271 |
The Effect of Omega-3 on Selected Cytokines Involved in Cytokine Storm |
https://ClinicalTrials.gov/show/NCT04483271 |
| NCT04482699 |
RAPA-501-Allo Off-the-Shelf Therapy of COVID-19 |
https://ClinicalTrials.gov/show/NCT04482699 |
| NCT04482686 |
Trial of Combination Therapy to Treat COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04482686 |
| NCT04482673 |
Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04482673 |
| NCT04482647 |
Breathing Techniques and Meditation for Health Care Workers During COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04482647 |
| NCT04482634 |
Tele-rehabilitation Versus Home Exercise Program in COVID-19 |
https://ClinicalTrials.gov/show/NCT04482634 |
| NCT04482621 |
Decitabine for Coronavirus (COVID-19) Pneumonia- Acute Respiratory Distress Syndrome (ARDS) Treatment: DART Trial |
https://ClinicalTrials.gov/show/NCT04482621 |
| NCT04482595 |
BIO 300 Oral Suspension in Discharged COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04482595 |
| NCT04481685 |
A Trial of Aclaris Therapeutics, Inc. (ATI)-450 in Patients With Moderate-severe Novel Coronavirus Disease 2019 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04481685 |
| NCT04481633 |
Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04481633 |
| NCT04480957 |
Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects |
https://ClinicalTrials.gov/show/NCT04480957 |
| NCT04479202 |
The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19 |
https://ClinicalTrials.gov/show/NCT04479202 |
| NCT04480112 |
Impact of Covid-19 on Frequent Social Interaction Through Communication Technologies in the Cognitive Status of Socially-isolated Older Adults |
https://ClinicalTrials.gov/show/NCT04480112 |
| NCT04479540 |
Assessment of the Risk of Pulmonary Embolism and Coagulation Profile in Patients With COVID-19 Lung Disease |
https://ClinicalTrials.gov/show/NCT04479540 |
| NCT04480593 |
The Use of Brazilian Green Propolis Extract (EPP-AF) in Patients Affected by COVID-19. |
https://ClinicalTrials.gov/show/NCT04480593 |
| NCT04479358 |
Low-dose Tocilizumab Versus Standard of Care in Hospitalized Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04479358 |
| NCT04479163 |
Prevention of Severe Covid-19 in Infected Elderly by Early Administration of Convalescent Plasma With High-titers of Antibody Against SARS-CoV2 |
https://ClinicalTrials.gov/show/NCT04479163 |
| NCT04478539 |
Extracorporeal Blood Purification as a Treatment Modality for COVID-19 |
https://ClinicalTrials.gov/show/NCT04478539 |
| NCT04478071 |
Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04478071 |
| NCT04478019 |
SHIELD Study: Using Naso-oropharyngeal Antiseptic Decolonization to Reduce COVID-19 Viral Shedding |
https://ClinicalTrials.gov/show/NCT04478019 |
| NCT04477993 |
Ruxolitinib for Acute Respiratory Disorder Syndrome Due to COVID-19 |
https://ClinicalTrials.gov/show/NCT04477993 |
| NCT04477954 |
Hyperbaric Oxygen as an Adjuvant Treatment for Patients With Covid-19 Severe Hypoxemia |
https://ClinicalTrials.gov/show/NCT04477954 |
| NCT04477083 |
Development and Validation of “Ready-to-Use” Inhalable Forms of Hydroxychloroquine for Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04477083 |
| NCT04477655 |
Prone Positioning in Non-intubated Patients With COVID-19 Associated Acute Respiratory Failure |
https://ClinicalTrials.gov/show/NCT04477655 |
| NCT04476888 |
Convalescent Plasma Treatment in COVID-19 |
https://ClinicalTrials.gov/show/NCT04476888 |
| NCT04476745 |
The Effect of D3 on Selected Cytokines Involved in Cytokine Storm in the Covid-19 Uninfected Jordanian People |
https://ClinicalTrials.gov/show/NCT04476745 |
| NCT04476992 |
Nitric Oxide Therapy for COVID-19 Patients With Oxygen Requirement |
https://ClinicalTrials.gov/show/NCT04476992 |
| NCT04476979 |
Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19 |
https://ClinicalTrials.gov/show/NCT04476979 |
| NCT04475913 |
Digital vs Analog Impression in Cases of All-on-4 - Prosthesis |
https://ClinicalTrials.gov/show/NCT04475913 |
| NCT04475601 |
Enzalutamide Treatment in COVID-19 |
https://ClinicalTrials.gov/show/NCT04475601 |
| NCT04475588 |
Efficacy and Safety of Itolizumab in COVID-19 Complications |
https://ClinicalTrials.gov/show/NCT04475588 |
| NCT04475302 |
BCG Vaccine in Reducing Morbidity and Mortality in Elderly Individuals in COVID-19 Hotspots |
https://ClinicalTrials.gov/show/NCT04475302 |
| NCT04475107 |
The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04475107 |
| NCT04475185 |
Safety and Effectiveness Assessment of the MakAir Artificial Ventilator |
https://ClinicalTrials.gov/show/NCT04475185 |
| NCT04475120 |
Efficacy and Safety of Liposomal Lactoferrin in COVID-19 Patients With Mild-to-Moderate Disease and in COVID-19 Asymptomatic Patients |
https://ClinicalTrials.gov/show/NCT04475120 |
| NCT04474483 |
Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19 |
https://ClinicalTrials.gov/show/NCT04474483 |
| NCT04473690 |
KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT04473690 |
| NCT04474340 |
COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients |
https://ClinicalTrials.gov/show/NCT04474340 |
| NCT04473274 |
GlitazOne Treatment for Coronavirus HypoxiA, a Safety and Tolerability Open Label With Matching Cohort Pilot Study |
https://ClinicalTrials.gov/show/NCT04473274 |
| NCT04473261 |
Efficacy of Iodine Complex Against COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04473261 |
| NCT04473248 |
Spartan COVID-19 System: Evaluation of Clinical Sample Collection |
https://ClinicalTrials.gov/show/NCT04473248 |
| NCT04473170 |
Study Evaluating the Safety and Efficacy of Autologous Non-Hematopoietic Peripheral Blood Stem Cells in COVID-19 |
https://ClinicalTrials.gov/show/NCT04473170 |
| NCT04473053 |
Rapid Experimental Medicine for COVID-19 |
https://ClinicalTrials.gov/show/NCT04473053 |
| NCT04472728 |
Testing the Efficacy and Safety of BIO101 for the Prevention of Respiratory Deterioration in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04472728 |
| NCT04472494 |
Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise |
https://ClinicalTrials.gov/show/NCT04472494 |
| NCT04471636 |
Telemedicine in Outpatient Covid-19 Patients |
https://ClinicalTrials.gov/show/NCT04471636 |
| NCT04470739 |
Is Thymus Size of Infants Who Born to COVID-19 Positive Mothers Associated With Neonatal Morbidities? |
https://ClinicalTrials.gov/show/NCT04470739 |
| NCT04471766 |
Locally Produced Cloth Face Mask and COVID-19 Like Illness Prevention |
https://ClinicalTrials.gov/show/NCT04471766 |
| NCT04470869 |
Impact on the OLAF Intervention to Prevent Post Traumatic Disorders During the Confinement. |
https://ClinicalTrials.gov/show/NCT04470869 |
| NCT04470531 |
Role of Co-trimoxazole in Severe COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04470531 |
| NCT04471519 |
Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT04471519 |
| NCT04470999 |
Changes in Cellular Immune Profile During COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04470999 |
| NCT04470622 |
Aprepitant Injectable Emulsion in Patients With COVID-19 (GUARDS-1) |
https://ClinicalTrials.gov/show/NCT04470622 |
| NCT04470609 |
Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 in People Aged ⩾60 Years |
https://ClinicalTrials.gov/show/NCT04470609 |
| NCT04470544 |
Camostat Mesilate Treating Patients With Hospitalized Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04470544 |
| NCT04470258 |
Elmo Respiratory Support Project - COVID-19 |
https://ClinicalTrials.gov/show/NCT04470258 |
| NCT04469634 |
Are SARS-CoV-2 Specific Antibodies a Correlate for Protection? |
https://ClinicalTrials.gov/show/NCT04469634 |
| NCT04469621 |
A Phase 1b Trial to Evaluate Safety and Effect of SAR443122 on Immune System in Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04469621 |
| NCT04468893 |
Online Positive Psychology Intervention for Depression and Anxiety Due to COVID-19 |
https://ClinicalTrials.gov/show/NCT04468893 |
| NCT04469179 |
Safety, Tolerability, and Pharmacokinetics of SAB-185 in Ambulatory Participants With COVID-19 |
https://ClinicalTrials.gov/show/NCT04469179 |
| NCT04468971 |
REgulatory T Cell infuSion fOr Lung Injury Due to COVID-19 PnEumonia |
https://ClinicalTrials.gov/show/NCT04468971 |
| NCT04466800 |
Functional and Respiratory Rehabilitation and Nutritional Care of COVID-19 Patients (RECOVER-19) |
https://ClinicalTrials.gov/show/NCT04466800 |
| NCT04468646 |
To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 Patients |
https://ClinicalTrials.gov/show/NCT04468646 |
| NCT04468009 |
Treatment of Critically Ill Patients With Covid-19 With Convalescent Plasma |
https://ClinicalTrials.gov/show/NCT04468009 |
| NCT04468139 |
The Study of Quadruple Therapy Zinc, Quercetin, Bromelain and Vitamin C on the Clinical Outcomes of Patients Infected With COVID-19 |
https://ClinicalTrials.gov/show/NCT04468139 |
| NCT04467918 |
CANnabiDiol for CoviD-19 pATiEnts With Mild to Moderate Symptoms |
https://ClinicalTrials.gov/show/NCT04467918 |
| NCT04466683 |
Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia |
https://ClinicalTrials.gov/show/NCT04466683 |
| NCT04466605 |
Effect of Tele-Yoga Therapy on Patients With Chronic Musculoskeletal Pain During Covid-19 Lockdown |
https://ClinicalTrials.gov/show/NCT04466605 |
| NCT04466540 |
Randomized Placebo-controlled Trial of Hydroxychloroquine in Outpatient Cases With Coronavirus Disease 2019 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04466540 |
| NCT04466670 |
Hemostasis in COVID-19: an Adaptive Clinical Trial |
https://ClinicalTrials.gov/show/NCT04466670 |
| NCT04466098 |
Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19) |
https://ClinicalTrials.gov/show/NCT04466098 |
| NCT04466280 |
Efficacy and Safety of Mucoadhesive Sustained Release, Mucodentol, in Comparison With Hydroxychloroquine to Prevent COVID-19 |
https://ClinicalTrials.gov/show/NCT04466280 |
| NCT04466085 |
Clinical Study of Recombinant Novel Coronavirus Vaccine |
https://ClinicalTrials.gov/show/NCT04466085 |
| NCT04465604 |
Hypertonic Saline for COVID-19 Symptoms |
https://ClinicalTrials.gov/show/NCT04465604 |
| NCT04465695 |
Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19 |
https://ClinicalTrials.gov/show/NCT04465695 |
| NCT04464486 |
Remote COVID-19 Symptom Tracking for Cancer Patients at Home During the Pandemic |
https://ClinicalTrials.gov/show/NCT04464486 |
| NCT04464408 |
Favipiravir Therapy in Adults With Mild COVID-19 |
https://ClinicalTrials.gov/show/NCT04464408 |
| NCT04463472 |
Study of COVID-19 DNA Vaccine (AG0301-COVID19) |
https://ClinicalTrials.gov/show/NCT04463472 |
| NCT04463602 |
Desidustat in the Management of COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04463602 |
| NCT04463433 |
Psychological Intervention for Parent-child Relationship and Couple Relationship Under COVID-19 in China |
https://ClinicalTrials.gov/show/NCT04463433 |
| NCT04463420 |
Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04463420 |
| NCT04463264 |
Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19) |
https://ClinicalTrials.gov/show/NCT04463264 |
| NCT04461379 |
Prevention, Efficacy and Safety of BCG Vaccine in COVID-19 Among Healthcare Workers |
https://ClinicalTrials.gov/show/NCT04461379 |
| NCT04461925 |
Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs |
https://ClinicalTrials.gov/show/NCT04461925 |
| NCT04461340 |
Efficacy and Safety of Sirolimus in COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04461340 |
| NCT04460534 |
Detection of COVID-19 (SARS-CoV-2) in the Semen of COVID+ Patients (Positive RT-PCR on a Nasopharyngeal Swab) |
https://ClinicalTrials.gov/show/NCT04460534 |
| NCT04460443 |
Sofosbuvir in Treatment of COVID 19 |
https://ClinicalTrials.gov/show/NCT04460443 |
| NCT04460703 |
COVID-19 Vaccine Messaging, Part 1 |
https://ClinicalTrials.gov/show/NCT04460703 |
| NCT04460690 |
Rapid, Onsite COVID-19 Detection |
https://ClinicalTrials.gov/show/NCT04460690 |
| NCT04460677 |
ASD (Autism Spectrum Disorder) Telehealth for Distress Related to COVID-19 |
https://ClinicalTrials.gov/show/NCT04460677 |
| NCT04460651 |
PREPARE-IT. Prevention of COVID19 With EPA in Healthcare Providers at Risk - Intervention Trial |
https://ClinicalTrials.gov/show/NCT04460651 |
| NCT04460183 |
A Study to Assess Efficacy and Safety of RESP301 Plus Standard of Care (SOC) Compared to SOC Alone in Hospitalized Participants With COVID-19 |
https://ClinicalTrials.gov/show/NCT04460183 |
| NCT04460027 |
W-SUDs for COVID-19 |
https://ClinicalTrials.gov/show/NCT04460027 |
| NCT04460014 |
Simple Cognitive Task Intervention After Trauma During COVID-19 In Hospital Staff EKUT-P RCT |
https://ClinicalTrials.gov/show/NCT04460014 |
| NCT04459676 |
Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04459676 |
| NCT04458948 |
Open Label Non-comparative Trial of the Combination of Hydroxychloroquine and Azithromycin in the Treatment of Hospitalized Patients |
https://ClinicalTrials.gov/show/NCT04458948 |
| NCT04459520 |
Effect of Availability of COVID-19 Testing on Choice to Isolate and Socially Distance |
https://ClinicalTrials.gov/show/NCT04459520 |
| NCT04459455 |
Project H-COVID: Evaluating Hyper-Brief, Online Materials During the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04459455 |
| NCT04459247 |
Short Term, High Dose Vitamin D Supplementation for COVID-19 |
https://ClinicalTrials.gov/show/NCT04459247 |
| NCT04459325 |
Tigerase® Efficacy and Safety as Part of Complex Therapy in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04459325 |
| NCT04458363 |
Convalescent Plasma in Pediatric COVID-19 |
https://ClinicalTrials.gov/show/NCT04458363 |
| NCT04458246 |
Home-based Aerobic Training Among Adolescents With Chronic Diseases During COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04458246 |
| NCT04458298 |
A Study to Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients |
https://ClinicalTrials.gov/show/NCT04458298 |
| NCT04458519 |
Efficacy of Intranasal Probiotic Treatment to Reduce Severity of Symptoms in COVID19 Infection |
https://ClinicalTrials.gov/show/NCT04458519 |
| NCT04457817 |
Compensatory Reserve Index (CRI) for Management of COVID-19 |
https://ClinicalTrials.gov/show/NCT04457817 |
| NCT04457609 |
Administration of Allogenic UC-MSCs as Adjuvant Therapy for Critically-Ill COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04457609 |
| NCT04457726 |
Part Two of Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04457726 |
| NCT04457388 |
Tele-Yoga Therapy for Chronic Pain |
https://ClinicalTrials.gov/show/NCT04457388 |
| NCT04457349 |
Therapeutic Plasma Exchange in Resistant Cytokine Storm of COVID 19 |
https://ClinicalTrials.gov/show/NCT04457349 |
| NCT04456413 |
Convalescent Plasma as Treatment for Subjects With Early COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04456413 |
| NCT04456361 |
Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19 |
https://ClinicalTrials.gov/show/NCT04456361 |
| NCT04455815 |
A Trial Looking at the Use of Camostat to Reduce Progression of Symptoms of Coronavirus (COVID-19) in People Who Have Tested Positive But Are Able to Stay at Home |
https://ClinicalTrials.gov/show/NCT04455815 |
| NCT04456452 |
Study of Ampion for the Treatment of Adult COVID-19 Patients Requiring Oxygen Supplementation |
https://ClinicalTrials.gov/show/NCT04456452 |
| NCT04456153 |
Atovaquone for Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04456153 |
| NCT04456062 |
Using Caring Contacts to Reduce Psychiatric Morbidity Following Hospitalization During the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04456062 |
| NCT04454606 |
The New Silicone N99 Half-Piece Respirator |
https://ClinicalTrials.gov/show/NCT04454606 |
| NCT04455360 |
Early EMDR Following Covid-19 Critical Illness: A Feasibility Trial |
https://ClinicalTrials.gov/show/NCT04455360 |
| NCT04455308 |
COVID-19 and Chilblains |
https://ClinicalTrials.gov/show/NCT04455308 |
| NCT04453852 |
Monovalent Recombinant COVID19 Vaccine |
https://ClinicalTrials.gov/show/NCT04453852 |
| NCT04453514 |
Feasibility of a Brief Trauma-informed Yoga Intervention for Anxiety During the Coronavirus Disease (COVID-19) Pandemic |
https://ClinicalTrials.gov/show/NCT04453514 |
| NCT04453475 |
Feasibility and Benefits of Digital Services During the COVID19 Pandemic |
https://ClinicalTrials.gov/show/NCT04453475 |
| NCT04452565 |
NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04452565 |
| NCT04453384 |
Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia |
https://ClinicalTrials.gov/show/NCT04453384 |
| NCT04452773 |
Clinical Trial to Evaluate the Efficacy of Food Supplement Manremyc® Against SARS- COV-2 Infection (COVID-19) in Healthcare Workers |
https://ClinicalTrials.gov/show/NCT04452773 |
| NCT04452435 |
Safety and Efficacy of C21 in Subjects With COVID-19 |
https://ClinicalTrials.gov/show/NCT04452435 |
| NCT04452318 |
COVID-19 Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults and Adolescents Who Are Household Contacts to an Individual With a Positive SARS-CoV-2 RT-PCR Assay |
https://ClinicalTrials.gov/show/NCT04452318 |
| NCT04451889 |
Probe-based Confocal Laser Endomicroscopy in Critically Ill COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04451889 |
| NCT04451174 |
Early Use of Corticosteroids in Non-critical Patients With COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04451174 |
| NCT04449718 |
Vitamin D Supplementation in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04449718 |
| NCT04450004 |
Safety, Tolerability and Immunogenicinity of a Coronavirus-Like Particle COVID-19 Vaccine in Adults Aged 18-55 Years. |
https://ClinicalTrials.gov/show/NCT04450004 |
| NCT04449380 |
Clinical Study for the Treatment With Interferon-ß-1a (IFNß-1a) of COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04449380 |
| NCT04449276 |
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults |
https://ClinicalTrials.gov/show/NCT04449276 |
| NCT04448769 |
Epidemiological Study of Seroprevalence Against the SARS-CoV-2 Virus (COVID-19) |
https://ClinicalTrials.gov/show/NCT04448769 |
| NCT04447781 |
Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19 |
https://ClinicalTrials.gov/show/NCT04447781 |
| NCT04448119 |
Control of COVID-19 Outbreaks in Long Term Care |
https://ClinicalTrials.gov/show/NCT04448119 |
| NCT04447534 |
Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04447534 |
| NCT04447469 |
Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation |
https://ClinicalTrials.gov/show/NCT04447469 |
| NCT04447404 |
DUR-928 in Subjects With SARS-CoV-2 With Acute Lung, Liver or Kidney Injury |
https://ClinicalTrials.gov/show/NCT04447404 |
| NCT04447235 |
Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04447235 |
| NCT04446377 |
A Study of LAM-002A for the Prevention of Progression of COVID-19 |
https://ClinicalTrials.gov/show/NCT04446377 |
| NCT04445935 |
Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial |
https://ClinicalTrials.gov/show/NCT04445935 |
| NCT04446104 |
A Preventive Treatment for Migrant Workers at High-risk of COVID-19 |
https://ClinicalTrials.gov/show/NCT04446104 |
| NCT04445467 |
An Adaptive Clinical Trial of Antivirals for COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04445467 |
| NCT04445454 |
Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection |
https://ClinicalTrials.gov/show/NCT04445454 |
| NCT04445428 |
OPV as Potential Protection Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04445428 |
| NCT04445389 |
Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults |
https://ClinicalTrials.gov/show/NCT04445389 |
| NCT04445376 |
Effect of Physical Therapy Exercises on Cardiorespiratory Fitness Level in COVID19 Patients After Recovery. |
https://ClinicalTrials.gov/show/NCT04445376 |
| NCT04445324 |
Effects of Online and Recovery-oriented Peer Support Groups Facilitated by Peer Support Workers in Times of COVID-19 |
https://ClinicalTrials.gov/show/NCT04445324 |
| NCT04445311 |
Ivermectin in Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04445311 |
| NCT04445285 |
Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure |
https://ClinicalTrials.gov/show/NCT04445285 |
| NCT04445246 |
Inhaled Iloprost for Suspected COVID-19 Respiratory Failure |
https://ClinicalTrials.gov/show/NCT04445246 |
| NCT04445220 |
A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy |
https://ClinicalTrials.gov/show/NCT04445220 |
| NCT04445194 |
Phase I Clinical Study of Recombinant Novel Coronavirus Vaccine |
https://ClinicalTrials.gov/show/NCT04445194 |
| NCT04444700 |
A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04444700 |
| NCT04444674 |
COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection |
https://ClinicalTrials.gov/show/NCT04444674 |
| NCT04445597 |
ANalyzing Olfactory Dysfunction Mechanisms In COVID-19 |
https://ClinicalTrials.gov/show/NCT04445597 |
| NCT04444596 |
Conjunctival Swab vs Nasopharyngeal Swab in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04444596 |
| NCT04444271 |
Mesenchymal Stem Cell Infusion for COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04444271 |
| NCT04442958 |
Effectiveness of Convalescent Immune Plasma Therapy |
https://ClinicalTrials.gov/show/NCT04442958 |
| NCT04443881 |
Clinical Trial of the Use of Anakinra in Cytokine Storm Syndrome Secondary to Covid-19 (ANA-COVID-GEAS) |
https://ClinicalTrials.gov/show/NCT04443881 |
| NCT04443673 |
Glycine Supplement for Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04443673 |
| NCT04442230 |
NasoVAX in Patients With Early Coronavirus Infectious Disease 2019 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04442230 |
| NCT04442191 |
Convalescent Plasma as a Possible Treatment for COVID-19 |
https://ClinicalTrials.gov/show/NCT04442191 |
| NCT04442152 |
Impact of COVID-19 on Family Dynamics on Bandebereho Study Participants |
https://ClinicalTrials.gov/show/NCT04442152 |
| NCT04442087 |
Study of Seroprevalence of Anti-SARS-CoV2 Among Children of Hospital Workers in AP-HP |
https://ClinicalTrials.gov/show/NCT04442087 |
| NCT04441918 |
Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects |
https://ClinicalTrials.gov/show/NCT04441918 |
| NCT04442048 |
Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure |
https://ClinicalTrials.gov/show/NCT04442048 |
| NCT04441996 |
Therapeutic Plasma Exchange for COVID-19-associated Hyperviscosity |
https://ClinicalTrials.gov/show/NCT04441996 |
| NCT04441684 |
Seroprevalence of SARS-CoV-2 in Strasbourg University Hospital, Strasbourg, France (COVID-19) |
https://ClinicalTrials.gov/show/NCT04441684 |
| NCT04441632 |
Effect of Positive Attitudes on Behavior and Wellness |
https://ClinicalTrials.gov/show/NCT04441632 |
| NCT04441385 |
Study to Evaluate the Efficacy and Safety of Maraviroc in SARS-CoV-2 Infection (COVID-19). |
https://ClinicalTrials.gov/show/NCT04441385 |
| NCT04441424 |
Convalescent Plasma Therapy on Critically-ill Novel Coronavirus (COVID-19) Patients |
https://ClinicalTrials.gov/show/NCT04441424 |
| NCT04439071 |
A Study to Evaluate Efficacy and Safety of PTC299 in Hospitalized Participants With Coronavirus (COVID-19) |
https://ClinicalTrials.gov/show/NCT04439071 |
| NCT04439045 |
Efficacy and Safety of VPM1002 in Reducing SARS-CoV-2 (COVID-19) Infection Rate and Severity |
https://ClinicalTrials.gov/show/NCT04439045 |
| NCT04439006 |
Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization |
https://ClinicalTrials.gov/show/NCT04439006 |
| NCT04438980 |
Glucocorticoids in COVID-19 (CORTIVID) |
https://ClinicalTrials.gov/show/NCT04438980 |
| NCT04438694 |
Assessment of the Effect of Convalescent Plasma Therapy in Patients With Life-threatening COVID19 Infection |
https://ClinicalTrials.gov/show/NCT04438694 |
| NCT04438850 |
COVidIVERmectin: Ivermectin for Treatment of Covid-19 |
https://ClinicalTrials.gov/show/NCT04438850 |
| NCT04438070 |
COVID Screening Strategies in Homeless Shelters |
https://ClinicalTrials.gov/show/NCT04438070 |
| NCT04438057 |
Evaluating the Efficacy of Convalescent Plasma in Symptomatic Outpatients Infected With COVID-19 |
https://ClinicalTrials.gov/show/NCT04438057 |
| NCT04437875 |
An Open Study of the Safety, Tolerability and Immunogenicity of “Gam-COVID-Vac Lyo” Vaccine Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04437875 |
| NCT04437823 |
Efficacy of Intravenous Infusions of Stem Cells in the Treatment of COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04437823 |
| NCT04437719 |
Prospective Cohort Study to Describe the Clinical Characteristics of COVID-19, the Acquired Immune Response and the Biological and Clinical Parameters of Patients Followed in Oncology by the Saint-Joseph Hospital Group for a Period of 6 Months During the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04437719 |
| NCT04435717 |
Efficacy of Tocilizumab in Modifying the Inflammatory Parameters of Patients With COVID-19 (COVITOZ-01) |
https://ClinicalTrials.gov/show/NCT04435717 |
| NCT04436471 |
An Open Study of the Safety, Tolerability and Immunogenicity of the Drug “Gam-COVID-Vac” Vaccine Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04436471 |
| NCT04435275 |
Virtual Assistant for COVID-19 PPE |
https://ClinicalTrials.gov/show/NCT04435275 |
| NCT04435353 |
Assessment of the Effectiveness of Vibroacoustic Therapy for Respiratory Failure Caused by COVID 19 |
https://ClinicalTrials.gov/show/NCT04435353 |
| NCT04435808 |
Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19 |
https://ClinicalTrials.gov/show/NCT04435808 |
| NCT04435795 |
Inhaled Ciclesonide for Outpatients With COVID19 |
https://ClinicalTrials.gov/show/NCT04435795 |
| NCT04435587 |
Ivermectin vs Combined Hydroxychloroquine and Antiretroviral Drugs (ART) Among Asymptomatic COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04435587 |
| NCT04435184 |
Crizanlizumab for Treating COVID-19 Vasculopathy |
https://ClinicalTrials.gov/show/NCT04435184 |
| NCT04433910 |
A Clinical Trial of Convalescent Plasma Compared to Best Supportive Care for Treatment of Patients With Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04433910 |
| NCT04434248 |
An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04434248 |
| NCT04434131 |
Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19 |
https://ClinicalTrials.gov/show/NCT04434131 |
| NCT04433949 |
Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04433949 |
| NCT04433546 |
Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS). |
https://ClinicalTrials.gov/show/NCT04433546 |
| NCT04432805 |
Descriptive and Evaluation Study of the Use of Pulmonary Ultrasound in the Initial Management of Pregnant Women in the Context of COVID-19 |
https://ClinicalTrials.gov/show/NCT04432805 |
| NCT04433078 |
RepurpoSing Old Drugs TO SuppRess a Modern Threat: COVID-19 STORM |
https://ClinicalTrials.gov/show/NCT04433078 |
| NCT04432987 |
Dornase Alpha for the Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04432987 |
| NCT04432298 |
Study of the Efficacy and Safety of Intravenous Pamrevlumab, in Hospitalized Patients With Acute COVID-19 Disease |
https://ClinicalTrials.gov/show/NCT04432298 |
| NCT04432272 |
ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS) |
https://ClinicalTrials.gov/show/NCT04432272 |
| NCT04432051 |
The Use of Lung Ultrasonography in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04432051 |
| NCT04431466 |
A Study to Compare the Efficacy and Safety of Different Doses of Ivermectin for COVID-19 |
https://ClinicalTrials.gov/show/NCT04431466 |
| NCT04431180 |
Recruit Blood Donors Via SMS During Epidemic of COVID-19 #Second Repeat Trial# |
https://ClinicalTrials.gov/show/NCT04431180 |
| NCT04431856 |
CO-PARENT: COVID-19 - Parent Action in Response to Emotions and Needs for Treatment |
https://ClinicalTrials.gov/show/NCT04431856 |
| NCT04430608 |
Remote Continues Glucose Monitoring During the COVID-19 Pandemic in Quarantined Hospitalized Patients |
https://ClinicalTrials.gov/show/NCT04430608 |
| NCT04429711 |
Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04429711 |
| NCT04429867 |
Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease |
https://ClinicalTrials.gov/show/NCT04429867 |
| NCT04429854 |
Donated Antibodies Working Against nCoV |
https://ClinicalTrials.gov/show/NCT04429854 |
| NCT04429594 |
Study of the Incidence of SARS-CoV-2 Infection (COVID-19) |
https://ClinicalTrials.gov/show/NCT04429594 |
| NCT04429555 |
Efficacy, Safety, Tolerability, and Biomarkers of MN-166 (Ibudilast) in Patients Hospitalized With COVID-19 and at Risk for ARDS |
https://ClinicalTrials.gov/show/NCT04429555 |
| NCT04429529 |
Safety of TY027, a Treatment for COVID-19, in Humans |
https://ClinicalTrials.gov/show/NCT04429529 |
| NCT04428099 |
Healthy Lifestyle Promotion as Adjunctive Teletherapy for Treatment-resistant Major Depression |
https://ClinicalTrials.gov/show/NCT04428099 |
| NCT04428021 |
Standard or Convalescent Plasma in Patients With Recent Onset of COVID-19 Respiratory Failure |
https://ClinicalTrials.gov/show/NCT04428021 |
| NCT04428008 |
Thymosin Alpha 1 to Prevent COVID-19 Infection in Renal Dialysis Patients |
https://ClinicalTrials.gov/show/NCT04428008 |
| NCT04427566 |
Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise |
https://ClinicalTrials.gov/show/NCT04427566 |
| NCT04426318 |
COVID-19 and the Healthy Minds Program for Educators |
https://ClinicalTrials.gov/show/NCT04426318 |
| NCT04426305 |
Community Health Workers Against COVID19 |
https://ClinicalTrials.gov/show/NCT04426305 |
| NCT04426292 |
SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel During the 2020 COVID-19 Outbreak |
https://ClinicalTrials.gov/show/NCT04426292 |
| NCT04427137 |
Accelerated LFR for Bipolar Patients During the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04427137 |
| NCT04427098 |
Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients |
https://ClinicalTrials.gov/show/NCT04427098 |
| NCT04426006 |
Serological Response to SARS-Cov-2 Virus in Personnel of the Institut Bergonié in the Context of the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04426006 |
| NCT04425915 |
Efficacy of Convalescent Plasma Therapy in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04425915 |
| NCT04425629 |
Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04425629 |
| NCT04425616 |
SafeFit Trial: Virtual Clinics to Deliver Universal Interventions in People With Cancer |
https://ClinicalTrials.gov/show/NCT04425616 |
| NCT04425317 |
Detection of SARS-CoV-2 in Follicular Fluid and Cumulus-oocyte-complexes in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04425317 |
| NCT04425252 |
Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04425252 |
| NCT04425005 |
Home-based Exercise Training During Covid-19 Pandemic in Post-bariatric |
https://ClinicalTrials.gov/show/NCT04425005 |
| NCT04424953 |
To Compare Videolaryngoscope Against Direct Laryngoscope for Intubation When Powered Air Purifying Respirator is Worn |
https://ClinicalTrials.gov/show/NCT04424953 |
| NCT04424901 |
Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04424901 |
| NCT04425031 |
Handling Oxygenation Targets in COVID-19 |
https://ClinicalTrials.gov/show/NCT04425031 |
| NCT04424797 |
Prone Positioning on Admission for Hospitalized COVID-19 Pneumonia Protocol |
https://ClinicalTrials.gov/show/NCT04424797 |
| NCT04424212 |
ICBT for Mental Health Problems Related to the Coronavirus Pandemic |
https://ClinicalTrials.gov/show/NCT04424212 |
| NCT04423991 |
Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning |
https://ClinicalTrials.gov/show/NCT04423991 |
| NCT04424082 |
External Dead Space in Ventilated COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04424082 |
| NCT04423289 |
Telematic Monitoring Through a Mobile Application of Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04423289 |
| NCT04422561 |
Prophylactic Ivermectin in COVID-19 Contacts |
https://ClinicalTrials.gov/show/NCT04422561 |
| NCT04422509 |
Lanadelumab for Treatment of COVID-19 Disease |
https://ClinicalTrials.gov/show/NCT04422509 |
| NCT04422353 |
Video Dance Class and Unsupervised Physical Activity During Covid-19 Pandemic in People With Parkinson’s Disease |
https://ClinicalTrials.gov/show/NCT04422353 |
| NCT04422613 |
Characterization of Persistent Pulmonary Abnormalities Following COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04422613 |
| NCT04421664 |
Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada) |
https://ClinicalTrials.gov/show/NCT04421664 |
| NCT04421508 |
A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04421508 |
| NCT04421625 |
Patients and Health Staff of Cancer Centres During the Covid-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04421625 |
| NCT04421404 |
Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients |
https://ClinicalTrials.gov/show/NCT04421404 |
| NCT04421391 |
QuadraMune(TM) for Prevention of COVID-19 |
https://ClinicalTrials.gov/show/NCT04421391 |
| NCT04420806 |
Effects of COVID-19 Lockdown in Exercising Early Postmenopausal Women |
https://ClinicalTrials.gov/show/NCT04420806 |
| NCT04420741 |
Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in COVID-19 Patients With Respiratory Failure |
https://ClinicalTrials.gov/show/NCT04420741 |
| NCT04420676 |
Synbiotic Therapy of Gastrointestinal Symptoms During Covid-19 Infection |
https://ClinicalTrials.gov/show/NCT04420676 |
| NCT04420299 |
Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19 |
https://ClinicalTrials.gov/show/NCT04420299 |
| NCT04420273 |
Targeted Melanoma Detection With Skin Self-Examination During COVID-19 Restricted Physician Access |
https://ClinicalTrials.gov/show/NCT04420273 |
| NCT04420247 |
Efficacy of Chloroquine or Hydroxychloroquine in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19 |
https://ClinicalTrials.gov/show/NCT04420247 |
| NCT04420390 |
Low Dose Radiotherapy for COVID-19 Pneumonitis |
https://ClinicalTrials.gov/show/NCT04420390 |
| NCT04420182 |
COVID-19 Virtual Care at Home |
https://ClinicalTrials.gov/show/NCT04420182 |
| NCT04420338 |
SeroCOVIDial Study: Assessment of COVID-19 Seroconversion in Patients on Chronic Hemodialysis and in Their Caregivers, a Cohort Study |
https://ClinicalTrials.gov/show/NCT04420338 |
| NCT04419623 |
A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer |
https://ClinicalTrials.gov/show/NCT04419623 |
| NCT04418947 |
Project Resurgence Communication Trial |
https://ClinicalTrials.gov/show/NCT04418947 |
| NCT04418518 |
A Trial of CONvalescent Plasma for Hospitalized Adults With Acute COVID-19 Respiratory Illness |
https://ClinicalTrials.gov/show/NCT04418518 |
| NCT04418505 |
Vielight RX Plus for the Treatment of COVID-19 Respiratory Symptoms |
https://ClinicalTrials.gov/show/NCT04418505 |
| NCT04418206 |
Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04418206 |
| NCT04417335 |
Reducing COVID-19 Related Hospital Admission in Elderly by BCG Vaccination |
https://ClinicalTrials.gov/show/NCT04417335 |
| NCT04417270 |
Reliability of the Freestyle Libre CGM in the Inpatient Setting During the COVID-19 Surge |
https://ClinicalTrials.gov/show/NCT04417270 |
| NCT04416919 |
Assessment of N-95 Facemask for Use in COVID-19 Pandemic in Case of Shortage of Personal Protective Equipment |
https://ClinicalTrials.gov/show/NCT04416919 |
| NCT04416360 |
Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder in Covid-19 Outbreak |
https://ClinicalTrials.gov/show/NCT04416360 |
| NCT04416334 |
PREEMPTIVE THERAPY WITH COLCHICINE IN PATIENTS OLDER THAN 60 YEARS WITH HIGH RISK OF SEVERE PNEUMONIAE DUE TO CORONAVIRUS |
https://ClinicalTrials.gov/show/NCT04416334 |
| NCT04416308 |
COVID 19 : Seroprevalence Study of Anti SRAS-CoV-2 Antibodies in GHT Employees in Haute Bretagne (AntiCoV-HB) |
https://ClinicalTrials.gov/show/NCT04416308 |
| NCT04416139 |
Mesenchymal Stem Cell for Acute Respiratory Distress Syndrome Due for COVID-19 |
https://ClinicalTrials.gov/show/NCT04416139 |
| NCT04415151 |
Tofacitinib for Treatment of Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04415151 |
| NCT04415086 |
Treatment of Patients With COVID-19 With Convalescent Plasma |
https://ClinicalTrials.gov/show/NCT04415086 |
| NCT04415060 |
SedAting With Volatile Anesthetics Critically Ill COVID-19 Patients in ICU: Effects On Ventilatory Parameters And Survival |
https://ClinicalTrials.gov/show/NCT04415060 |
| NCT04414371 |
Tools for Wellbeing COVID-19 National Study of Undergraduate Students |
https://ClinicalTrials.gov/show/NCT04414371 |
| NCT04414267 |
Bacillus Calmette-guérin Vaccination to Prevent COVID-19 |
https://ClinicalTrials.gov/show/NCT04414267 |
| NCT04413968 |
COVID-19 Infection and Transmission in Exposed, Confined and Community-based Infants |
https://ClinicalTrials.gov/show/NCT04413968 |
| NCT04413864 |
Immunomodulatory Profile of Dexmedetomidine Sedation in Patients Recovering After ARDS Covid-19 |
https://ClinicalTrials.gov/show/NCT04413864 |
| NCT04414124 |
A Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Outpatients With Mild-to-moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04414124 |
| NCT04413006 |
Self-compassion for Chronic Pain Virtual Group Treatment Program |
https://ClinicalTrials.gov/show/NCT04413006 |
| NCT04412785 |
Cyclosporine in Patients With Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04412785 |
| NCT04412772 |
Trial of Tocilizumab for Treatment of Severe COVID-19: ARCHITECTS |
https://ClinicalTrials.gov/show/NCT04412772 |
| NCT04412239 |
To Assess the Efficiency and Satisfaction of Pharmacist Giving Patient-centred Advice on Telephone Consultation in TB Patients: Experience of the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04412239 |
| NCT04412538 |
Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04412538 |
| NCT04412486 |
COVID-19 Convalescent Plasma (CCP) Transfusion |
https://ClinicalTrials.gov/show/NCT04412486 |
| NCT04412356 |
Timing of Tracheotomy in Covid-19 Patients |
https://ClinicalTrials.gov/show/NCT04412356 |
| NCT04412343 |
The Seniors COvid-19 Pandemic and Exercise Study |
https://ClinicalTrials.gov/show/NCT04412343 |
| NCT04412330 |
Optimizing Outcomes With Physical Therapy Treatment for IndividuALs Surviving an ICU Admission for Covid-19 |
https://ClinicalTrials.gov/show/NCT04412330 |
| NCT04412057 |
Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury |
https://ClinicalTrials.gov/show/NCT04412057 |
| NCT04412018 |
An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19 |
https://ClinicalTrials.gov/show/NCT04412018 |
| NCT04411680 |
Study of Sargramostim in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04411680 |
| NCT04411667 |
Study of SOC Plus IVIG Compared to SOC Alone in the Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04411667 |
| NCT04411628 |
A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19 |
https://ClinicalTrials.gov/show/NCT04411628 |
| NCT04411602 |
Feasibility Study of Anti-SARS-CoV-2 Plasma Transfusions in COVID-19 Patients With SRD |
https://ClinicalTrials.gov/show/NCT04411602 |
| NCT04411446 |
Cholecalciferol to Improve the Outcomes of COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04411446 |
| NCT04410692 |
Can the Prediction Market Improve Predictions of COVID-19? |
https://ClinicalTrials.gov/show/NCT04410692 |
| NCT04410159 |
Povidone-Iodine Vs Essential Oil Vs Tap Water Gargling For COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04410159 |
| NCT04410328 |
Aggrenox To Treat Acute Covid-19 |
https://ClinicalTrials.gov/show/NCT04410328 |
| NCT04410562 |
Hydroxychloroquine Efficacy and Safety in Preventing SARS-CoV-2 Infection and COVID-19 Disease Severity During Pregnancy and Postpartum |
https://ClinicalTrials.gov/show/NCT04410562 |
| NCT04410549 |
Pulmonary Optical Coherence Tomography in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04410549 |
| NCT04410536 |
Home Detox in Medication Overuse Headache (MOH) During Covid-19 Emergency |
https://ClinicalTrials.gov/show/NCT04410536 |
| NCT04410510 |
P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19 |
https://ClinicalTrials.gov/show/NCT04410510 |
| NCT04410458 |
Recruit Blood Donors Via SMS During Epidemic of COVID-19 （Repeat Trial） |
https://ClinicalTrials.gov/show/NCT04410458 |
| NCT04410354 |
Study of Merimepodib in Combination With Remdesivir in Adult Patients With Advanced COVID-19 |
https://ClinicalTrials.gov/show/NCT04410354 |
| NCT04410016 |
Evaluation of Staff COVID-19 Wellbeing Centres in a Healthcare Workplace: COVID-WELL Study |
https://ClinicalTrials.gov/show/NCT04410016 |
| NCT04409925 |
DISmantling COvid iNduced Neutrophil ExtraCellular Traps (DISCONNECT-1) |
https://ClinicalTrials.gov/show/NCT04409925 |
| NCT04409509 |
Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04409509 |
| NCT04409834 |
Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial |
https://ClinicalTrials.gov/show/NCT04409834 |
| NCT04409496 |
Chat-based Support for Preventing Smoking Relapse |
https://ClinicalTrials.gov/show/NCT04409496 |
| NCT04409743 |
Brief Telehealth CBT-I Intervention in the Context of the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04409743 |
| NCT04408456 |
Efficacy of Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19 |
https://ClinicalTrials.gov/show/NCT04408456 |
| NCT04409522 |
Evaluation of Therapeutic Effects of Melatonin by Inhibition of NLRP3 Inflammasome in COVID19 Patients |
https://ClinicalTrials.gov/show/NCT04409522 |
| NCT04408209 |
Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04408209 |
| NCT04408183 |
GLS-1200 Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19) in Health Care Personnel |
https://ClinicalTrials.gov/show/NCT04408183 |
| NCT04408157 |
A Research Study to Evaluate the Benefits of a Self-management Booklet to Promote Wellbeing During the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04408157 |
| NCT04408131 |
Morbi-mortality by COVID-19 Among Homeless People in Marseille: a Cohort Study |
https://ClinicalTrials.gov/show/NCT04408131 |
| NCT04408066 |
COVID-19: A POC Test Under Research & Evaluation |
https://ClinicalTrials.gov/show/NCT04408066 |
| NCT04407689 |
InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection FR BL Cohort |
https://ClinicalTrials.gov/show/NCT04407689 |
| NCT04408040 |
Use of Convalescent Plasma for COVID-19 |
https://ClinicalTrials.gov/show/NCT04408040 |
| NCT04407208 |
Convalescent Plasma Therapy in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04407208 |
| NCT04407182 |
Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19 |
https://ClinicalTrials.gov/show/NCT04407182 |
| NCT04407390 |
Effects of Nicotinamide Riboside on the Clinical Outcome of Covid-19 in the Elderly |
https://ClinicalTrials.gov/show/NCT04407390 |
| NCT04407286 |
Vitamin D Testing and Treatment for COVID 19 |
https://ClinicalTrials.gov/show/NCT04407286 |
| NCT04406493 |
Monitoring COVID-19 Patients’ Lung Fluid Using Impedance Technique |
https://ClinicalTrials.gov/show/NCT04406493 |
| NCT04406181 |
Psychological Well-being of Patients Awaiting for Cardiac Surgery During the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04406181 |
| NCT04406246 |
Prevention of Coronavirus Disease (COVID-19) Outbreaks With Nitazoxanide |
https://ClinicalTrials.gov/show/NCT04406246 |
| NCT04406389 |
Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial) |
https://ClinicalTrials.gov/show/NCT04406389 |
| NCT04405570 |
A Safety, Tolerability and Efficacy of Molnupiravir (EIDD-2801) to Eliminate Infectious Virus Detection in Persons With COVID-19 |
https://ClinicalTrials.gov/show/NCT04405570 |
| NCT04405843 |
Efficacy of Ivermectin in Adult Patients With Early Stages of COVID-19 (EPIC Trial) |
https://ClinicalTrials.gov/show/NCT04405843 |
| NCT04405739 |
The Safety of Molnupiravir (EIDD-2801) and Its Effect on Viral Shedding of SARS-CoV-2 (END-COVID) |
https://ClinicalTrials.gov/show/NCT04405739 |
| NCT04405999 |
Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease |
https://ClinicalTrials.gov/show/NCT04405999 |
| NCT04405986 |
Exploring Brain Damages After COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04405986 |
| NCT04405908 |
SCB-2019 as COVID-19 Vaccine |
https://ClinicalTrials.gov/show/NCT04405908 |
| NCT04405544 |
Determination of Acute Encephalopathy Predictors in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04405544 |
| NCT04405102 |
COVID-19 Ozanimod Intervention Study |
https://ClinicalTrials.gov/show/NCT04405102 |
| NCT04405310 |
Convalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center Trial |
https://ClinicalTrials.gov/show/NCT04405310 |
| NCT04404361 |
PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer |
https://ClinicalTrials.gov/show/NCT04404361 |
| NCT04404218 |
The Açaà Berry COVID-19 Anti-Inflammation Trial |
https://ClinicalTrials.gov/show/NCT04404218 |
| NCT04403100 |
Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: “The Hope Coalition - 1” |
https://ClinicalTrials.gov/show/NCT04403100 |
| NCT04403477 |
Convalescent Plasma Therapy in Severe COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04403477 |
| NCT04402983 |
The Effectiveness of Telerehabilitation-Based Physiotherapy in COVID 19 Patients |
https://ClinicalTrials.gov/show/NCT04402983 |
| NCT04402957 |
LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04402957 |
| NCT04402918 |
Study of Viral Load and Maternal-fetal Serology in the Interpretation of the Vertical Transmission of SARS Cov-2 (COVID-19) During Pregnancy |
https://ClinicalTrials.gov/show/NCT04402918 |
| NCT04402879 |
CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals |
https://ClinicalTrials.gov/show/NCT04402879 |
| NCT04403685 |
Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers |
https://ClinicalTrials.gov/show/NCT04403685 |
| NCT04403646 |
Tannin Specific Natural Extract for COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04403646 |
| NCT04403555 |
Ivermectin as a Novel Therapy in COVID-19 Treatment |
https://ClinicalTrials.gov/show/NCT04403555 |
| NCT04403269 |
NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER, COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE |
https://ClinicalTrials.gov/show/NCT04403269 |
| NCT04402840 |
Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS) |
https://ClinicalTrials.gov/show/NCT04402840 |
| NCT04401046 |
COVID-19 and Reorganisation of Cancer Patient Care: Self- Evaluation of Potential Post-traumatic Stress Disorder |
https://ClinicalTrials.gov/show/NCT04401046 |
| NCT04402203 |
Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of Bangladesh |
https://ClinicalTrials.gov/show/NCT04402203 |
| NCT04401579 |
Adaptive COVID-19 Treatment Trial 2 (ACTT-2) |
https://ClinicalTrials.gov/show/NCT04401579 |
| NCT04402060 |
A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19 |
https://ClinicalTrials.gov/show/NCT04402060 |
| NCT04401475 |
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC vs. Placebo + SOC in Adult Hospitalized Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04401475 |
| NCT04401423 |
TXA127 for the Treatment of Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04401423 |
| NCT04401202 |
Nigella Sativa in COVID-19 |
https://ClinicalTrials.gov/show/NCT04401202 |
| NCT04401150 |
Lessening Organ Dysfunction With VITamin C - COVID-19 |
https://ClinicalTrials.gov/show/NCT04401150 |
| NCT04401293 |
Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04401293 |
| NCT04400838 |
Investigating a Vaccine Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04400838 |
| NCT04400929 |
Using GM-CSF as a Host Directed Therapeutic Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04400929 |
| NCT04400799 |
Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04400799 |
| NCT04400890 |
Randomized Proof-of-Concept Trial to Evaluate the Safety and Explore the Effectiveness of a Plant Polyphenol for COVID-19 |
https://ClinicalTrials.gov/show/NCT04400890 |
| NCT04400279 |
The COVID-19 Pandemic and Exercise Study |
https://ClinicalTrials.gov/show/NCT04400279 |
| NCT04399746 |
Ivermectin-Azithromycin-Cholecalciferol (IvAzCol) Combination Therapy for COVID-19 |
https://ClinicalTrials.gov/show/NCT04399746 |
| NCT04400305 |
“Increasing Physical Activity in Canadian Adults Affected by COVID-19 Social Distancing Restrictions: A Feasibility Trial of an Online Intervention” |
https://ClinicalTrials.gov/show/NCT04400305 |
| NCT04400058 |
Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression |
https://ClinicalTrials.gov/show/NCT04400058 |
| NCT04400032 |
Cellular Immuno-Therapy for COVID-19 Acute Respiratory Distress Syndrome - Vanguard |
https://ClinicalTrials.gov/show/NCT04400032 |
| NCT04399980 |
Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation |
https://ClinicalTrials.gov/show/NCT04399980 |
| NCT04399967 |
COVID-19 Brief Advice and Chat-based Support for Smoking Cessation Via “Quit to Win” Contest 2020 |
https://ClinicalTrials.gov/show/NCT04399967 |
| NCT04399889 |
hCT-MSCs for COVID19 ARDS |
https://ClinicalTrials.gov/show/NCT04399889 |
| NCT04399681 |
The Utility of Bedside Lung Ultrasonography on Diagnosis of COVID-19 |
https://ClinicalTrials.gov/show/NCT04399681 |
| NCT04399109 |
Evaluation of a Remote Monitoring Smartphone Application and Care Model of COVID-19 Patients in the Community (ReCOVER) |
https://ClinicalTrials.gov/show/NCT04399109 |
| NCT04399356 |
Niclosamide for Mild to Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04399356 |
| NCT04399317 |
Flow Controlled Ventilation in ARDS Associated With COVID-19 |
https://ClinicalTrials.gov/show/NCT04399317 |
| NCT04399252 |
Effect of Lactobacillus on the Microbiome of Household Contacts Exposed to COVID-19 |
https://ClinicalTrials.gov/show/NCT04399252 |
| NCT04399005 |
The Efficacy Comparing Daily and After-each-case Room Disinfection. |
https://ClinicalTrials.gov/show/NCT04399005 |
| NCT04398004 |
Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early |
https://ClinicalTrials.gov/show/NCT04398004 |
| NCT04398277 |
A Daily Coping Toolkit for Medical Personnel and First-Responders During COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04398277 |
| NCT04397796 |
Study of the Safety of Therapeutic Tx With Immunomodulatory MSC in Adults With COVID-19 Infection Requiring Mechanical Ventilation |
https://ClinicalTrials.gov/show/NCT04397796 |
| NCT04397666 |
RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19 |
https://ClinicalTrials.gov/show/NCT04397666 |
| NCT04397757 |
COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2. |
https://ClinicalTrials.gov/show/NCT04397757 |
| NCT04397718 |
Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization |
https://ClinicalTrials.gov/show/NCT04397718 |
| NCT04397692 |
Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial) |
https://ClinicalTrials.gov/show/NCT04397692 |
| NCT04397562 |
A Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04397562 |
| NCT04397523 |
Efficacy and Safety of COVID-19 Convalescent Plasma |
https://ClinicalTrials.gov/show/NCT04397523 |
| NCT04397510 |
Nebulized Heparin for the Treatment of COVID-19 Induced Lung Injury |
https://ClinicalTrials.gov/show/NCT04397510 |
| NCT04395911 |
Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections |
https://ClinicalTrials.gov/show/NCT04395911 |
| NCT04396106 |
Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19) |
https://ClinicalTrials.gov/show/NCT04396106 |
| NCT04395807 |
Helmet CPAP Versus HFNC in COVID-19 |
https://ClinicalTrials.gov/show/NCT04395807 |
| NCT04395768 |
International ALLIANCE Study of Therapies to Prevent Progression of COVID-19 |
https://ClinicalTrials.gov/show/NCT04395768 |
| NCT04395144 |
COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEss |
https://ClinicalTrials.gov/show/NCT04395144 |
| NCT04395105 |
Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial |
https://ClinicalTrials.gov/show/NCT04395105 |
| NCT04394793 |
Low Dose Radiation Therapy for Covid-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04394793 |
| NCT04394377 |
Full Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial |
https://ClinicalTrials.gov/show/NCT04394377 |
| NCT04393727 |
Transfusion of Convalescent Plasma for the Early Treatment of Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04393727 |
| NCT04394182 |
Ultra Low Doses of Therapy With Radiation Applicated to COVID-19 |
https://ClinicalTrials.gov/show/NCT04394182 |
| NCT04394169 |
Early Care Program for the Management of Post-ICU Syndrome and Chronic Pain After COVID-19 Infection. |
https://ClinicalTrials.gov/show/NCT04394169 |
| NCT04394117 |
Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease |
https://ClinicalTrials.gov/show/NCT04394117 |
| NCT04394455 |
Brief Cognitive Behavioral Therapy Versus Crisis Intervention Therapy Through Telepsychiatry on Psychiatric Symptoms |
https://ClinicalTrials.gov/show/NCT04394455 |
| NCT04394442 |
Hydroxychloroquine in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04394442 |
| NCT04394416 |
Trial of Imatinib for Hospitalized Adults With COVID-19 |
https://ClinicalTrials.gov/show/NCT04394416 |
| NCT04394013 |
A Web-Based Gentle Body Stretching to Alleviate Loneliness and Improve Mental Fitness During COVID-19 Isolation Period |
https://ClinicalTrials.gov/show/NCT04394013 |
| NCT04393961 |
At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study |
https://ClinicalTrials.gov/show/NCT04393961 |
| NCT04393948 |
Lung Irradiation for COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04393948 |
| NCT04393818 |
Mobile Phone Based Intervention to Protect Mental Health in Healthcare Workers at Frontline Against COVID19 |
https://ClinicalTrials.gov/show/NCT04393818 |
| NCT04393792 |
SINUS WASH Pilot Study in Adults Testing Positive for COVID-19 |
https://ClinicalTrials.gov/show/NCT04393792 |
| NCT04393636 |
Digital Cardiac Counseling Trial: DCC Trial |
https://ClinicalTrials.gov/show/NCT04393636 |
| NCT04393415 |
Using PRP and Cord Blood in Treatment of Covid -19 |
https://ClinicalTrials.gov/show/NCT04393415 |
| NCT04392778 |
Clinical Use of Stem Cells for the Treatment of Covid-19 |
https://ClinicalTrials.gov/show/NCT04392778 |
| NCT04393077 |
Emotional Freedom Technique (EFT) Effect on Nurses |
https://ClinicalTrials.gov/show/NCT04393077 |
| NCT04392713 |
Efficacy of Ivermectin in COVID-19 |
https://ClinicalTrials.gov/show/NCT04392713 |
| NCT04393246 |
mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Experimental Drugs and Mechanisms |
https://ClinicalTrials.gov/show/NCT04393246 |
| NCT04393038 |
ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04393038 |
| NCT04392973 |
FAvipiravir and HydroxyChloroquine Combination Therapy |
https://ClinicalTrials.gov/show/NCT04392973 |
| NCT04392323 |
Incidence of COVID-19 Test Conversion in Post-surgical Patients |
https://ClinicalTrials.gov/show/NCT04392323 |
| NCT04392414 |
Hyperimmune Convalescent Plasma in Moderate and Severe COVID-19 Disease |
https://ClinicalTrials.gov/show/NCT04392414 |
| NCT04392141 |
Colchicine Plus Phenolic Monoterpenes to Treat COVID-19 |
https://ClinicalTrials.gov/show/NCT04392141 |
| NCT04392232 |
A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection |
https://ClinicalTrials.gov/show/NCT04392232 |
| NCT04392219 |
COVID-19 First In Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of EIDD-2801 in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT04392219 |
| NCT04391829 |
Detection of SARS-CoV-2 in Semen of COVID-19 Positive Males |
https://ClinicalTrials.gov/show/NCT04391829 |
| NCT04391712 |
Photobiomodulation Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease |
https://ClinicalTrials.gov/show/NCT04391712 |
| NCT04391140 |
Prone Positioning and High-flow Nasal Cannula in COVID-19 Induced ARDS |
https://ClinicalTrials.gov/show/NCT04391140 |
| NCT04391127 |
Hydroxychloroquine and Ivermectin for the Treatment of COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04391127 |
| NCT04390594 |
Efficacy and Safety Evaluation of Treatment Regimens in Adult COVID-19 Patients in Senegal |
https://ClinicalTrials.gov/show/NCT04390594 |
| NCT04390516 |
Respiratory Decompensation and Model for the Triage of COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04390516 |
| NCT04390191 |
Early CPAP in COVID-19 Confirmed or Suspected Patients |
https://ClinicalTrials.gov/show/NCT04390191 |
| NCT04390178 |
Convalescent Plasma as Treatment for Acute Coronavirus Disease (COVID-19) |
https://ClinicalTrials.gov/show/NCT04390178 |
| NCT04390152 |
Safety and Efficacy of Intravenous Wharton’s Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19 |
https://ClinicalTrials.gov/show/NCT04390152 |
| NCT04390139 |
Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19 |
https://ClinicalTrials.gov/show/NCT04390139 |
| NCT04390503 |
Convalescent Plasma for COVID-19 Close Contacts |
https://ClinicalTrials.gov/show/NCT04390503 |
| NCT04390477 |
Study to Evaluate the Effect of a Probiotic in COVID-19 |
https://ClinicalTrials.gov/show/NCT04390477 |
| NCT04390464 |
mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Repurposed Drugs (TACTIC-R) |
https://ClinicalTrials.gov/show/NCT04390464 |
| NCT04390412 |
Low Dose Radiotherapy in COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04390412 |
| NCT04390022 |
Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial |
https://ClinicalTrials.gov/show/NCT04390022 |
| NCT04389944 |
Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04389944 |
| NCT04389710 |
Convalescent Plasma for the Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04389710 |
| NCT04389333 |
Feasibility of Non-contact Magnetically-controlled Capsule Endoscopy During COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04389333 |
| NCT04389450 |
Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04389450 |
| NCT04389385 |
COVID-19 Specific T Cell Derived Exosomes (CSTC-Exo) |
https://ClinicalTrials.gov/show/NCT04389385 |
| NCT04389372 |
Effectiveness and Acceptability of MINDFULNESS by Smartphone, for Patients With Chronic Migraine and Medication Overuse |
https://ClinicalTrials.gov/show/NCT04389372 |
| NCT04388514 |
Blood Ozonization in Patients With SARS-CoV-2 Respiratory Failure |
https://ClinicalTrials.gov/show/NCT04388514 |
| NCT04388410 |
Safety and Efficacy of Convalescent Plasma Transfusion for Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04388410 |
| NCT04387955 |
Analysis of Chilblains pROfile During coVID-19 Epidemic (ACROVID) |
https://ClinicalTrials.gov/show/NCT04387955 |
| NCT04387760 |
Favipiravir vs Hydroxychloroquine in COVID -19 |
https://ClinicalTrials.gov/show/NCT04387760 |
| NCT04387409 |
Study to Assess VPM1002 in Reducing Healthcare Professionals’ Absenteeism in COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04387409 |
| NCT04387292 |
Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic |
https://ClinicalTrials.gov/show/NCT04387292 |
| NCT04387253 |
Study of Late Fetal Loss in Poitou-Charentes. GYNE-COVID |
https://ClinicalTrials.gov/show/NCT04387253 |
| NCT04386850 |
Oral 25-hydroxyvitamin D3 and COVID-19 |
https://ClinicalTrials.gov/show/NCT04386850 |
| NCT04386798 |
Stress and Anxiety Levels of Mothers Lying in the Baby Newborn Intensive Care Unit |
https://ClinicalTrials.gov/show/NCT04386798 |
| NCT04386291 |
Meditation and Kundalini Yoga for Heightened Anxiety Related to COVID-19 |
https://ClinicalTrials.gov/show/NCT04386291 |
| NCT04386694 |
Photobiomodulation Therapy Combined With Static Magnetic Field in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04386694 |
| NCT04386668 |
Let It Out (LIO) and COVID19: Testing an Online Emotional Disclosure-based Intervention During the COVID19 Pandemic |
https://ClinicalTrials.gov/show/NCT04386668 |
| NCT04386239 |
Study on the Use of Sarilumab in Patients With COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04386239 |
| NCT04385836 |
Trial of Alpha One Antitrypsin Inhalation in Treating Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) |
https://ClinicalTrials.gov/show/NCT04385836 |
| NCT04385810 |
Description of Ophthalmologic Injuries in Intensive Care During the SARS-CoV2 Epidemic - COVID19 |
https://ClinicalTrials.gov/show/NCT04385810 |
| NCT04385771 |
Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation |
https://ClinicalTrials.gov/show/NCT04385771 |
| NCT04385199 |
Convalescent Plasma for Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04385199 |
| NCT04385108 |
Predictive Immune Biomarkers for COVID-19 Pathogenesis |
https://ClinicalTrials.gov/show/NCT04385108 |
| NCT04385095 |
Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection |
https://ClinicalTrials.gov/show/NCT04385095 |
| NCT04384900 |
Accelerated Prone Position Ventilation of Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04384900 |
| NCT04385043 |
Hyperimmune Plasma in Patients With COVID-19 Severe Infection |
https://ClinicalTrials.gov/show/NCT04385043 |
| NCT04385017 |
Role of Inflammasomes in COVID-19 Disease |
https://ClinicalTrials.gov/show/NCT04385017 |
| NCT04384458 |
Comparative Study of Hydroxychloroquine and Ivermectin in COVID-19 Prophylaxis |
https://ClinicalTrials.gov/show/NCT04384458 |
| NCT04384445 |
Zofin (Organicell Flow) for Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04384445 |
| NCT04384380 |
Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04384380 |
| NCT04384588 |
COVID19-Convalescent Plasma for Treating Patients With Active Symptomatic COVID 19 Infection (FALP-COVID) |
https://ClinicalTrials.gov/show/NCT04384588 |
| NCT04384549 |
Efficacy of BCG Vaccination in the Prevention of COVID19 Via the Strengthening of Innate Immunity in Health Care Workers |
https://ClinicalTrials.gov/show/NCT04384549 |
| NCT04384497 |
Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study |
https://ClinicalTrials.gov/show/NCT04384497 |
| NCT04382846 |
Novel Regimens in COVID-19 Treatment |
https://ClinicalTrials.gov/show/NCT04382846 |
| NCT04382768 |
Inhaled Ibuprofen to Treat COVID-19 |
https://ClinicalTrials.gov/show/NCT04382768 |
| NCT04382560 |
Coping Strategies and Responsiveness to a Brief Online Intervention During COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04382560 |
| NCT04382547 |
Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells |
https://ClinicalTrials.gov/show/NCT04382547 |
| NCT04382391 |
Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms |
https://ClinicalTrials.gov/show/NCT04382391 |
| NCT04380818 |
Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19 |
https://ClinicalTrials.gov/show/NCT04380818 |
| NCT04729491 |
EAT-DUTA AndroCoV Trial |
https://ClinicalTrials.gov/show/NCT04729491 |
| NCT04380532 |
Tableted COVID-19 Therapeutic Vaccine |
https://ClinicalTrials.gov/show/NCT04380532 |
| NCT04380519 |
Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19) |
https://ClinicalTrials.gov/show/NCT04380519 |
| NCT04379661 |
SUNLIGHT Study: Online Support Groups for MS to Address COVID-19 |
https://ClinicalTrials.gov/show/NCT04379661 |
| NCT04379518 |
Rintatolimod and IFN Alpha-2b for the Treatment of Mild or Moderate COVID-19 Infection in Cancer Patients |
https://ClinicalTrials.gov/show/NCT04379518 |
| NCT04379453 |
Robot Assisted Percutaneous Cardiovascular Intervention as a Strategy to Reduce or Risk of Intra-Procedure Contamination by COVID-19 and Other Respiratory Viruses |
https://ClinicalTrials.gov/show/NCT04379453 |
| NCT04379271 |
A Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator’s Choice of Standard of Care Therapy, in Patients With Coronavirus Disease 19 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04379271 |
| NCT04378738 |
Social Media and Covid19 Pandemic |
https://ClinicalTrials.gov/show/NCT04378738 |
| NCT04378712 |
Hydrogen/Oxygen Mixed Gas Inhalation for Coronavirus Disease 2019 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04378712 |
| NCT04377750 |
The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation |
https://ClinicalTrials.gov/show/NCT04377750 |
| NCT04377711 |
A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04377711 |
| NCT04377672 |
Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04377672 |
| NCT04377620 |
Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT) |
https://ClinicalTrials.gov/show/NCT04377620 |
| NCT04377568 |
Efficacy of Human Coronavirus-immune Convalescent Plasma for the Treatment of COVID-19 Disease in Hospitalized Children |
https://ClinicalTrials.gov/show/NCT04377568 |
| NCT04377477 |
COVID-19 Pneumonitis Low Dose Lung Radiotherapy (COLOR-19) |
https://ClinicalTrials.gov/show/NCT04377477 |
| NCT04377165 |
Innovative Tool to Limit Spread of SARS-CoV-2 (COVID 19) in Residential Aged Care Facilities |
https://ClinicalTrials.gov/show/NCT04377165 |
| NCT04376684 |
Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease |
https://ClinicalTrials.gov/show/NCT04376684 |
| NCT04376476 |
Host-pathogen Interactions During SARS-CoV-2 Infection |
https://ClinicalTrials.gov/show/NCT04376476 |
| NCT04376034 |
Convalescent Plasma Collection and Treatment in Pediatrics and Adults |
https://ClinicalTrials.gov/show/NCT04376034 |
| NCT04374019 |
Novel Agents for Treatment of High-risk COVID-19 Positive Patients |
https://ClinicalTrials.gov/show/NCT04374019 |
| NCT04375397 |
Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury |
https://ClinicalTrials.gov/show/NCT04375397 |
| NCT04375124 |
Treatment of Angiotensin Peptide (1-7) for COVID-19 |
https://ClinicalTrials.gov/show/NCT04375124 |
| NCT04375098 |
Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04375098 |
| NCT04374942 |
Does Hydroxychloroquine Before & During Patient Exposure Protect Healthcare Workers From Coronavirus? |
https://ClinicalTrials.gov/show/NCT04374942 |
| NCT04374591 |
The Role of Sodium Bicarbonate as Adjuvant Treatment of Computed Tomography Identified COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04374591 |
| NCT04374565 |
Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia |
https://ClinicalTrials.gov/show/NCT04374565 |
| NCT04374539 |
Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial |
https://ClinicalTrials.gov/show/NCT04374539 |
| NCT04374526 |
Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression. |
https://ClinicalTrials.gov/show/NCT04374526 |
| NCT04374487 |
Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications |
https://ClinicalTrials.gov/show/NCT04374487 |
| NCT04374149 |
Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS |
https://ClinicalTrials.gov/show/NCT04374149 |
| NCT04374084 |
Moxibustion Plus Cupping in Convalescent Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04374084 |
| NCT04374032 |
Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04374032 |
| NCT04373161 |
Home Pulse Oximeter Use in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04373161 |
| NCT04373824 |
Max Ivermectin- COVID 19 Study Versus Standard of Care Treatment for COVID 19 Cases. A Pilot Study |
https://ClinicalTrials.gov/show/NCT04373824 |
| NCT04383574 |
Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19) |
https://ClinicalTrials.gov/show/NCT04383574 |
| NCT04383535 |
Convalescent Plasma and Placebo for the Treatment of COVID-19 Severe Pneumonia |
https://ClinicalTrials.gov/show/NCT04383535 |
| NCT04383002 |
High Dose Inhaled Nitric Oxide for COVID-19 (ICU Patients) |
https://ClinicalTrials.gov/show/NCT04383002 |
| NCT04382924 |
Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Hospitalized Patient With Confirmed COVID-19 Disease |
https://ClinicalTrials.gov/show/NCT04382924 |
| NCT04382755 |
Zilucoplan® in Improving Oxygenation and Short- and Long-term Outcome of COVID-19 Patients With Acute Hypoxic Respiratory Failure |
https://ClinicalTrials.gov/show/NCT04382755 |
| NCT04382729 |
Neuromuscular Electrical Stimulation in Patients With COVID19 Associated Pneumonia |
https://ClinicalTrials.gov/show/NCT04382729 |
| NCT04382651 |
Study of Efficacy and Safety of MAS825 in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04382651 |
| NCT04382131 |
Hypertonic Saline Nasal Irrigation and Gargling in Suspected or Confirmed COVID-19 (ELVIS COVID-19) |
https://ClinicalTrials.gov/show/NCT04382131 |
| NCT04382092 |
Co-infection Management in COVID-19 Critically Ill |
https://ClinicalTrials.gov/show/NCT04382092 |
| NCT04382066 |
Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04382066 |
| NCT04382053 |
Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04382053 |
| NCT04382040 |
A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19 |
https://ClinicalTrials.gov/show/NCT04382040 |
| NCT04381988 |
A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy |
https://ClinicalTrials.gov/show/NCT04381988 |
| NCT04381962 |
A Multicentre Open-label Two-arm Randomised Superiority Clinical Trial of Azithromycin Versus Usual Care In Ambulatory COVID19 (ATOMIC2) |
https://ClinicalTrials.gov/show/NCT04381962 |
| NCT04381884 |
Ivermectin Effect on SARS-CoV-2 Replication in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04381884 |
| NCT04381858 |
Convalescent Plasma vs Human Immunoglobulin to Treat COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04381858 |
| NCT04381364 |
Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19) |
https://ClinicalTrials.gov/show/NCT04381364 |
| NCT04381000 |
Quarantine and Telerehabilitation in Chronic Pain Patients During COVID-19 Pandemic. |
https://ClinicalTrials.gov/show/NCT04381000 |
| NCT04380935 |
Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome |
https://ClinicalTrials.gov/show/NCT04380935 |
| NCT04380909 |
ROCO - Self-help for People With Psychological Distress Due to the Covid-19 Situation |
https://ClinicalTrials.gov/show/NCT04380909 |
| NCT04380688 |
Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19. |
https://ClinicalTrials.gov/show/NCT04380688 |
| NCT04380376 |
Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia |
https://ClinicalTrials.gov/show/NCT04380376 |
| NCT04379531 |
LDCT in COVID-19 Pneumonia: a Prospective Moscow Study |
https://ClinicalTrials.gov/show/NCT04379531 |
| NCT04379375 |
Nudges to Improve Health Behaviors That Limit COVID-19 Spread |
https://ClinicalTrials.gov/show/NCT04379375 |
| NCT04379336 |
BCG Vaccination for Healthcare Workers in COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04379336 |
| NCT04379154 |
Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by SARS-COV-2 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04379154 |
| NCT04379037 |
Vagus Nerve Stimulation ARDS Prevention Trial for COVID-19 Hospitalized Patients |
https://ClinicalTrials.gov/show/NCT04379037 |
| NCT04378803 |
Mindfulness Training for Seniors |
https://ClinicalTrials.gov/show/NCT04378803 |
| NCT04377659 |
Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04377659 |
| NCT04377308 |
Fluoxetine to Reduce Intubation and Death After COVID19 Infection |
https://ClinicalTrials.gov/show/NCT04377308 |
| NCT04376840 |
Prevalence of Long-term Respiratory Complications of Severe SARS-CoV-2 Pneumonia - COVID-19 |
https://ClinicalTrials.gov/show/NCT04376840 |
| NCT04376814 |
Favipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19 |
https://ClinicalTrials.gov/show/NCT04376814 |
| NCT04376788 |
Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04376788 |
| NCT04376593 |
PET/CT Imaging in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04376593 |
| NCT04376515 |
Harnessing Online Peer Education Online Support Intervention for COVID-19 (HOPE COVID-19) |
https://ClinicalTrials.gov/show/NCT04376515 |
| NCT04375774 |
Verification of Alternative Do-it-yourself Equipment Respirators for the COVID-19 Personal Protective Equipment (PPE) |
https://ClinicalTrials.gov/show/NCT04375774 |
| NCT04375202 |
Colchicine in COVID-19: a Pilot Study |
https://ClinicalTrials.gov/show/NCT04375202 |
| NCT04374786 |
Effects of Mobile App in House Staff Health and Well-being During COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04374786 |
| NCT04374461 |
A Study of N-acetylcysteine in Patients With COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04374461 |
| NCT04373460 |
Convalescent Plasma to Limit SARS-CoV-2 Associated Complications |
https://ClinicalTrials.gov/show/NCT04373460 |
| NCT04373707 |
Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19 |
https://ClinicalTrials.gov/show/NCT04373707 |
| NCT04373044 |
Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04373044 |
| NCT04373200 |
Human Ab Response & immunoMONItoring of COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04373200 |
| NCT04373135 |
Understanding Community Considerations, Opinions, Values, Impacts, and Decisions for COVID-19 |
https://ClinicalTrials.gov/show/NCT04373135 |
| NCT04373096 |
Enhanced Hood PPE to Minimize COVID-19 Transmission to Front-line Health Care Workers |
https://ClinicalTrials.gov/show/NCT04373096 |
| NCT04373382 |
Peer Champion Support for Hospital Staff During and After the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04373382 |
| NCT04372979 |
Efficacy of Convalescent Plasma Therapy in the Early Care of COVID-19 Patients. |
https://ClinicalTrials.gov/show/NCT04372979 |
| NCT04372693 |
Unplanned Shifting to Online Distance Learning: Nursing Students’ Perception and Achievement |
https://ClinicalTrials.gov/show/NCT04372693 |
| NCT04372680 |
WeanINg From Mechanical Ventilation for ARDS CovId-19 Patients Guided by Combined Thoracic UltraSound |
https://ClinicalTrials.gov/show/NCT04372680 |
| NCT04372628 |
Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19 |
https://ClinicalTrials.gov/show/NCT04372628 |
| NCT04372017 |
Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04372017 |
| NCT04372004 |
Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19) |
https://ClinicalTrials.gov/show/NCT04372004 |
| NCT04371978 |
Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19 |
https://ClinicalTrials.gov/show/NCT04371978 |
| NCT04371965 |
Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Naso- Pharyngeal Viral Load in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04371965 |
| NCT04371419 |
COVID-19 Health Messaging to Underserved Communities |
https://ClinicalTrials.gov/show/NCT04371419 |
| NCT04371601 |
Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019 |
https://ClinicalTrials.gov/show/NCT04371601 |
| NCT04371393 |
MSCs in COVID-19 ARDS |
https://ClinicalTrials.gov/show/NCT04371393 |
| NCT04371367 |
Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia ( FORCE ) |
https://ClinicalTrials.gov/show/NCT04371367 |
| NCT04371510 |
Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Chronic Haemodialysis Patients |
https://ClinicalTrials.gov/show/NCT04371510 |
| NCT04370886 |
Recruit Blood Donors Via SMS During Epidemic of COVID-19 |
https://ClinicalTrials.gov/show/NCT04370886 |
| NCT04371029 |
Impact of Neck Inspiratory Muscle Activation During Sleep in ICU Patients After a COVID 19 ARDS |
https://ClinicalTrials.gov/show/NCT04371029 |
| NCT04370834 |
Tocilizumab for Patients With Cancer and COVID-19 Disease |
https://ClinicalTrials.gov/show/NCT04370834 |
| NCT04370782 |
Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting |
https://ClinicalTrials.gov/show/NCT04370782 |
| NCT04370288 |
Clinical Application of Methylene Blue for Treatment of Covid-19 Patients |
https://ClinicalTrials.gov/show/NCT04370288 |
| NCT04370262 |
Multi-site Adaptive Trials for COVID-19 |
https://ClinicalTrials.gov/show/NCT04370262 |
| NCT04369820 |
C5a Receptor Expression - COVID-19 (C5-COV) |
https://ClinicalTrials.gov/show/NCT04369820 |
| NCT04369794 |
COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement |
https://ClinicalTrials.gov/show/NCT04369794 |
| NCT04369378 |
Effectiveness of Using a Meditation App in Reducing Anxiety and Improving Well-being During the Covid-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04369378 |
| NCT04369365 |
A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic |
https://ClinicalTrials.gov/show/NCT04369365 |
| NCT04369456 |
Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients |
https://ClinicalTrials.gov/show/NCT04369456 |
| NCT04368988 |
Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant |
https://ClinicalTrials.gov/show/NCT04368988 |
| NCT04368923 |
Management of Covid-19 Patients During Home Isolation |
https://ClinicalTrials.gov/show/NCT04368923 |
| NCT04368676 |
Breath Regulation and Yogic Exercise An Online Therapy for Calm and Happiness |
https://ClinicalTrials.gov/show/NCT04368676 |
| NCT04707534 |
Dexamethasone for COVID-19 |
https://ClinicalTrials.gov/show/NCT04707534 |
| NCT04368260 |
Clinical Validation of New Injection Molded Flocked Nasopharyngeal Swabs in Response to the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04368260 |
| NCT04368377 |
Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04368377 |
| NCT04368299 |
Telemedicine for Follow-up of Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT04368299 |
| NCT04367662 |
Study of the Vascular Compartment and Hypercoagulability During Coronavirus Infection COVID-19 |
https://ClinicalTrials.gov/show/NCT04367662 |
| NCT04367831 |
Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04367831 |
| NCT04368000 |
Prone Positioning in Awake Patients With COVID-19 Requiring Hospitalization |
https://ClinicalTrials.gov/show/NCT04368000 |
| NCT04367545 |
Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04367545 |
| NCT04689542 |
Surgical Face Mask Effects in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04689542 |
| NCT04367168 |
Colchicine Twice Daily During 10 Days as an Option for the Treatment of Symptoms Induced by Inflammation in Patients With Mild and Severe Coronavirus Disease |
https://ClinicalTrials.gov/show/NCT04367168 |
| NCT04366960 |
Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04366960 |
| NCT04367077 |
MultiStem Administration for COVID-19 Induced ARDS (MACoVIA) |
https://ClinicalTrials.gov/show/NCT04367077 |
| NCT04366882 |
Minimal Invasive Autopsies to Investigate Changes in Deceased COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04366882 |
| NCT04366947 |
Intravascular Access in Suspected/Confirmed COVID-19 Patient |
https://ClinicalTrials.gov/show/NCT04366947 |
| NCT04366856 |
PROne Positioning in coVID-19 Oxygeno-dependent Patients in Spontaneous Ventilation (PROVID Study) |
https://ClinicalTrials.gov/show/NCT04366856 |
| NCT04366323 |
Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19 |
https://ClinicalTrials.gov/show/NCT04366323 |
| NCT04366271 |
Clinical Trial of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04366271 |
| NCT04682041 |
Evaluating the Impact of EnteraGam In People With COVID-19 |
https://ClinicalTrials.gov/show/NCT04682041 |
| NCT04366297 |
Intravascular Access of COVID-19 Patient Under Personal Protective Equipment |
https://ClinicalTrials.gov/show/NCT04366297 |
| NCT04366180 |
Evaluation of the Probiotic Lactobacillus Coryniformis K8 on COVID-19 Prevention in Healthcare Workers |
https://ClinicalTrials.gov/show/NCT04366180 |
| NCT04366245 |
Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04366245 |
| NCT04366232 |
Efficacy of Intravenous Anakinra and Ruxolitinib During COVID-19 Inflammation |
https://ClinicalTrials.gov/show/NCT04366232 |
| NCT04366141 |
COVID-19 (Coronavirus Disease 2019) Intubation Barrier Box |
https://ClinicalTrials.gov/show/NCT04366141 |
| NCT04365985 |
Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19 |
https://ClinicalTrials.gov/show/NCT04365985 |
| NCT04365972 |
Attention Bias Modification for Reducing Health Anxiety During the Coronavirus Pandemic |
https://ClinicalTrials.gov/show/NCT04365972 |
| NCT04366089 |
Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora |
https://ClinicalTrials.gov/show/NCT04366089 |
| NCT04365738 |
Pulmonary Rehabilitation in Post-Acute Period of COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04365738 |
| NCT04366063 |
Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress Syndrome |
https://ClinicalTrials.gov/show/NCT04366063 |
| NCT04365699 |
Cardiovascular Effects of COVID-19 |
https://ClinicalTrials.gov/show/NCT04365699 |
| NCT04366050 |
Ramipril for the Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04366050 |
| NCT04365309 |
Protective Effect of Aspirin on COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04365309 |
| NCT04365257 |
Prazosin to Prevent COVID-19 (PREVENT-COVID Trial) |
https://ClinicalTrials.gov/show/NCT04365257 |
| NCT04365608 |
Prehospital Intubation of COVID-19 Patient With Personal Protective Equipment |
https://ClinicalTrials.gov/show/NCT04365608 |
| NCT04365127 |
Progesterone for the Treatment of COVID-19 in Hospitalized Men |
https://ClinicalTrials.gov/show/NCT04365127 |
| NCT04365101 |
Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 |
https://ClinicalTrials.gov/show/NCT04365101 |
| NCT04364802 |
COVID-19: Povidone-Iodine Intranasal Prophylaxis in Front-line Healthcare Personnel and Inpatients |
https://ClinicalTrials.gov/show/NCT04364802 |
| NCT04364893 |
Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19 |
https://ClinicalTrials.gov/show/NCT04364893 |
| NCT04364763 |
A Study to Evaluate the Effect of RBT-9 on Progression of COVID-19 in High-Risk Individuals (The PREVENT Study) |
https://ClinicalTrials.gov/show/NCT04364763 |
| NCT04364594 |
COVID-19 Search in Conjunctival Cells |
https://ClinicalTrials.gov/show/NCT04364594 |
| NCT04363814 |
Clinical Impact of BACTEK-R in Subject With Mild Pneumonia Due to COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04363814 |
| NCT04364022 |
Efficacy of Pragmatic Same-day COVID-19 Ring Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland |
https://ClinicalTrials.gov/show/NCT04364022 |
| NCT04364009 |
Anakinra for COVID-19 Respiratory Symptoms |
https://ClinicalTrials.gov/show/NCT04364009 |
| NCT04363736 |
A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04363736 |
| NCT04363541 |
Local Thermotherapy for Patients With Mild-to-moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04363541 |
| NCT04363853 |
Tocilizumab Treatment in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04363853 |
| NCT04363528 |
Incidence of Deep Vein Thrombosis at Doppler Echo in Covid-19 Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU |
https://ClinicalTrials.gov/show/NCT04363528 |
| NCT04363463 |
Impact of Prone Position in Patients Under Spontaneous Breathing on Intubation or Non-invasive Ventilation or Death Incidence During COVID-19 Acute Respiratory Distress |
https://ClinicalTrials.gov/show/NCT04363463 |
| NCT04363450 |
Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP) |
https://ClinicalTrials.gov/show/NCT04363450 |
| NCT04363437 |
COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19 |
https://ClinicalTrials.gov/show/NCT04363437 |
| NCT04363385 |
Collection of Biological Samples With Clinical Characterization of Covid-19 Patients |
https://ClinicalTrials.gov/show/NCT04363385 |
| NCT04363372 |
A Study for Efficacy and Safety of Live Biotherapeutic MRx4DP0004 to Treat COVID-19 |
https://ClinicalTrials.gov/show/NCT04363372 |
| NCT04363606 |
Chronic Fatigue Etiology and Recovery in Covid-19 Patients: the Role of Fatigability |
https://ClinicalTrials.gov/show/NCT04363606 |
| NCT04363593 |
Serology COVID-19 From the Cornwall Hospital Union |
https://ClinicalTrials.gov/show/NCT04363593 |
| NCT04362332 |
Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04362332 |
| NCT04361942 |
Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stromal Cells (COVID_MSV) |
https://ClinicalTrials.gov/show/NCT04361942 |
| NCT04361916 |
Home Care for Patients With COVID-19: Active Monitoring in Two Italian Health Units (Casale Monferrato and Torino) |
https://ClinicalTrials.gov/show/NCT04361916 |
| NCT04362189 |
Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04362189 |
| NCT04362176 |
Passive Immunity Trial for Our Nation to Treat COVID-19 in Hospitalized Adults |
https://ClinicalTrials.gov/show/NCT04362176 |
| NCT04362111 |
Early Treatment of Cytokine Storm Syndrome in Covid-19 |
https://ClinicalTrials.gov/show/NCT04362111 |
| NCT04362059 |
A Clinical Trial of Nebulized Surfactant for the Treatment of Moderate to Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04362059 |
| NCT04362137 |
Phase 3 Randomized, Double-blind, Placebo-controlled Multi-center Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm (RUXCOVID) |
https://ClinicalTrials.gov/show/NCT04362137 |
| NCT04361838 |
The COVID-19 ICU PRAYER Study |
https://ClinicalTrials.gov/show/NCT04361838 |
| NCT04361526 |
Pilot Study on Cytokine Filtration in COVID-19 ARDS |
https://ClinicalTrials.gov/show/NCT04361526 |
| NCT04361474 |
Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity |
https://ClinicalTrials.gov/show/NCT04361474 |
| NCT04361253 |
Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy |
https://ClinicalTrials.gov/show/NCT04361253 |
| NCT04361214 |
Leflunomide in Mild COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04361214 |
| NCT04361396 |
Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum of COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04361396 |
| NCT04358614 |
Baricitinib Therapy in COVID-19 |
https://ClinicalTrials.gov/show/NCT04358614 |
| NCT04360980 |
The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection |
https://ClinicalTrials.gov/show/NCT04360980 |
| NCT04360837 |
PEEP Incremental and Decremental Alveolar Recruitment of Critically Ill Corona Virus Disease-19 (COVID-19) Patients |
https://ClinicalTrials.gov/show/NCT04360837 |
| NCT04360824 |
Covid-19 Associated Coagulopathy |
https://ClinicalTrials.gov/show/NCT04360824 |
| NCT04360811 |
Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04360811 |
| NCT04360551 |
Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04360551 |
| NCT04359537 |
Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19 |
https://ClinicalTrials.gov/show/NCT04359537 |
| NCT04359654 |
Nebulised Dornase Alfa for Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04359654 |
| NCT04359953 |
Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04359953 |
| NCT04359901 |
Sarilumab for Patients With Moderate COVID-19 Disease |
https://ClinicalTrials.gov/show/NCT04359901 |
| NCT04359862 |
Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection |
https://ClinicalTrials.gov/show/NCT04359862 |
| NCT04359810 |
Plasma Therapy of COVID-19 in Severely Ill Patients |
https://ClinicalTrials.gov/show/NCT04359810 |
| NCT04359797 |
COVID-19 Patient Positioning Pragmatic Trial |
https://ClinicalTrials.gov/show/NCT04359797 |
| NCT04359329 |
Estrogen Patch for COVID-19 Symptoms |
https://ClinicalTrials.gov/show/NCT04359329 |
| NCT04359290 |
Ruxolitinib for Treatment of Covid-19 Induced Lung Injury ARDS |
https://ClinicalTrials.gov/show/NCT04359290 |
| NCT04359277 |
A Randomized Trial of Anticoagulation Strategies in COVID-19 |
https://ClinicalTrials.gov/show/NCT04359277 |
| NCT04359264 |
Direct Income SupporT and Advice Negating Spread of Epidemic COVID-19: a Randomized Controlled Trial |
https://ClinicalTrials.gov/show/NCT04359264 |
| NCT04359251 |
Different PEEP Settings of COVID-19 Induced ARDS |
https://ClinicalTrials.gov/show/NCT04359251 |
| NCT04358939 |
Prone Position in Patients on High-flow Nasal Oxygen Therapy for COVID-19 (HIGH-PRONE-COVID-19) |
https://ClinicalTrials.gov/show/NCT04358939 |
| NCT04358809 |
Clinical Trial of Mycobacterium w in COVID-19 Positive Patients, Hospitalized But Not Critically Ill |
https://ClinicalTrials.gov/show/NCT04358809 |
| NCT04358783 |
Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia |
https://ClinicalTrials.gov/show/NCT04358783 |
| NCT04355728 |
Use of UC-MSCs for COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04355728 |
| NCT04358081 |
Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease |
https://ClinicalTrials.gov/show/NCT04358081 |
| NCT04358068 |
Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19 |
https://ClinicalTrials.gov/show/NCT04358068 |
| NCT04358003 |
Plasma Adsorption in Patients With Confirmed COVID-19 |
https://ClinicalTrials.gov/show/NCT04358003 |
| NCT04357990 |
Viruxal Oral and Nasal Spray for Treating the Symptoms of COVID-19 |
https://ClinicalTrials.gov/show/NCT04357990 |
| NCT04357730 |
Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04357730 |
| NCT04357457 |
Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related Pneumonia |
https://ClinicalTrials.gov/show/NCT04357457 |
| NCT04357782 |
Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation |
https://ClinicalTrials.gov/show/NCT04357782 |
| NCT04357444 |
Low Dose of IL-2 In Acute Respiratory DistrEss Syndrome Related to COVID-19 |
https://ClinicalTrials.gov/show/NCT04357444 |
| NCT04357340 |
The Effects of Pulmonary Physiotherapy Treatments on Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04357340 |
| NCT04357327 |
Rapid Salivary Test to Detect SARS-CoV-2 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04357327 |
| NCT04357106 |
COPLA Study: Treatment of Severe Forms of COronavirus Infection With Convalescent PLAsma |
https://ClinicalTrials.gov/show/NCT04357106 |
| NCT04356937 |
Efficacy of Tocilizumab on Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04356937 |
| NCT04356833 |
Nebulised Rt-PA for ARDS Due to COVID-19 |
https://ClinicalTrials.gov/show/NCT04356833 |
| NCT04356690 |
Etoposide in Patients With COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04356690 |
| NCT04356495 |
Trial of COVID-19 Outpatient Treatment in Individuals With Risk Factors for Aggravation |
https://ClinicalTrials.gov/show/NCT04356495 |
| NCT04356482 |
CONVALESCENT PLASMA FOR ILL PATIENTS BY COVID-19 |
https://ClinicalTrials.gov/show/NCT04356482 |
| NCT04356534 |
Convalescent Plasma Trial in COVID -19 Patients |
https://ClinicalTrials.gov/show/NCT04356534 |
| NCT04590430 |
Study to Assess the Safety, Tolerability, and Pharmacokinetics of HFB30132A Against COVID-19 in Healthy Adults |
https://ClinicalTrials.gov/show/NCT04590430 |
| NCT04591613 |
Late Clinical Events Associated With COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04591613 |
| NCT04355936 |
Telmisartan for Treatment of COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04355936 |
| NCT04355897 |
CoVID-19 Plasma in Treatment of COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04355897 |
| NCT04355767 |
Convalescent Plasma in Outpatients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04355767 |
| NCT04355962 |
Sevoflurane in COVID-19 ARDS (SevCov) |
https://ClinicalTrials.gov/show/NCT04355962 |
| NCT04355637 |
Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia |
https://ClinicalTrials.gov/show/NCT04355637 |
| NCT04355364 |
Efficacy and Safety of aerosolizedDornase Alfa Administration in Patients With COVID19 Induced ARDS (COVIDORNASE) |
https://ClinicalTrials.gov/show/NCT04355364 |
| NCT04355351 |
Study of Immune Response During SARS-CoV-2 Infection - (COVID-19) |
https://ClinicalTrials.gov/show/NCT04355351 |
| NCT04355533 |
Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19 |
https://ClinicalTrials.gov/show/NCT04355533 |
| NCT04354870 |
COVID-19 PrEP HCW HCQ Study |
https://ClinicalTrials.gov/show/NCT04354870 |
| NCT04355247 |
Prophylactic Corticosteroid to Prevent COVID-19 Cytokine Storm |
https://ClinicalTrials.gov/show/NCT04355247 |
| NCT04355234 |
Prevalence and Impact of COVID-19 Infection in Pregnant Women, Fetuses and Newborns |
https://ClinicalTrials.gov/show/NCT04355234 |
| NCT04355143 |
Colchicine to Reduce Cardiac Injury in COVID-19 (COLHEART-19) |
https://ClinicalTrials.gov/show/NCT04355143 |
| NCT04355026 |
Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04355026 |
| NCT04354831 |
A Study Evaluating the Efficacy and Safety of High-Titer Anti-SARS-CoV-2 Plasma in Hospitalized Patients With COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04354831 |
| NCT04354610 |
Cardiovascular and Renal Biomarkers to Predict Acute Heart or Kidney Injury in Severe Covid-19 Infection |
https://ClinicalTrials.gov/show/NCT04354610 |
| NCT04354428 |
Treatment for COVID-19 in High-Risk Adult Outpatients |
https://ClinicalTrials.gov/show/NCT04354428 |
| NCT04354259 |
Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19 |
https://ClinicalTrials.gov/show/NCT04354259 |
| NCT04354155 |
COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial |
https://ClinicalTrials.gov/show/NCT04354155 |
| NCT04353674 |
Modulation of Hyperinflammation in COVID-19 |
https://ClinicalTrials.gov/show/NCT04353674 |
| NCT04353518 |
Clinical Trial to Evaluate Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19 |
https://ClinicalTrials.gov/show/NCT04353518 |
| NCT04353596 |
Stopping ACE-inhibitors in COVID-19 |
https://ClinicalTrials.gov/show/NCT04353596 |
| NCT04353037 |
PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine |
https://ClinicalTrials.gov/show/NCT04353037 |
| NCT04353336 |
Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment |
https://ClinicalTrials.gov/show/NCT04353336 |
| NCT04353284 |
Camostat Mesylate in COVID-19 Outpatients |
https://ClinicalTrials.gov/show/NCT04353284 |
| NCT04353271 |
Trial of Hydroxychloroquine In Covid-19 Kinetics |
https://ClinicalTrials.gov/show/NCT04353271 |
| NCT04353206 |
Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure |
https://ClinicalTrials.gov/show/NCT04353206 |
| NCT04353128 |
Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers. |
https://ClinicalTrials.gov/show/NCT04353128 |
| NCT04352751 |
Experimental Use of Convalescent Plasma for Passive Immunization in Current COVID-19 Pandemic in Pakistan in 2020 |
https://ClinicalTrials.gov/show/NCT04352751 |
| NCT04352608 |
Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19) |
https://ClinicalTrials.gov/show/NCT04352608 |
| NCT04352933 |
PROLIFIC ChemoprophylaxisTrial (COVID-19) |
https://ClinicalTrials.gov/show/NCT04352933 |
| NCT04351763 |
Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms |
https://ClinicalTrials.gov/show/NCT04351763 |
| NCT04352348 |
Cohort of Patients Infected With SARS-CoV2 (COVID-19) or Suspected of Being |
https://ClinicalTrials.gov/show/NCT04352348 |
| NCT04351906 |
Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome |
https://ClinicalTrials.gov/show/NCT04351906 |
| NCT04351620 |
High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19 |
https://ClinicalTrials.gov/show/NCT04351620 |
| NCT04351581 |
Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04351581 |
| NCT04351542 |
Ayurveda for Flu Like Illness During Covid-19 Outbreak |
https://ClinicalTrials.gov/show/NCT04351542 |
| NCT04351789 |
Impact of a Minimal Psychoeducational Intervention on Anxiety Among Hospitalized COVID-19 Patients in Denmark |
https://ClinicalTrials.gov/show/NCT04351789 |
| NCT04351243 |
A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE) |
https://ClinicalTrials.gov/show/NCT04351243 |
| NCT04351347 |
The Efficacy of Ivermectin and Nitazoxanide in COVID-19 Treatment |
https://ClinicalTrials.gov/show/NCT04351347 |
| NCT04351191 |
PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds |
https://ClinicalTrials.gov/show/NCT04351191 |
| NCT04351295 |
Efficacy of Faviprevir in COVID-19 Treatment |
https://ClinicalTrials.gov/show/NCT04351295 |
| NCT04351152 |
Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04351152 |
| NCT04350736 |
First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19 |
https://ClinicalTrials.gov/show/NCT04350736 |
| NCT04350684 |
Umifenovir in Hospitalized COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04350684 |
| NCT04350671 |
Interferon Beta 1a in Hospitalized COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04350671 |
| NCT04350580 |
Polyvalent Immunoglobulin in COVID-19 Related ARds |
https://ClinicalTrials.gov/show/NCT04350580 |
| NCT04350723 |
Awake Prone Position in Hypoxemic Patients With Coronavirus Disease 19 (COVI-PRONE): A Randomized Clinical Trial |
https://ClinicalTrials.gov/show/NCT04350723 |
| NCT04498377 |
Study of F-652 (IL-22:IgG2 Fusion Protein) in Patients With Moderate to Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04498377 |
| NCT04350281 |
Double Therapy With IFN-beta 1b and Hydroxychloroquine |
https://ClinicalTrials.gov/show/NCT04350281 |
| NCT04349410 |
The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol |
https://ClinicalTrials.gov/show/NCT04349410 |
| NCT04349631 |
A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04349631 |
| NCT04349592 |
Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19 |
https://ClinicalTrials.gov/show/NCT04349592 |
| NCT04350320 |
Trial to Study the Benefit of Colchicine in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04350320 |
| NCT04349241 |
Efficacy and Safety of Favipiravir in Management of COVID-19 |
https://ClinicalTrials.gov/show/NCT04349241 |
| NCT04348929 |
Birth Experience During COVID-19 Confinement |
https://ClinicalTrials.gov/show/NCT04348929 |
| NCT04349098 |
Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04349098 |
| NCT04348305 |
Hydrocortisone for COVID-19 and Severe Hypoxia |
https://ClinicalTrials.gov/show/NCT04348305 |
| NCT04348695 |
Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19. |
https://ClinicalTrials.gov/show/NCT04348695 |
| NCT04348656 |
CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1) |
https://ClinicalTrials.gov/show/NCT04348656 |
| NCT04348435 |
A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Allogeneic Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04348435 |
| NCT04348409 |
Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04348409 |
| NCT04348370 |
BCG Vaccine for Health Care Workers as Defense Against COVID 19 |
https://ClinicalTrials.gov/show/NCT04348370 |
| NCT04480138 |
Pegylated Interferon - α2b With SARSCoV- 2 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04480138 |
| NCT04348513 |
Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04348513 |
| NCT04348500 |
Clazakizumab (Anti-IL- 6 Monoclonal) Compared to Placebo for COVID19 Disease |
https://ClinicalTrials.gov/show/NCT04348500 |
| NCT04347980 |
Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19 |
https://ClinicalTrials.gov/show/NCT04347980 |
| NCT04347954 |
PVP-I Nasal Sprays and SARS-CoV-2 Nasopharyngeal Titers (for COVID-19) |
https://ClinicalTrials.gov/show/NCT04347954 |
| NCT04347941 |
Awake Prone Positioning to Reduce Invasive VEntilation in COVID-19 Induced Acute Respiratory failurE |
https://ClinicalTrials.gov/show/NCT04347941 |
| NCT04347915 |
The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04347915 |
| NCT04462627 |
Reduction of COVID 19 Transmission to Health Care Professionals |
https://ClinicalTrials.gov/show/NCT04462627 |
| NCT04347681 |
Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04347681 |
| NCT04347538 |
Impact of Nasal Saline Irrigations on Viral Load in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04347538 |
| NCT04347382 |
Honey & Nigella Sativa Trial Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04347382 |
| NCT04347239 |
Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04347239 |
| NCT04347226 |
Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04347226 |
| NCT04347174 |
A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients |
https://ClinicalTrials.gov/show/NCT04347174 |
| NCT04347031 |
A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19 |
https://ClinicalTrials.gov/show/NCT04347031 |
| NCT04346667 |
Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds |
https://ClinicalTrials.gov/show/NCT04346667 |
| NCT04346628 |
Oral Favipiravir Compared to Placebo in Subjects With Mild COVID-19 |
https://ClinicalTrials.gov/show/NCT04346628 |
| NCT04346589 |
Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients |
https://ClinicalTrials.gov/show/NCT04346589 |
| NCT04346797 |
CORIMUNO19-ECU: Trial Evaluating Efficacy and Safety of Eculizumab (Soliris) in Patients With COVID-19 Infection, Nested in the CORIMUNO-19 Cohort |
https://ClinicalTrials.gov/show/NCT04346797 |
| NCT04346693 |
An Open Randomized Study of Dalargin Effectiveness in Patients With Severe and Critical Manifestations of SARS-COVID-19 |
https://ClinicalTrials.gov/show/NCT04346693 |
| NCT04346446 |
Efficacy of Convalescent Plasma Therapy in Severely Sick COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04346446 |
| NCT04346420 |
Impact of the Double-Trunk Mask on Oxygenation Titration in COVID-19 |
https://ClinicalTrials.gov/show/NCT04346420 |
| NCT04346355 |
Efficacy of Early Administration of Tocilizumab in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04346355 |
| NCT04345991 |
Efficacy of Convalescent Plasma to Treat COVID-19 Patients, a Nested Trial in the CORIMUNO-19 Cohort |
https://ClinicalTrials.gov/show/NCT04345991 |
| NCT04346017 |
Evaluation of Interleukine 6 (and Other Cytokines and Inflammatory Markers) in COVID-19 Patients With a Systemic Inflammatory Response Syndrome |
https://ClinicalTrials.gov/show/NCT04346017 |
| NCT04345653 |
Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers |
https://ClinicalTrials.gov/show/NCT04345653 |
| NCT04345861 |
Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial) |
https://ClinicalTrials.gov/show/NCT04345861 |
| NCT04345848 |
Preventing COVID-19 Complications With Low- and High-dose Anticoagulation |
https://ClinicalTrials.gov/show/NCT04345848 |
| NCT04345549 |
Ayurveda Self-Management for Flu Like Symptoms During the Covid-19 Outbreak |
https://ClinicalTrials.gov/show/NCT04345549 |
| NCT04345289 |
Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04345289 |
| NCT04345276 |
Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection |
https://ClinicalTrials.gov/show/NCT04345276 |
| NCT04345692 |
A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients |
https://ClinicalTrials.gov/show/NCT04345692 |
| NCT04345419 |
Remdesivir vs Chloroquine in Coronavirus Disease |
https://ClinicalTrials.gov/show/NCT04345419 |
| NCT04344951 |
Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial |
https://ClinicalTrials.gov/show/NCT04344951 |
| NCT04344600 |
Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) Infection |
https://ClinicalTrials.gov/show/NCT04344600 |
| NCT04344457 |
Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19 |
https://ClinicalTrials.gov/show/NCT04344457 |
| NCT04344444 |
Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease |
https://ClinicalTrials.gov/show/NCT04344444 |
| NCT04344431 |
Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04344431 |
| NCT04344587 |
Awake Prone Position for Early Hypoxemia in COVID-19 |
https://ClinicalTrials.gov/show/NCT04344587 |
| NCT04344561 |
Incline Positioning in COVID-19 Patients for Improvement in Oxygen Saturation |
https://ClinicalTrials.gov/show/NCT04344561 |
| NCT04344535 |
Convalescent Plasma vs. Standard Plasma for COVID-19 |
https://ClinicalTrials.gov/show/NCT04344535 |
| NCT04344288 |
Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection |
https://ClinicalTrials.gov/show/NCT04344288 |
| NCT04343989 |
A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04343989 |
| NCT04343976 |
Pegylated Interferon Lambda Treatment for COVID-19 |
https://ClinicalTrials.gov/show/NCT04343976 |
| NCT04343963 |
Pyridostigmine in Severe SARS-CoV-2 Infection |
https://ClinicalTrials.gov/show/NCT04343963 |
| NCT04344236 |
Gargling and Nasal Rinses to Reduce Oro- and Nasopharyngeal Viral Load in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04344236 |
| NCT04344210 |
Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus |
https://ClinicalTrials.gov/show/NCT04344210 |
| NCT04344106 |
Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study |
https://ClinicalTrials.gov/show/NCT04344106 |
| NCT04344080 |
Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04344080 |
| NCT04344041 |
COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial) |
https://ClinicalTrials.gov/show/NCT04344041 |
| NCT04343755 |
Convalescent Plasma as Treatment for Hospitalized Subjects With COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04343755 |
| NCT04343729 |
Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19 |
https://ClinicalTrials.gov/show/NCT04343729 |
| NCT04344015 |
COVID-19 Plasma Collection |
https://ClinicalTrials.gov/show/NCT04344015 |
| NCT04343053 |
Pro-thrombotic Status in Patients With SARS-Cov-2 Infection |
https://ClinicalTrials.gov/show/NCT04343053 |
| NCT04343651 |
Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04343651 |
| NCT04343092 |
Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management |
https://ClinicalTrials.gov/show/NCT04343092 |
| NCT04343794 |
Using Biovitals® Sentinel to Monitor Disease Progression in Subjects Quarantined for Suspected COVID-19 |
https://ClinicalTrials.gov/show/NCT04343794 |
| NCT04343768 |
An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial |
https://ClinicalTrials.gov/show/NCT04343768 |
| NCT04343261 |
Convalescent Plasma in the Treatment of COVID 19 |
https://ClinicalTrials.gov/show/NCT04343261 |
| NCT04342897 |
A Study of LY3127804 in Participants With COVID-19 |
https://ClinicalTrials.gov/show/NCT04342897 |
| NCT04341922 |
A Online-delivered Cognitive-behavioral Intervention for Dysfunctional Worry Related to the Covid-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04341922 |
| NCT04342689 |
The Role of Resistant Starch in COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04342689 |
| NCT04342663 |
A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04342663 |
| NCT04342650 |
Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection |
https://ClinicalTrials.gov/show/NCT04342650 |
| NCT04342221 |
Hydroxychloroquine for COVID-19 |
https://ClinicalTrials.gov/show/NCT04342221 |
| NCT04342182 |
Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study) |
https://ClinicalTrials.gov/show/NCT04342182 |
| NCT04342169 |
University of Utah COVID-19 Hydrochloroquine Trial |
https://ClinicalTrials.gov/show/NCT04342169 |
| NCT04341415 |
Impact of Auricular Vagus Nerve Neuromodulation on COVID-19 Positive Inpatients Outcome |
https://ClinicalTrials.gov/show/NCT04341415 |
| NCT04341675 |
Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04341675 |
| NCT04341441 |
Will Hydroxychloroquine Impede or Prevent COVID-19 |
https://ClinicalTrials.gov/show/NCT04341441 |
| NCT04341493 |
Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04341493 |
| NCT04341142 |
Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER |
https://ClinicalTrials.gov/show/NCT04341142 |
| NCT04341116 |
Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04341116 |
| NCT04341389 |
A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector) |
https://ClinicalTrials.gov/show/NCT04341389 |
| NCT04341207 |
Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients |
https://ClinicalTrials.gov/show/NCT04341207 |
| NCT04341038 |
Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury |
https://ClinicalTrials.gov/show/NCT04341038 |
| NCT04372186 |
A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04372186 |
| NCT04368845 |
Telerehabilitation in Patients With COVID-19 After Hospitalization. The ATHLOS Study |
https://ClinicalTrials.gov/show/NCT04368845 |
| NCT04340557 |
Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection |
https://ClinicalTrials.gov/show/NCT04340557 |
| NCT04340544 |
Hydroxychloroquine for the Treatment of Mild COVID-19 Disease |
https://ClinicalTrials.gov/show/NCT04340544 |
| NCT04350593 |
Dapagliflozin in Respiratory Failure in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04350593 |
| NCT04340050 |
COVID-19 Convalescent Plasma |
https://ClinicalTrials.gov/show/NCT04340050 |
| NCT04340349 |
Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals |
https://ClinicalTrials.gov/show/NCT04340349 |
| NCT04339712 |
Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction |
https://ClinicalTrials.gov/show/NCT04339712 |
| NCT04338958 |
Ruxolitinib in Covid-19 Patients With Defined Hyperinflammation |
https://ClinicalTrials.gov/show/NCT04338958 |
| NCT04339660 |
Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04339660 |
| NCT04339816 |
Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial |
https://ClinicalTrials.gov/show/NCT04339816 |
| NCT04339426 |
Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04339426 |
| NCT04333472 |
Piclidenoson for Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04333472 |
| NCT04338841 |
HOME-CoV: Hospitalization or Outpatient ManagEment of Patients With a SARS-CoV-2 Infection |
https://ClinicalTrials.gov/show/NCT04338841 |
| NCT04338698 |
Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT |
https://ClinicalTrials.gov/show/NCT04338698 |
| NCT04338568 |
Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study |
https://ClinicalTrials.gov/show/NCT04338568 |
| NCT04338009 |
Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019 |
https://ClinicalTrials.gov/show/NCT04338009 |
| NCT04337541 |
Reduction in COVID-19 Infection Using Surgical Facial Masks Outside the Healthcare System |
https://ClinicalTrials.gov/show/NCT04337541 |
| NCT04336904 |
Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19 |
https://ClinicalTrials.gov/show/NCT04336904 |
| NCT04337008 |
Renin Angiotensin System - CoronaVirus |
https://ClinicalTrials.gov/show/NCT04337008 |
| NCT04336462 |
Hydrogen-Oxygen Generator With Nebulizer in the Improvement of Symptoms in Patients Infected With COVID-19 |
https://ClinicalTrials.gov/show/NCT04336462 |
| NCT04336254 |
Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04336254 |
| NCT04336410 |
Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT04336410 |
| NCT04335851 |
Video-Based Exercises and Well-Being During Social Isolation |
https://ClinicalTrials.gov/show/NCT04335851 |
| NCT04335786 |
Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease |
https://ClinicalTrials.gov/show/NCT04335786 |
| NCT04335552 |
Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection |
https://ClinicalTrials.gov/show/NCT04335552 |
| NCT04335136 |
Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04335136 |
| NCT04335305 |
Checkpoint Blockade in COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04335305 |
| NCT04335123 |
Study of Open Label Losartan in COVID-19 |
https://ClinicalTrials.gov/show/NCT04335123 |
| NCT04335279 |
Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together Program |
https://ClinicalTrials.gov/show/NCT04335279 |
| NCT04335097 |
Sensor Based Vital Signs Monitoring of Covid 19 Patients During Home Isolation |
https://ClinicalTrials.gov/show/NCT04335097 |
| NCT04335071 |
Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19) |
https://ClinicalTrials.gov/show/NCT04335071 |
| NCT04334980 |
Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19 |
https://ClinicalTrials.gov/show/NCT04334980 |
| NCT04334928 |
Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel |
https://ClinicalTrials.gov/show/NCT04334928 |
| NCT04334629 |
LIBERATE Trial in COVID-19 |
https://ClinicalTrials.gov/show/NCT04334629 |
| NCT04334512 |
A Study of Quintuple Therapy to Treat COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04334512 |
| NCT04334850 |
Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04334850 |
| NCT04334460 |
Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects |
https://ClinicalTrials.gov/show/NCT04334460 |
| NCT04334382 |
Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19 |
https://ClinicalTrials.gov/show/NCT04334382 |
| NCT04333914 |
Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection |
https://ClinicalTrials.gov/show/NCT04333914 |
| NCT04334265 |
Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019 |
https://ClinicalTrials.gov/show/NCT04334265 |
| NCT04333589 |
Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive |
https://ClinicalTrials.gov/show/NCT04333589 |
| NCT04333550 |
Application of Desferal to Treat COVID-19 |
https://ClinicalTrials.gov/show/NCT04333550 |
| NCT04333420 |
Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04333420 |
| NCT04332991 |
Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease |
https://ClinicalTrials.gov/show/NCT04332991 |
| NCT04333368 |
Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS |
https://ClinicalTrials.gov/show/NCT04333368 |
| NCT04333654 |
Hydroxychloroquine in Outpatient Adults With COVID-19 |
https://ClinicalTrials.gov/show/NCT04333654 |
| NCT04333628 |
Chloroquine for Mild Symptomatic and Asymptomatic COVID-19 |
https://ClinicalTrials.gov/show/NCT04333628 |
| NCT04333407 |
Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial. |
https://ClinicalTrials.gov/show/NCT04333407 |
| NCT04332107 |
Azithromycin for COVID-19 Treatment in Outpatients Nationwide |
https://ClinicalTrials.gov/show/NCT04332107 |
| NCT04333225 |
Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers |
https://ClinicalTrials.gov/show/NCT04333225 |
| NCT04332835 |
Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study |
https://ClinicalTrials.gov/show/NCT04332835 |
| NCT04332380 |
Convalescent Plasma for Patients With COVID-19: A Pilot Study |
https://ClinicalTrials.gov/show/NCT04332380 |
| NCT04331795 |
Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis |
https://ClinicalTrials.gov/show/NCT04331795 |
| NCT04331899 |
Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19 |
https://ClinicalTrials.gov/show/NCT04331899 |
| NCT04332094 |
Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04332094 |
| NCT04332081 |
Hyperbaric Oxygen for COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04332081 |
| NCT04331808 |
CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI) |
https://ClinicalTrials.gov/show/NCT04331808 |
| NCT04330690 |
Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial |
https://ClinicalTrials.gov/show/NCT04330690 |
| NCT04331613 |
Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDS |
https://ClinicalTrials.gov/show/NCT04331613 |
| NCT04331054 |
Protective Role of Inhaled Steroids for Covid-19 Infection |
https://ClinicalTrials.gov/show/NCT04331054 |
| NCT04331470 |
Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04331470 |
| NCT04330638 |
Treatment of COVID-19 Patients With Anti-interleukin Drugs |
https://ClinicalTrials.gov/show/NCT04330638 |
| NCT04329650 |
Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04329650 |
| NCT04329832 |
Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19 |
https://ClinicalTrials.gov/show/NCT04329832 |
| NCT04329923 |
The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine) |
https://ClinicalTrials.gov/show/NCT04329923 |
| NCT04329533 |
Effects of Using Mobile App on Perceived Stress During COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04329533 |
| NCT04329611 |
ALBERTA HOPE COVID-19 for the Prevention of Severe COVID19 Disease |
https://ClinicalTrials.gov/show/NCT04329611 |
| NCT04328961 |
Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP) |
https://ClinicalTrials.gov/show/NCT04328961 |
| NCT04329195 |
ACE Inhibitors or ARBs Discontinuation in Context of SARS-CoV-2 Pandemic |
https://ClinicalTrials.gov/show/NCT04329195 |
| NCT04328129 |
Household Transmission Investigation Study for COVID-19 in Tropical Regions |
https://ClinicalTrials.gov/show/NCT04328129 |
| NCT04328493 |
The Vietnam Chloroquine Treatment on COVID-19 |
https://ClinicalTrials.gov/show/NCT04328493 |
| NCT04328480 |
The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients. |
https://ClinicalTrials.gov/show/NCT04328480 |
| NCT04328467 |
Pre-exposure Prophylaxis for SARS-Coronavirus-2 |
https://ClinicalTrials.gov/show/NCT04328467 |
| NCT04328441 |
Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine |
https://ClinicalTrials.gov/show/NCT04328441 |
| NCT04328285 |
Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers |
https://ClinicalTrials.gov/show/NCT04328285 |
| NCT04327401 |
COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III |
https://ClinicalTrials.gov/show/NCT04327401 |
| NCT04327388 |
Sarilumab COVID-19 |
https://ClinicalTrials.gov/show/NCT04327388 |
| NCT04327505 |
Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04327505 |
| NCT04327349 |
Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial |
https://ClinicalTrials.gov/show/NCT04327349 |
| NCT04326920 |
Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC) |
https://ClinicalTrials.gov/show/NCT04326920 |
| NCT04326790 |
The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention |
https://ClinicalTrials.gov/show/NCT04326790 |
| NCT04326452 |
Treating COVID-19 With a Bidirectional Oxygenation Valve |
https://ClinicalTrials.gov/show/NCT04326452 |
| NCT04326426 |
ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04326426 |
| NCT04326075 |
Early CPAP in COVID-19 Patients With Respiratory Failure. |
https://ClinicalTrials.gov/show/NCT04326075 |
| NCT04326036 |
Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04326036 |
| NCT04325906 |
Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS |
https://ClinicalTrials.gov/show/NCT04325906 |
| NCT04325893 |
Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease |
https://ClinicalTrials.gov/show/NCT04325893 |
| NCT04325867 |
Integrated Distance Management Strategy for Patients With Cardiovascular Diseases in the Context of COVID-19 |
https://ClinicalTrials.gov/show/NCT04325867 |
| NCT04324996 |
A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19 |
https://ClinicalTrials.gov/show/NCT04324996 |
| NCT04324606 |
A Study of a Candidate COVID-19 Vaccine (COV001) |
https://ClinicalTrials.gov/show/NCT04324606 |
| NCT04324528 |
Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation |
https://ClinicalTrials.gov/show/NCT04324528 |
| NCT04324489 |
DAS181 for Severe COVID-19: Compassionate Use |
https://ClinicalTrials.gov/show/NCT04324489 |
| NCT04324463 |
Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial |
https://ClinicalTrials.gov/show/NCT04324463 |
| NCT04324073 |
Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI |
https://ClinicalTrials.gov/show/NCT04324073 |
| NCT04324190 |
DIgital Online SuPport for COVID-19 StrEss |
https://ClinicalTrials.gov/show/NCT04324190 |
| NCT04323800 |
Convalescent Plasma to Stem Coronavirus (CSSC-001) |
https://ClinicalTrials.gov/show/NCT04323800 |
| NCT04324021 |
Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection. |
https://ClinicalTrials.gov/show/NCT04324021 |
| NCT04323345 |
Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus |
https://ClinicalTrials.gov/show/NCT04323345 |
| NCT04323527 |
Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2 |
https://ClinicalTrials.gov/show/NCT04323527 |
| NCT04323228 |
Anti-inflammatory/Antioxidant Oral Nutrition Supplementation in COVID-19 |
https://ClinicalTrials.gov/show/NCT04323228 |
| NCT04323514 |
Use of Ascorbic Acid in Patients With COVID 19 |
https://ClinicalTrials.gov/show/NCT04323514 |
| NCT04322682 |
Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA) |
https://ClinicalTrials.gov/show/NCT04322682 |
| NCT04322773 |
Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure |
https://ClinicalTrials.gov/show/NCT04322773 |
| NCT04322565 |
Colchicine Counteracting Inflammation in COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04322565 |
| NCT04322344 |
Escin in Patients With Covid-19 Infection |
https://ClinicalTrials.gov/show/NCT04322344 |
| NCT04321616 |
The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients |
https://ClinicalTrials.gov/show/NCT04321616 |
| NCT04321993 |
Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients |
https://ClinicalTrials.gov/show/NCT04321993 |
| NCT04321928 |
Personalized Health Education Against the Health Damage of Novel Coronavirus (COVID-19) Outbreak in Hungary |
https://ClinicalTrials.gov/show/NCT04321928 |
| NCT04322123 |
Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19) |
https://ClinicalTrials.gov/show/NCT04322123 |
| NCT04321421 |
Hyperimmune Plasma for Critical Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04321421 |
| NCT04321278 |
Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II) |
https://ClinicalTrials.gov/show/NCT04321278 |
| NCT04321096 |
The Impact of Camostat Mesilate on COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04321096 |
| NCT04321174 |
COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir |
https://ClinicalTrials.gov/show/NCT04321174 |
| NCT04320615 |
A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04320615 |
| NCT04320238 |
Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical Staff |
https://ClinicalTrials.gov/show/NCT04320238 |
| NCT04319900 |
Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia |
https://ClinicalTrials.gov/show/NCT04319900 |
| NCT04320056 |
Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decrease During SARS-CoV-2 Pneumonia (COVID-19) |
https://ClinicalTrials.gov/show/NCT04320056 |
| NCT04319731 |
A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure |
https://ClinicalTrials.gov/show/NCT04319731 |
| NCT04319445 |
Mindfulness During COVID-19 |
https://ClinicalTrials.gov/show/NCT04319445 |
| NCT04318444 |
Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19) |
https://ClinicalTrials.gov/show/NCT04318444 |
| NCT04318431 |
Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children |
https://ClinicalTrials.gov/show/NCT04318431 |
| NCT04317092 |
Tocilizumab in COVID-19 Pneumonia (TOCIVID-19) |
https://ClinicalTrials.gov/show/NCT04317092 |
| NCT04318015 |
Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial) |
https://ClinicalTrials.gov/show/NCT04318015 |
| NCT04316377 |
Norwegian Coronavirus Disease 2019 Study |
https://ClinicalTrials.gov/show/NCT04316377 |
| NCT04315896 |
Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial) |
https://ClinicalTrials.gov/show/NCT04315896 |
| NCT04315298 |
Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04315298 |
| NCT04315480 |
Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis |
https://ClinicalTrials.gov/show/NCT04315480 |
| NCT04313322 |
Treatment of COVID-19 Patients Using Wharton’s Jelly-Mesenchymal Stem Cells |
https://ClinicalTrials.gov/show/NCT04313322 |
| NCT04312243 |
NO Prevention of COVID-19 for Healthcare Providers |
https://ClinicalTrials.gov/show/NCT04312243 |
| NCT04313127 |
Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults |
https://ClinicalTrials.gov/show/NCT04313127 |
| NCT04313023 |
The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2 |
https://ClinicalTrials.gov/show/NCT04313023 |
| NCT04312997 |
The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection |
https://ClinicalTrials.gov/show/NCT04312997 |
| NCT04308668 |
Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2 |
https://ClinicalTrials.gov/show/NCT04308668 |
| NCT04310228 |
Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019 |
https://ClinicalTrials.gov/show/NCT04310228 |
| NCT04308317 |
Tetrandrine Tablets Used in the Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04308317 |
| NCT04307693 |
Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19) |
https://ClinicalTrials.gov/show/NCT04307693 |
| NCT04306393 |
Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19 |
https://ClinicalTrials.gov/show/NCT04306393 |
| NCT04305457 |
Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04305457 |
| NCT04304053 |
Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention |
https://ClinicalTrials.gov/show/NCT04304053 |
| NCT04303507 |
Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting |
https://ClinicalTrials.gov/show/NCT04303507 |
| NCT04306055 |
Blood Donor Recruitment During Epidemic of COVID-19 |
https://ClinicalTrials.gov/show/NCT04306055 |
| NCT04305106 |
Bevacizumab in Severe or Critically Severe Patients With COVID-19 Pneumonia-RCT |
https://ClinicalTrials.gov/show/NCT04305106 |
| NCT04304690 |
COVID-19 Seroconversion Among Front Line Medical and Paramedical Staff in Emergency, Intensive Care Units and Infectious Disease Departments During the 2020 Epidemic |
https://ClinicalTrials.gov/show/NCT04304690 |
| NCT04304313 |
A Pilot Study of Sildenafil in COVID-19 |
https://ClinicalTrials.gov/show/NCT04304313 |
| NCT04303299 |
Favipiravir, Protease Inhibitors, Oseltamivir -Gpo, Hydroxychloroquine for Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04303299 |
| NCT04299724 |
Safety and Immunity of Covid-19 aAPC Vaccine |
https://ClinicalTrials.gov/show/NCT04299724 |
| NCT04292899 |
Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734â„¢) in Participants With Severe Coronavirus Disease (COVID-19) |
https://ClinicalTrials.gov/show/NCT04292899 |
| NCT04292730 |
Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734â„¢) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment |
https://ClinicalTrials.gov/show/NCT04292730 |
| NCT04291729 |
Evaluation of Ganovo （Danoprevir ） Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection |
https://ClinicalTrials.gov/show/NCT04291729 |
| NCT04288102 |
Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04288102 |
| NCT04282902 |
A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection |
https://ClinicalTrials.gov/show/NCT04282902 |
| NCT04280705 |
Adaptive COVID-19 Treatment Trial (ACTT) |
https://ClinicalTrials.gov/show/NCT04280705 |
| NCT04279197 |
Treatment of Pulmonary Fibrosis Due to COVID-19 With Fuzheng Huayu |
https://ClinicalTrials.gov/show/NCT04279197 |
| NCT04280224 |
NK Cells Treatment for COVID-19 |
https://ClinicalTrials.gov/show/NCT04280224 |
| NCT04276987 |
A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia |
https://ClinicalTrials.gov/show/NCT04276987 |
| NCT04276688 |
Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment |
https://ClinicalTrials.gov/show/NCT04276688 |
| NCT04276896 |
Immunity and Safety of Covid-19 Synthetic Minigene Vaccine |
https://ClinicalTrials.gov/show/NCT04276896 |
| NCT04275414 |
Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04275414 |
| NCT04275245 |
Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia |
https://ClinicalTrials.gov/show/NCT04275245 |
| NCT04273763 |
Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19) |
https://ClinicalTrials.gov/show/NCT04273763 |
| NCT04273321 |
Efficacy and Safety of Corticosteroids in COVID-19 |
https://ClinicalTrials.gov/show/NCT04273321 |
| NCT04269525 |
Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia |
https://ClinicalTrials.gov/show/NCT04269525 |
| NCT04264533 |
Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia |
https://ClinicalTrials.gov/show/NCT04264533 |
| NCT04263402 |
The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia |
https://ClinicalTrials.gov/show/NCT04263402 |
| NCT04261517 |
Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04261517 |
| NCT04261270 |
A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia |
https://ClinicalTrials.gov/show/NCT04261270 |
| NCT04257656 |
A Trial of Remdesivir in Adults With Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04257656 |
| NCT04252885 |
The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection |
https://ClinicalTrials.gov/show/NCT04252885 |
| NCT04254874 |
A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia |
https://ClinicalTrials.gov/show/NCT04254874 |
| NCT04255017 |
A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia |
https://ClinicalTrials.gov/show/NCT04255017 |
| NCT04252118 |
Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19 |
https://ClinicalTrials.gov/show/NCT04252118 |
| NCT04252274 |
Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04252274 |
| NCT04251871 |
Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04251871 |
| NCT04244591 |
Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure |
https://ClinicalTrials.gov/show/NCT04244591 |
| NCT04730427 |
Safety and Preliminary Efficacy Study of GX-I7 in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04730427 |
| NCT04731116 |
Cannabidiol Treatment for Severe and Critical Coronavirus (COVID-19) Pulmonary Infection |
https://ClinicalTrials.gov/show/NCT04731116 |
| NCT04730401 |
Convalescent Plasma in the Treatment of Covid-19 |
https://ClinicalTrials.gov/show/NCT04730401 |
| NCT04730323 |
TOCILIZUMAB - An Option for Patients With COVID-19 Associated Cytokine Release Syndrome; A Single Center Experience |
https://ClinicalTrials.gov/show/NCT04730323 |
| NCT04730284 |
Evaluation of a Synbiotic Formula in Patient With COVID-19 |
https://ClinicalTrials.gov/show/NCT04730284 |
| NCT04723524 |
Jinhua Qinggan Granules in the Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04723524 |
| NCT04695301 |
Functional Outcomes in COVID-19 Survivors and Use of a Digital Platform for Rehabilitation |
https://ClinicalTrials.gov/show/NCT04695301 |
| NCT04625725 |
Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult. |
https://ClinicalTrials.gov/show/NCT04625725 |
| NCT04575038 |
CRISIS2: A Phase 2 Study of the Safety and Antiviral Activity of Brequinar in Non-hospitalized Pts With COVID-19 |
https://ClinicalTrials.gov/show/NCT04575038 |
| NCT04640233 |
Clinical Trial to Assess Safety and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Сov-2) Infection |
https://ClinicalTrials.gov/show/NCT04640233 |
| NCT04448756 |
Study of M5049 in Participants With Coronavirus Disease 2019 (COVID-19) Pneumonia |
https://ClinicalTrials.gov/show/NCT04448756 |
| NCT04583592 |
Camostat Efficacy vs. Placebo for Outpatient Treatment of COVID-19 (CAMELOT) |
https://ClinicalTrials.gov/show/NCT04583592 |
| NCT04545060 |
VIR-7831 for the Early Treatment of COVID-19 in Outpatients |
https://ClinicalTrials.gov/show/NCT04545060 |
| NCT04464395 |
Study of CPI-006 as Immunotherapy for Hospitalized COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04464395 |
| NCT04459962 |
Covid-19 Breath Test |
https://ClinicalTrials.gov/show/NCT04459962 |
| NCT04557046 |
Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag Test |
https://ClinicalTrials.gov/show/NCT04557046 |
| NCT04401410 |
Anti-SARS Cov-2 T Cell Infusions for COVID 19 |
https://ClinicalTrials.gov/show/NCT04401410 |
| NCT04345601 |
Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease) |
https://ClinicalTrials.gov/show/NCT04345601 |
| NCT04414618 |
A Study of Opaganib in Coronavirus Disease 2019 Pneumonia |
https://ClinicalTrials.gov/show/NCT04414618 |
| NCT04412668 |
Study to Evaluate the Safety and Efficacy of ATYR1923 In Patients With Severe Pneumonia Related to COVID-19 |
https://ClinicalTrials.gov/show/NCT04412668 |
| NCT04734912 |
Evaluation of Transnasal Endoscopy During COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04734912 |
| NCT04362085 |
Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care |
https://ClinicalTrials.gov/show/NCT04362085 |
| NCT04380701 |
A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy and Immunocompromised Adults |
https://ClinicalTrials.gov/show/NCT04380701 |
| NCT04734886 |
The Effect of Probiotic Supplementation on SARS-CoV-2 Antibody Response After COVID-19 |
https://ClinicalTrials.gov/show/NCT04734886 |
| NCT04733833 |
A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04733833 |
| NCT04734717 |
Coordination and Locomotor Problems in Patients With Covid-19 Virus |
https://ClinicalTrials.gov/show/NCT04734717 |
| NCT04734171 |
Social Activity, Loneliness and Stigma During COVID-19 Outbreak |
https://ClinicalTrials.gov/show/NCT04734171 |
| NCT04732949 |
Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19 |
https://ClinicalTrials.gov/show/NCT04732949 |
| NCT04733625 |
The Effect of Vitamin D Therapy on Morbidity and Moratlity in Patients With SARS-CoV 2 Infection |
https://ClinicalTrials.gov/show/NCT04733625 |
| NCT04732819 |
Improving COVID-19 Vaccine Uptake in Nursing Homes |
https://ClinicalTrials.gov/show/NCT04732819 |
| NCT04729140 |
An Outpatient Clinical Trial Using Ivermectin and Doxycycline in COVID-19 Positive Patients at High Risk to Prevent COVID-19 Related Hospitalization |
https://ClinicalTrials.gov/show/NCT04729140 |
| NCT04728594 |
Emails Promoting COVID-19 Vaccination Among Healthcare Workers |
https://ClinicalTrials.gov/show/NCT04728594 |
| NCT04726163 |
Tele-expertise in Patients With Diabetes Hospitalized for Covid-19 Infection |
https://ClinicalTrials.gov/show/NCT04726163 |
| NCT04723290 |
COVID-19 Seroconversion Study Among GHdC Staff Members - Summer 2020 |
https://ClinicalTrials.gov/show/NCT04723290 |
| NCT04713488 |
An Open Study on the Safety, Tolerability, and Immunogenicity of “Sputnik Light” Vaccine |
https://ClinicalTrials.gov/show/NCT04713488 |
| NCT04716426 |
APTâ„¢ T3X on the COVID-19 Contamination Rate |
https://ClinicalTrials.gov/show/NCT04716426 |
| NCT04674644 |
Analysing the Psychosocial Effects of COVID-19 Pandemic on Dental Professionals Using the Turkish Version of the Fear of COVID-19 and Coronavirus Anxiety Scales |
https://ClinicalTrials.gov/show/NCT04674644 |
| NCT04681430 |
Reconvalescent Plasma/Camostat Mesylate Early in SARS-CoV-2 Q-PCR (COVID-19) Positive High-risk Individuals |
https://ClinicalTrials.gov/show/NCT04681430 |
| NCT04671017 |
Dose Finding Study to Evaluate Safety, Tolerability and Immunogenicity of an Inactiviated Adjuvanted Sars-Cov-2 Virus Vaccine Candidate Against Covid-19 in Healthy Adults |
https://ClinicalTrials.gov/show/NCT04671017 |
| NCT04639375 |
Polio Vaccine (IPV) for SARS-CoV-2 and Prevention of Coronavirus Disease (COVID-19) |
https://ClinicalTrials.gov/show/NCT04639375 |
| NCT04635605 |
Methylene Blue Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04635605 |
| NCT04604704 |
Pilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 Syndrome |
https://ClinicalTrials.gov/show/NCT04604704 |
| NCT04646603 |
MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04646603 |
| NCT04627675 |
CORVax12: SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine Trial for COVID-19 (SARS-CoV-2) |
https://ClinicalTrials.gov/show/NCT04627675 |
| NCT04623021 |
A Study Evaluating the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04623021 |
| NCT04548934 |
Effect of Wearing Personal Protective Equipment (PPE) on CPR Quality in Times of the COVID-19-pandemic |
https://ClinicalTrials.gov/show/NCT04548934 |
| NCT04588792 |
Furosemide as Supportive Therapy for COVID-19 Respiratory Failure |
https://ClinicalTrials.gov/show/NCT04588792 |
| NCT04565249 |
Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04565249 |
| NCT04498442 |
A Study on Prevalence, Protection and Recovery From COVID-19 in Seasoned Yoga Practitioners in Comparison to Age and Gender Matched Controls |
https://ClinicalTrials.gov/show/NCT04498442 |
| NCT04528667 |
Study of the Safety and Efficacy of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized Due to COVID-19 |
https://ClinicalTrials.gov/show/NCT04528667 |
| NCT04528368 |
Convalescent Plasma for Treating Patients With COVID-19 Pneumonia Without Indication of Ventilatory Support |
https://ClinicalTrials.gov/show/NCT04528368 |
| NCT04488575 |
Safety and Efficacy of EDP1815 in the Treatment of Patients Hospitalized With COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04488575 |
| NCT04519411 |
Transpulmonary Pressure Measurements in Intubated Children With Covid-19 Respiratory Failure |
https://ClinicalTrials.gov/show/NCT04519411 |
| NCT04452669 |
VentaProst in Subjects With COVID-19 Requiring Mechanical Ventilation |
https://ClinicalTrials.gov/show/NCT04452669 |
| NCT04486001 |
Study of Intravenous Administration of Allogeneic Adipose Stem Cells for COVID-19 |
https://ClinicalTrials.gov/show/NCT04486001 |
| NCT04469114 |
Tofacitinib in Hospitalized Patients With COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04469114 |
| NCT04435379 |
Study to Assess VPM1002 in Reducing Hospital Admissions and/or Severe Respiratory Infectious Diseases in Elderly in COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04435379 |
| NCT04459286 |
The Nitazoxanide Plus Atazanavir for COVID-19 Study |
https://ClinicalTrials.gov/show/NCT04459286 |
| NCT04388683 |
Inhaled Nitric Oxide for Preventing Progression in COVID-19 |
https://ClinicalTrials.gov/show/NCT04388683 |
| NCT04411433 |
Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04411433 |
| NCT04391179 |
Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19 |
https://ClinicalTrials.gov/show/NCT04391179 |
| NCT04388527 |
COVID-19 Convalescent Plasma for Mechanically Ventilated Population |
https://ClinicalTrials.gov/show/NCT04388527 |
| NCT04373291 |
Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04373291 |
| NCT04372589 |
Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC) |
https://ClinicalTrials.gov/show/NCT04372589 |
| NCT04345614 |
A Study of Auxora in Patients With Severe COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04345614 |
| NCT04365153 |
Canakinumab in Covid-19 Cardiac Injury (The Three C Study) |
https://ClinicalTrials.gov/show/NCT04365153 |
| NCT04364737 |
CONTAIN COVID-19: Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients |
https://ClinicalTrials.gov/show/NCT04364737 |
| NCT04346199 |
Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19. |
https://ClinicalTrials.gov/show/NCT04346199 |
| NCT04345523 |
Convalescent Plasma Therapy vs. SOC for the Treatment of COVID-19 in Hospitalized Patients |
https://ClinicalTrials.gov/show/NCT04345523 |
| NCT04388826 |
COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111 |
https://ClinicalTrials.gov/show/NCT04388826 |
| NCT04363346 |
Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia |
https://ClinicalTrials.gov/show/NCT04363346 |
| NCT04358406 |
Rhu-pGSN for Severe Covid-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04358406 |
| NCT04351724 |
Austrian CoronaVirus Adaptive Clinical Trial (COVID-19) |
https://ClinicalTrials.gov/show/NCT04351724 |
| NCT04341584 |
CORIMUNO-ANA: Trial Evaluating Efficacy Of Anakinra In Patients With Covid-19 Infection |
https://ClinicalTrials.gov/show/NCT04341584 |
| NCT04334044 |
Treatment of SARS Caused by COVID-19 With Ruxolitinib |
https://ClinicalTrials.gov/show/NCT04334044 |
| NCT04333732 |
CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION |
https://ClinicalTrials.gov/show/NCT04333732 |
| NCT04700163 |
RU Anti-SARS-CoV-2 (COVID-19) mAbs in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT04700163 |
| NCT04677660 |
A Study of TAK-919 in Healthy Japanese Adults (COVID-19) |
https://ClinicalTrials.gov/show/NCT04677660 |
| NCT04678700 |
Implementation of a Respiratory Physiotherapy Program in Post COVID-19 Patients Through Tele-assistance |
https://ClinicalTrials.gov/show/NCT04678700 |
| NCT04678687 |
COVID-19 and Tissue Damage in Vital Organs |
https://ClinicalTrials.gov/show/NCT04678687 |
| NCT04649086 |
Muscular Rehabilitation by Eccentric Exercise After Severe COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04649086 |
| NCT04578158 |
Trial to Study the Adjuvant Benefits of Quercetin Phytosome in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04578158 |
| NCT04581200 |
Lift Mobile Mindfulness for COVID-19 Distress Symptoms |
https://ClinicalTrials.gov/show/NCT04581200 |
| NCT04537949 |
A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults |
https://ClinicalTrials.gov/show/NCT04537949 |
| NCT04529499 |
Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04529499 |
| NCT04525417 |
Rapid Screening Test for Covid-19 Antibodies in Healthcare Workers |
https://ClinicalTrials.gov/show/NCT04525417 |
| NCT04511949 |
COVID-19: Epidemiological Study of the Spread of SARS-CoV-2 in the Household of a Person Who Has Had a COVID-19 Disease |
https://ClinicalTrials.gov/show/NCT04511949 |
| NCT04446429 |
Anti-Androgen Treatment for COVID-19 |
https://ClinicalTrials.gov/show/NCT04446429 |
| NCT04445272 |
Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04445272 |
| NCT04384731 |
Curosurf® in Adult Acute Respiratory Distress Syndrome Due to COVID-19 |
https://ClinicalTrials.gov/show/NCT04384731 |
| NCT04440007 |
Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized With COVID-19 |
https://ClinicalTrials.gov/show/NCT04440007 |
| NCT04369469 |
Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia |
https://ClinicalTrials.gov/show/NCT04369469 |
| NCT04409821 |
Tele-based Psychological Emotional Support for Informal CARegivers of COVID-19 Patients in Intensive Care |
https://ClinicalTrials.gov/show/NCT04409821 |
| NCT04369066 |
COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie and Institute Pasteur |
https://ClinicalTrials.gov/show/NCT04369066 |
| NCT04358926 |
Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19) |
https://ClinicalTrials.gov/show/NCT04358926 |
| NCT04334434 |
Telerehabilitation in Individuals Over 65 Years of Age Having Social Isolation Due to Coronavirus (Covid-19) |
https://ClinicalTrials.gov/show/NCT04334434 |
| NCT04325061 |
Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19 |
https://ClinicalTrials.gov/show/NCT04325061 |
| NCT04315948 |
Trial of Treatments for COVID-19 in Hospitalized Adults |
https://ClinicalTrials.gov/show/NCT04315948 |
| NCT04739410 |
Effectiveness of Ivermectin in SARS-CoV-2/COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04739410 |
| NCT04738045 |
Comparison of Remdesivir Versus Lopinavir/ Ritonavir and Remdesivir Combination in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04738045 |
| NCT04703036 |
Glutathione, Oxidative Stress and Mitochondrial Function in COVID-19 |
https://ClinicalTrials.gov/show/NCT04703036 |
| NCT04695652 |
A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adult |
https://ClinicalTrials.gov/show/NCT04695652 |
| NCT04647747 |
Silent Hypoxia and Awake Proning in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04647747 |
| NCT04663555 |
Effect of Two Different Doses of Dexamethasone in Patients With ARDS and COVID-19 |
https://ClinicalTrials.gov/show/NCT04663555 |
| NCT04611802 |
A Study Looking at the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults at Risk for SARS-CoV-2 |
https://ClinicalTrials.gov/show/NCT04611802 |
| NCT04611399 |
MIND-VR: Virtual Reality for COVID-19 Operators’ Psychological Support |
https://ClinicalTrials.gov/show/NCT04611399 |
| NCT04539262 |
Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation |
https://ClinicalTrials.gov/show/NCT04539262 |
| NCT04511819 |
Losmapimod Safety and Efficacy in COVID-19 |
https://ClinicalTrials.gov/show/NCT04511819 |
| NCT04501952 |
Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734â„¢) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting |
https://ClinicalTrials.gov/show/NCT04501952 |
| NCT04466241 |
Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial |
https://ClinicalTrials.gov/show/NCT04466241 |
| NCT04426695 |
Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04426695 |
| NCT04435522 |
Maraviroc in Patients With Moderate and Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04435522 |
| NCT04361344 |
Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection |
https://ClinicalTrials.gov/show/NCT04361344 |
| NCT04407130 |
Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection. |
https://ClinicalTrials.gov/show/NCT04407130 |
| NCT04409262 |
A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04409262 |
| NCT04663945 |
Predictors of Recovery and the App-Facilitated Tele-Rehabilitation (AFTER) Program for COVID-19 Survivors |
https://ClinicalTrials.gov/show/NCT04663945 |
| NCT04663737 |
Evaluating Safety, Pharmacokinetics and Clinical Benefit of Silmitasertib (CX-4945) in Subjects With Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04663737 |
| NCT04595773 |
COVID-19, Chronic Adaptation and Response to Exercise (COVID-CARE) |
https://ClinicalTrials.gov/show/NCT04595773 |
| NCT04569786 |
Dose Ranging Trial to Assess Safety and Immunogenicity of V590 (COVID-19 Vaccine) in Healthy Adults (V590-001) |
https://ClinicalTrials.gov/show/NCT04569786 |
| NCT04568122 |
Rapid Turnaround, Home-based Saliva Testing for COVID-19 |
https://ClinicalTrials.gov/show/NCT04568122 |
| NCT04584567 |
OD-doxy-PNV-COVID-19 Old Drug " DOXY " for Prevention of New Virus " COVID-19 " |
https://ClinicalTrials.gov/show/NCT04584567 |
| NCT04402970 |
Dornase Alfa for ARDS in Patients With SARS-CoV-2 |
https://ClinicalTrials.gov/show/NCT04402970 |
| NCT04404426 |
CACOLAC : Citrulline Administration in the Hospital Patient in Intensive Care for COVID-19 Acute Respiratory Distress Syndrome |
https://ClinicalTrials.gov/show/NCT04404426 |
| NCT04370236 |
INB03 for the Treatment of Pulmonary Complications From COVID-19 |
https://ClinicalTrials.gov/show/NCT04370236 |
| NCT04358549 |
Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19 |
https://ClinicalTrials.gov/show/NCT04358549 |
| NCT04746183 |
AGILE (Early Phase Platform Trial for COVID-19) |
https://ClinicalTrials.gov/show/NCT04746183 |
| NCT04330586 |
A Trial of Ciclesonide in Adults With Mild-to-moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04330586 |
| NCT04327206 |
BCG Vaccination to Protect Healthcare Workers Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04327206 |
| NCT04746365 |
Ivermectin Role in Covid-19 Clinical Trial |
https://ClinicalTrials.gov/show/NCT04746365 |
| NCT04745442 |
Pilot Study of Antithrombin as Prophylaxis of Acute Respiratory Distress Syndrome in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04745442 |
| NCT04742738 |
Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With Aluminum Hydroxide (COVID-19) |
https://ClinicalTrials.gov/show/NCT04742738 |
| NCT04743349 |
Steam Inhalations in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04743349 |
| NCT04742595 |
SARS-CoV-2 Specific Cytotoxic T Lymphocytes for the Treatment of COVID-19 in Patients With Cancer |
https://ClinicalTrials.gov/show/NCT04742595 |
| NCT04739462 |
SMS Maama Project COVID-19 |
https://ClinicalTrials.gov/show/NCT04739462 |
| NCT04730661 |
Efficacy of the Sit to Stand Test in the Decision to Hospitalize a Patient Consulting the Emergency Dept for COVID 19 |
https://ClinicalTrials.gov/show/NCT04730661 |
| NCT04716569 |
Evaluation of Ivermectin Mucoadhesive Nanosuspension as Nasal Spray in Management of Early Covid-19 |
https://ClinicalTrials.gov/show/NCT04716569 |
| NCT04723459 |
Efficacy of Nano-Ivermectin Impregnated Masks in Prevention of Covid-19 Among Healthy Contacts and Medical Staff |
https://ClinicalTrials.gov/show/NCT04723459 |
| NCT04685655 |
RescuE pLAsma eXchange in Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04685655 |
| NCT04668625 |
Risk of Infection of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), COVID-19, in a Massive Musical Show With Transmission Prevention Measures |
https://ClinicalTrials.gov/show/NCT04668625 |
| NCT04644120 |
Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 Moves Through the Body of Adult Participants Hospitalized With Coronavirus Disease 2019 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04644120 |
| NCT04623671 |
Intravenous Infusion of CAP-1002 in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04623671 |
| NCT04627519 |
Effectiveness and Safety of Rhea Health Tone® as add-on Therapy for COVID-19 in Hospitalized Adults in Indonesia |
https://ClinicalTrials.gov/show/NCT04627519 |
| NCT04640194 |
A Study to Test Whether Different Doses of Alteplase Help People With Severe Breathing Problems Because of COVID-19 |
https://ClinicalTrials.gov/show/NCT04640194 |
| NCT04636697 |
Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults |
https://ClinicalTrials.gov/show/NCT04636697 |
| NCT04604184 |
ACTION ON COVID-19: A Study to Test Whether BI 764198 Helps Lung Health of People Hospitalised With COVID-19 |
https://ClinicalTrials.gov/show/NCT04604184 |
| NCT04584710 |
A Phase 2 Study of RTB101 as COVID-19 Post-Exposure Prophylaxis in Older Adults |
https://ClinicalTrials.gov/show/NCT04584710 |
| NCT04615429 |
Clinical Trial to Assess the Efficacy of MSC in Patients With ARDS Due to COVID-19 |
https://ClinicalTrials.gov/show/NCT04615429 |
| NCT04591015 |
Dulce Digital-COVID Aware (DD-CA) Discharge Texting Platform for US/Mexico Border Hispanics With Diabetes + COVID-19 |
https://ClinicalTrials.gov/show/NCT04591015 |
| NCT04557241 |
Brief Informational Intervention for COVID-19 Misinformation Prophylaxis |
https://ClinicalTrials.gov/show/NCT04557241 |
| NCT04516759 |
AZD1656 in Diabetic Patients Hospitalised With Suspected or Confirmed COVID-19 |
https://ClinicalTrials.gov/show/NCT04516759 |
| NCT04547660 |
Convalescent Plasma for Severe COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04547660 |
| NCT04536376 |
First Responder Resiliency Program During COVID-19 |
https://ClinicalTrials.gov/show/NCT04536376 |
| NCT04534790 |
Anti-inflammatory Effect of Low-Dose Whole-Lung Radiation for COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04534790 |
| NCT04510454 |
Evaluation of a ddPCR Technology for the SARS-CoV-2 Detection in Symptomatic Patients With Suspicion of COVID-19 |
https://ClinicalTrials.gov/show/NCT04510454 |
| NCT04508023 |
A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection |
https://ClinicalTrials.gov/show/NCT04508023 |
| NCT04486313 |
Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04486313 |
| NCT04505722 |
A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants |
https://ClinicalTrials.gov/show/NCT04505722 |
| NCT04492475 |
Adaptive COVID-19 Treatment Trial 3 (ACTT-3) |
https://ClinicalTrials.gov/show/NCT04492475 |
| NCT04486508 |
Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04486508 |
| NCT04453657 |
Tele-Wellness Supported App for Family Child Care Home Providers and Families to Promote Health, Family Engagement, and School Readiness Amid COVID-19 |
https://ClinicalTrials.gov/show/NCT04453657 |
| NCT04416399 |
STerOids in COVID-19 Study |
https://ClinicalTrials.gov/show/NCT04416399 |
| NCT04417257 |
Study of LAU-7b for the Treatment of COVID-19 Disease in Adults |
https://ClinicalTrials.gov/show/NCT04417257 |
| NCT04402866 |
TD-0903 for ALI Associated With COVID-19 |
https://ClinicalTrials.gov/show/NCT04402866 |
| NCT04394403 |
Pilot Internet-based Self-Help Program for Managing Corona (COVID-19) Stress |
https://ClinicalTrials.gov/show/NCT04394403 |
| NCT04408027 |
Mental Health Support for SickKids Children and Families During COVID-19 Using Established eHealth Interventions |
https://ClinicalTrials.gov/show/NCT04408027 |
| NCT04385901 |
Long Term Functional Outcomes of COVID-19 Patients Treated by Rehabilitation Services viaTelehealth |
https://ClinicalTrials.gov/show/NCT04385901 |
| NCT04359680 |
Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection |
https://ClinicalTrials.gov/show/NCT04359680 |
| NCT04359095 |
Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia |
https://ClinicalTrials.gov/show/NCT04359095 |
| NCT04343248 |
Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF) |
https://ClinicalTrials.gov/show/NCT04343248 |
| NCT04344184 |
SAFEty Study of Early Infusion of Vitamin C for Treatment of Novel Coronavirus Acute Lung Injury (SAFE EVICT CORONA-ALI) |
https://ClinicalTrials.gov/show/NCT04344184 |
| NCT04747574 |
Evaluation of the Safety of CD24-Exosomes in Patients With COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04747574 |
| NCT04348383 |
Defibrotide as Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome of Covid 19. |
https://ClinicalTrials.gov/show/NCT04348383 |
| NCT04344730 |
Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04344730 |
| NCT04335084 |
A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04335084 |
| NCT04748120 |
Operative vs Non-Operative Management of Acute Appendicitis and Acute Cholecystitis in COVID-19 Positive Patients |
https://ClinicalTrials.gov/show/NCT04748120 |
| NCT04747821 |
An Effectiveness Study of the Sinovac’s Adsorbed COVID-19 (Inactivated) Vaccine |
https://ClinicalTrials.gov/show/NCT04747821 |
| NCT04747158 |
COVID-19 Convalescent Plasma Therapy |
https://ClinicalTrials.gov/show/NCT04747158 |
| NCT04747132 |
Effectiveness of a Telegeriatric Intervention in Older Adults During the Covid-19 Contingency |
https://ClinicalTrials.gov/show/NCT04747132 |
| NCT04743232 |
COVID-19 Resuscitation Plans and Decisions on Escalation and Limitation of Treatment |
https://ClinicalTrials.gov/show/NCT04743232 |
| NCT04739020 |
Respiratory Aerosols in Patients With COVID-19 and Healthy Controls |
https://ClinicalTrials.gov/show/NCT04739020 |
| NCT04734873 |
CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 Patients |
https://ClinicalTrials.gov/show/NCT04734873 |
| NCT04643678 |
Anakinra in the Management of COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04643678 |
| NCT04668950 |
Fluvoxamine for Early Treatment of Covid-19 (Stop Covid 2) |
https://ClinicalTrials.gov/show/NCT04668950 |
| NCT04651790 |
Efficacy, Safety, and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against COVID-19 in Adults |
https://ClinicalTrials.gov/show/NCT04651790 |
| NCT04701489 |
UNITE Study (UMN-GE) for COVID-19 |
https://ClinicalTrials.gov/show/NCT04701489 |
| NCT04661839 |
A COVID-19 Study to Evaluate Safety and Pharmacokinetics of COVID-HIGIV Administered in Healthy Adults |
https://ClinicalTrials.gov/show/NCT04661839 |
| NCT04659239 |
The Efficacy, Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04659239 |
| NCT04642950 |
A Phase II/III Study of Sargramostim |
https://ClinicalTrials.gov/show/NCT04642950 |
| NCT04582201 |
An Experiment to Evaluate the Safety of agenT-797 in COVID-19 Patients With Severe Difficulty Breathing. |
https://ClinicalTrials.gov/show/NCT04582201 |
| NCT04575597 |
Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002) |
https://ClinicalTrials.gov/show/NCT04575597 |
| NCT04568889 |
Minnesota COVID-19 Testing Project |
https://ClinicalTrials.gov/show/NCT04568889 |
| NCT04568811 |
The Phase I Clinical Trial of Booster Vaccination of Adenovirus Type-5 Vectored COVID-19 Vaccine |
https://ClinicalTrials.gov/show/NCT04568811 |
| NCT04590586 |
Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients |
https://ClinicalTrials.gov/show/NCT04590586 |
| NCT04575584 |
Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001) |
https://ClinicalTrials.gov/show/NCT04575584 |
| NCT04547127 |
A Study to Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04547127 |
| NCT04432324 |
Study to Evaluate the Safety and Efficacy of High Dose IVIG in Hospitalized Participants With Coronavirus Disease (COVID-19) |
https://ClinicalTrials.gov/show/NCT04432324 |
| NCT04480424 |
Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19) |
https://ClinicalTrials.gov/show/NCT04480424 |
| NCT04511923 |
Nebulised Heparin to Reduce COVID-19 Induced Acute Lung Injury |
https://ClinicalTrials.gov/show/NCT04511923 |
| NCT04504032 |
A Trial to Evaluate Safety and Efficacy of Rivaroxaban (COVID-19) |
https://ClinicalTrials.gov/show/NCT04504032 |
| NCT04383613 |
Prone Positioning for Patients on General Medical Wards With COVID19 |
https://ClinicalTrials.gov/show/NCT04383613 |
| NCT04409327 |
Phase 2 Study to Determine if RTB101 Reduces the Severity of COVID-19 in Older Adults Residing in Nursing Homes |
https://ClinicalTrials.gov/show/NCT04409327 |
| NCT04368728 |
Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals |
https://ClinicalTrials.gov/show/NCT04368728 |
| NCT04392531 |
Clinical Trial to Assess Efficacy of cYclosporine Plus Standard of Care in Hospitalized Patients With COVID19 |
https://ClinicalTrials.gov/show/NCT04392531 |
| NCT04381936 |
Randomised Evaluation of COVID-19 Therapy |
https://ClinicalTrials.gov/show/NCT04381936 |
| NCT04372602 |
Duvelisib to Combat COVID-19 |
https://ClinicalTrials.gov/show/NCT04372602 |
| NCT04333355 |
Safety in Convalescent Plasma Transfusion to COVID-19 |
https://ClinicalTrials.gov/show/NCT04333355 |
| NCT04349371 |
Saved From COVID-19 |
https://ClinicalTrials.gov/show/NCT04349371 |
| NCT04346147 |
Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19 |
https://ClinicalTrials.gov/show/NCT04346147 |
| NCT04337918 |
Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04337918 |
| NCT04751617 |
Pulmonary Rehabilitation of Patients With a History of COVID-19 |
https://ClinicalTrials.gov/show/NCT04751617 |
| NCT04751604 |
Improvement of the Nutritional Status Regarding Nicotinamide (Vitamin B3) and the Disease Course of COVID-19 |
https://ClinicalTrials.gov/show/NCT04751604 |
| NCT04751474 |
The Effect of Motivational Messages on Optimism, Hopelessness and Life Satisfaction |
https://ClinicalTrials.gov/show/NCT04751474 |
| NCT04397705 |
Remote Monitoring of Cancer Patients With Suspected Covid-19 |
https://ClinicalTrials.gov/show/NCT04397705 |
| NCT04750343 |
Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With or Without AS03 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04750343 |
| NCT04680949 |
suPAR-Guided Anakinra Treatment for Management of Severe Respiratory Failure by COVID-19 |
https://ClinicalTrials.gov/show/NCT04680949 |
| NCT04662671 |
Phase I/II Randomized, Dose Escalation Study to Evaluate the Safety and Antiviral Activity of the RD-X19 Device in SARS-CoV-2 Infected Individuals With Uncomplicated COVID-19 |
https://ClinicalTrials.gov/show/NCT04662671 |
| NCT04621461 |
Placebo Controlled Trial to Evaluate Zinc for the Treatment of COVID-19 in the Outpatient Setting |
https://ClinicalTrials.gov/show/NCT04621461 |
| NCT04583956 |
ACTIV-5 / Big Effect Trial (BET-A) for the Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04583956 |
| NCT04583969 |
ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04583969 |
| NCT04535778 |
COMPASS Study: an Online Cognitive-behavioural Therapy (CBT) Program Treating Anxiety and Low Mood in Long-term Conditions During the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04535778 |
| NCT04530656 |
Phase I Trial of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell) |
https://ClinicalTrials.gov/show/NCT04530656 |
| NCT04527575 |
Study of the Safety, Reactogenicity and Immunogenicity of “EpiVacCorona” Vaccine for the Prevention of COVID-19 |
https://ClinicalTrials.gov/show/NCT04527575 |
| NCT04405076 |
Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older |
https://ClinicalTrials.gov/show/NCT04405076 |
| NCT04750265 |
Robotic Assisted Early Mobilization in Ventilated ICU Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04750265 |
| NCT04749121 |
Ultraviolet Germicidal Irradiation on the New Silicone Half-Piece Elastometric Respirators |
https://ClinicalTrials.gov/show/NCT04749121 |
| NCT04652765 |
Camostat With Bicalutamide for COVID-19 |
https://ClinicalTrials.gov/show/NCT04652765 |
| NCT04652596 |
Reducing Food Insecurity During COVID-19 |
https://ClinicalTrials.gov/show/NCT04652596 |
| NCT04603924 |
Study of Niclosamide in Moderate and Severe Hospitalized Coronavirus-19 (COVID-19) Patients |
https://ClinicalTrials.gov/show/NCT04603924 |
| NCT04591717 |
COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral-COVID-19 in Normal Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT04591717 |
| NCT04581863 |
COVID-19 Watch + COVID-19 Pulse |
https://ClinicalTrials.gov/show/NCT04581863 |
| NCT04579393 |
Fostamatinib for Hospitalized Adults With COVID-19 |
https://ClinicalTrials.gov/show/NCT04579393 |
| NCT04522830 |
A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19 |
https://ClinicalTrials.gov/show/NCT04522830 |
| NCT04521309 |
SARS-CoV-2 Antibodies Based IVIG Therapy for COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04521309 |
| NCT04512079 |
FREEDOM COVID-19 Anticoagulation Strategy |
https://ClinicalTrials.gov/show/NCT04512079 |
| NCT04497987 |
A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Preventing SARS-CoV-2 Infection and COVID-19 in Nursing Home Residents and Staff |
https://ClinicalTrials.gov/show/NCT04497987 |
| NCT04494984 |
A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19. |
https://ClinicalTrials.gov/show/NCT04494984 |
| NCT04490824 |
Inhalation of KELEA Excellerated Water in Covid-19 Infected Individuals |
https://ClinicalTrials.gov/show/NCT04490824 |
| NCT04456595 |
Clinical Trial of Efficacy and Safety of Sinovac’s Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals |
https://ClinicalTrials.gov/show/NCT04456595 |
| NCT04449588 |
Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI/ARDS |
https://ClinicalTrials.gov/show/NCT04449588 |
| NCT04431453 |
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Remdesivir (GS-5734â„¢) in Participants From Birth to < 18 Years of Age With Coronavirus Disease 2019 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04431453 |
| NCT04419610 |
RAS and Coagulopathy in COVID19 |
https://ClinicalTrials.gov/show/NCT04419610 |
| NCT04389294 |
HSS Covid-19 Antibody Serology Among Surgeons & Anesthesiologists |
https://ClinicalTrials.gov/show/NCT04389294 |
| NCT04382586 |
Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants |
https://ClinicalTrials.gov/show/NCT04382586 |
| NCT04363827 |
Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19) |
https://ClinicalTrials.gov/show/NCT04363827 |
| NCT04362813 |
Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia |
https://ClinicalTrials.gov/show/NCT04362813 |
| NCT04357808 |
Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID) |
https://ClinicalTrials.gov/show/NCT04357808 |
| NCT04352959 |
COVID-19: Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses |
https://ClinicalTrials.gov/show/NCT04352959 |
| NCT04336332 |
Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19 |
https://ClinicalTrials.gov/show/NCT04336332 |
| NCT04317040 |
CD24Fc as a Non-antiviral Immunomodulator in COVID-19 Treatment |
https://ClinicalTrials.gov/show/NCT04317040 |
| NCT04655586 |
Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19 |
https://ClinicalTrials.gov/show/NCT04655586 |
| NCT04331600 |
Chloroquine as Antiviral Treatment in Coronavirus Infection 2020 |
https://ClinicalTrials.gov/show/NCT04331600 |
| NCT04296643 |
Medical Masks vs N95 Respirators for COVID-19 |
https://ClinicalTrials.gov/show/NCT04296643 |
| NCT04753645 |
BRAC Institute of Governance and Development-Hygiene Behavioural Change and Coalition |
https://ClinicalTrials.gov/show/NCT04753645 |
| NCT04748536 |
Safety and PK of Repeated Doses of IRL201104 in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT04748536 |
| NCT04750317 |
Efficacy and Safety of Tofacitinib in Patients With COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04750317 |
| NCT04649021 |
Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b2) in Chinese Healthy Population |
https://ClinicalTrials.gov/show/NCT04649021 |
| NCT04723394 |
Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults |
https://ClinicalTrials.gov/show/NCT04723394 |
| NCT04703140 |
COVIDISC: Rapid Diagnostic Tests on Nasopharyngeal Swabs for the Detection of COVID-19 |
https://ClinicalTrials.gov/show/NCT04703140 |
| NCT04640168 |
Adaptive COVID-19 Treatment Trial 4 (ACTT-4) |
https://ClinicalTrials.gov/show/NCT04640168 |
| NCT04638634 |
Pharmacokinetics, Safety, and Tolerability of CSL760, an Intravenous Anti-SARS-CoV-2 Hyperimmune Globulin, in Healthy Adult Subjects |
https://ClinicalTrials.gov/show/NCT04638634 |
| NCT04593940 |
Immune Modulators for Treating COVID-19 |
https://ClinicalTrials.gov/show/NCT04593940 |
| NCT04591210 |
The COVID-RASi Trial (COVID-19) |
https://ClinicalTrials.gov/show/NCT04591210 |
| NCT04546581 |
Inpatient Treatment With Anti-Coronavirus Immunoglobulin (ITAC) |
https://ClinicalTrials.gov/show/NCT04546581 |
| NCT04501978 |
ACTIV-3: Therapeutics for Inpatients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04501978 |
| NCT04530617 |
Camostat and Artemisia Annua vs Placebo in COVID-19 Outpatients |
https://ClinicalTrials.gov/show/NCT04530617 |
| NCT04384965 |
Accelerated iTBS for Depressed Patients During the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04384965 |
| NCT04414293 |
Low Dose Pulmonary Irradiation in Patients With COVID-19 Infection of Bad Prognosis |
https://ClinicalTrials.gov/show/NCT04414293 |
| NCT04322396 |
Proactive Protection With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04322396 |
| NCT04392453 |
Upper Limb Robotic Rehabilitation During COVID-19 Outbreak |
https://ClinicalTrials.gov/show/NCT04392453 |
| NCT04366908 |
Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome |
https://ClinicalTrials.gov/show/NCT04366908 |
| NCT04361448 |
Performance of 3 Sampling Methods for the Detection of SARS-CoV-2 (COVID-19) With Real-time Reverse Transcriptase PCR |
https://ClinicalTrials.gov/show/NCT04361448 |
| NCT04357366 |
suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE) |
https://ClinicalTrials.gov/show/NCT04357366 |
| NCT04349618 |
Ultraprotective Ventilation Without Extracorporeal Circulation During COVID 19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04349618 |
| NCT04312009 |
Losartan for Patients With COVID-19 Requiring Hospitalization |
https://ClinicalTrials.gov/show/NCT04312009 |
| NCT04311177 |
Losartan for Patients With COVID-19 Not Requiring Hospitalization |
https://ClinicalTrials.gov/show/NCT04311177 |
| NCT04760743 |
Safety and Immunogenicity of a SARS-CoV-2 Vaccine (NBP2001) in Healthy Adults (COVID-19) |
https://ClinicalTrials.gov/show/NCT04760743 |
| NCT04760821 |
Prevention of Acute Myocardial Injury by Trimetazidine in Patients Hospitalized for COVID |
https://ClinicalTrials.gov/show/NCT04760821 |
| NCT04758286 |
Anesthetic & Surgical Protocol for Emergency Surgeries During the Era of COVID-19 |
https://ClinicalTrials.gov/show/NCT04758286 |
| NCT04758273 |
A Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19) |
https://ClinicalTrials.gov/show/NCT04758273 |
| NCT04757857 |
COVID Antithrombotic Rivaroxaban Evaluation |
https://ClinicalTrials.gov/show/NCT04757857 |
| NCT04757818 |
Double-blind, Randomized, Parallel, Placebo-controlled Clinical Study to Evaluate the Viral Load of SARS-CoV-2 in the Oral Cavity of SARS-CoV-2 Positive Subjects After the Use of a Mouthwash Containing Cetylpyridinium Chloride 0,07%. |
https://ClinicalTrials.gov/show/NCT04757818 |
| NCT04758962 |
A Study of the Safety of and Immune Response to Varying Doses of a Vaccine Against COVID-19 in Healthy Adults |
https://ClinicalTrials.gov/show/NCT04758962 |
| NCT04756323 |
A Study to Evaluate Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19) |
https://ClinicalTrials.gov/show/NCT04756323 |
| NCT04757298 |
COVID-19 Treatment Cascade Optimization Study |
https://ClinicalTrials.gov/show/NCT04757298 |
| NCT04756466 |
Effect of the Consumption of a Lactobacillus Strain on the Incidence of Covid-19 in the Elderly |
https://ClinicalTrials.gov/show/NCT04756466 |
| NCT04756128 |
Impact of Colchicine and Low-dose Naltrexone on COVID-19 |
https://ClinicalTrials.gov/show/NCT04756128 |
| NCT04756271 |
Safety and Immunogenicity of SARS-Cov-2 Inactivated Vaccine |
https://ClinicalTrials.gov/show/NCT04756271 |
| NCT04749173 |
To Assess the Safety, Tolerability and Pharmacokinetic Properties of Niclosamide Injectable (DWRX2003) Which is the Treatment of COVID-19 in Healthy Volunteers. |
https://ClinicalTrials.gov/show/NCT04749173 |
| NCT04755972 |
Mucolytics in Patients on Invasive Mechanical Ventilation Due to Severe Acute Respiratory Syndrome Coronavirus 2 |
https://ClinicalTrials.gov/show/NCT04755972 |
| NCT04753619 |
Effectiveness of Niclosamide as Add-on Therapy to the Standard of Care Measures in COVID-19 Management |
https://ClinicalTrials.gov/show/NCT04753619 |
| NCT04753476 |
Treatment of Severe COVID-19 Patients Using Secretome of Hypoxia-Mesenchymal Stem Cells in Indonesia |
https://ClinicalTrials.gov/show/NCT04753476 |
| NCT04750759 |
Safety and Preliminary Efficacy of the Combination of Niclosamide and Camostat |
https://ClinicalTrials.gov/show/NCT04750759 |
| NCT04750720 |
Study of the Kinetics of COVID-19 Antibodies for 24 Months in Patients With Confirmed SARS-CoV-2 Infection |
https://ClinicalTrials.gov/show/NCT04750720 |
| NCT04723537 |
Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease |
https://ClinicalTrials.gov/show/NCT04723537 |
| NCT04703608 |
Prevention and Treatment for COVID -19 (Severe Acute Respiratory Syndrome Coronavirus 2 SARS-CoV-2) Associated Severe Pneumonia in the Gambia |
https://ClinicalTrials.gov/show/NCT04703608 |
| NCT04698798 |
Skeletal Muscle Wasting in SARS-CoV-2 |
https://ClinicalTrials.gov/show/NCT04698798 |
| NCT04673292 |
Community Collaboration to Combat COVID-19 (C-FORWARD) |
https://ClinicalTrials.gov/show/NCT04673292 |
| NCT04655625 |
Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19) |
https://ClinicalTrials.gov/show/NCT04655625 |
| NCT04646590 |
A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19 |
https://ClinicalTrials.gov/show/NCT04646590 |
| NCT04649151 |
A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19 |
https://ClinicalTrials.gov/show/NCT04649151 |
| NCT04634409 |
A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness |
https://ClinicalTrials.gov/show/NCT04634409 |
| NCT04644198 |
Convalescent Plasma Transfusion in Severe COVID-19 Patients in Jamaica |
https://ClinicalTrials.gov/show/NCT04644198 |
| NCT04614948 |
A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults |
https://ClinicalTrials.gov/show/NCT04614948 |
| NCT04609462 |
High-Flow Nasal Cannula in Severe COVID-19 With Acute Hypoxemic Respiratory Failure. |
https://ClinicalTrials.gov/show/NCT04609462 |
| NCT04583410 |
Efficacy of Nicotine in Preventing COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04583410 |
| NCT04582344 |
Clinical Trial For SARS-CoV-2 Vaccine (COVID-19) |
https://ClinicalTrials.gov/show/NCT04582344 |
| NCT04540419 |
Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04540419 |
| NCT04540406 |
NBT-NM108 as an Early Treatment of Suspected or Confirmed COVID-19 in Patients With Prediabetes or Type 2 Diabetes |
https://ClinicalTrials.gov/show/NCT04540406 |
| NCT04540120 |
Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome |
https://ClinicalTrials.gov/show/NCT04540120 |
| NCT04517422 |
Efficacy of L. Plantarum and P. Acidilactici in Adults With SARS-CoV-2 and COVID-19 |
https://ClinicalTrials.gov/show/NCT04517422 |
| NCT04530539 |
The Effect of Melatonin and Vitamin C on COVID-19 |
https://ClinicalTrials.gov/show/NCT04530539 |
| NCT04530409 |
Timing of Corticosteroids in COVID-19 |
https://ClinicalTrials.gov/show/NCT04530409 |
| NCT04529525 |
Ivermectin to Prevent Hospitalizations in COVID-19 |
https://ClinicalTrials.gov/show/NCT04529525 |
| NCT04533347 |
Tafenoquine in Patients With Mild to Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04533347 |
| NCT04517162 |
Intramuscular Effect of Polymerized Type I Collagen on the Cytokine Storm in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04517162 |
| NCT04501458 |
Western Kenya Integrated COVID-19 Response |
https://ClinicalTrials.gov/show/NCT04501458 |
| NCT04494646 |
BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04494646 |
| NCT04477668 |
Helmet Non-Invasive Ventilation for COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04477668 |
| NCT04492410 |
COVID-19 Infection Screening in Cancer Patients (NEOSCREENCOVID) |
https://ClinicalTrials.gov/show/NCT04492410 |
| NCT04476953 |
COVID-FISETIN: Pilot in SARS-CoV-2 of Fisetin to Alleviate Dysfunction and Inflammation |
https://ClinicalTrials.gov/show/NCT04476953 |
| NCT04476667 |
Online Delivery of Psychotherapy, Tailored to Patients’ Suffering From Mental Health Problems Due to COVID-19 |
https://ClinicalTrials.gov/show/NCT04476667 |
| NCT04467840 |
Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04467840 |
| NCT04473898 |
Telerehabilitation After Coronavirus |
https://ClinicalTrials.gov/show/NCT04473898 |
| NCT04472585 |
Efficacy of Subcutaneous Ivermectin With or Without Zinc in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04472585 |
| NCT04470427 |
A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19 |
https://ClinicalTrials.gov/show/NCT04470427 |
| NCT04463004 |
Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation |
https://ClinicalTrials.gov/show/NCT04463004 |
| NCT04463849 |
Effects of COVID-19 Infection on Beta-cell Function in Euglycemic Patients |
https://ClinicalTrials.gov/show/NCT04463849 |
| NCT04442178 |
InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I ) |
https://ClinicalTrials.gov/show/NCT04442178 |
| NCT04436276 |
A Study of Ad26.COV2.S in Adults (COVID-19) |
https://ClinicalTrials.gov/show/NCT04436276 |
| NCT04427501 |
A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness |
https://ClinicalTrials.gov/show/NCT04427501 |
| NCT04416048 |
Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19 |
https://ClinicalTrials.gov/show/NCT04416048 |
| NCT04426201 |
InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic Patients With COVID-19 Infection ( ILIAD-7-US-O ) |
https://ClinicalTrials.gov/show/NCT04426201 |
| NCT04421027 |
A Study of Baricitinib (LY3009104) in Participants With COVID-19 |
https://ClinicalTrials.gov/show/NCT04421027 |
| NCT04419025 |
Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease |
https://ClinicalTrials.gov/show/NCT04419025 |
| NCT04414631 |
Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04414631 |
| NCT04412291 |
A Study in Patients With COVID-19 and Respiratory Distress Not Requiring Mechanical Ventilation, to Compare Standard-of-care With Anakinra and Tocilizumab Treatment The Immunomodulation-CoV Assessment (ImmCoVA) Study |
https://ClinicalTrials.gov/show/NCT04412291 |
| NCT04425538 |
A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19). |
https://ClinicalTrials.gov/show/NCT04425538 |
| NCT04389840 |
Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure |
https://ClinicalTrials.gov/show/NCT04389840 |
| NCT04386616 |
A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04386616 |
| NCT04368156 |
Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms |
https://ClinicalTrials.gov/show/NCT04368156 |
| NCT04381377 |
Efficacy and Safety of Polyoxidonium® in Hospitalized Patients With Coronavirus Disease COVID-19 |
https://ClinicalTrials.gov/show/NCT04381377 |
| NCT04380961 |
A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19 |
https://ClinicalTrials.gov/show/NCT04380961 |
| NCT04378920 |
A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other Causes |
https://ClinicalTrials.gov/show/NCT04378920 |
| NCT04377789 |
Effect of Quercetin on Prophylaxis and Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04377789 |
| NCT04377100 |
Impact on Anxiety and Motivation of COVID-19 and Predictors of Individual Responses |
https://ClinicalTrials.gov/show/NCT04377100 |
| NCT04373733 |
Early Intervention in COVID-19: Favipiravir Verses Standard Care |
https://ClinicalTrials.gov/show/NCT04373733 |
| NCT04379076 |
InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection UK Cohort |
https://ClinicalTrials.gov/show/NCT04379076 |
| NCT04364828 |
NGS Diagnostic in COVID-19 Hosts - Genetic Cause Relating to the Course of Disease Progression |
https://ClinicalTrials.gov/show/NCT04364828 |
| NCT04348864 |
COVID-19 Diagnostic Self-testing Using Virtual Point-of-care |
https://ClinicalTrials.gov/show/NCT04348864 |
| NCT04363502 |
Use of the Interleukin-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04363502 |
| NCT04342728 |
Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation |
https://ClinicalTrials.gov/show/NCT04342728 |
| NCT04346615 |
Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen |
https://ClinicalTrials.gov/show/NCT04346615 |
| NCT04338828 |
Nitric Oxide Inhalation Therapy for COVID-19 Infections in the ED |
https://ClinicalTrials.gov/show/NCT04338828 |
| NCT04335201 |
Defibrotide in COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04335201 |
| NCT04338074 |
TXA and Corona Virus 2019 (COVID19) in Outpatients |
https://ClinicalTrials.gov/show/NCT04338074 |
| NCT04331834 |
Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04331834 |
| NCT04331366 |
Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19 |
https://ClinicalTrials.gov/show/NCT04331366 |
| NCT04311697 |
Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure |
https://ClinicalTrials.gov/show/NCT04311697 |
| NCT04328012 |
COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With COVID-19 |
https://ClinicalTrials.gov/show/NCT04328012 |
| NCT04283461 |
Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19) |
https://ClinicalTrials.gov/show/NCT04283461 |
